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ABSTRACT
Ataxia telangiectasia (A-T) is caused by loss-of-function mutations in the 
ATM (Ataxia Telangiectasia mutated) kinase, and represents a paradigm for cancer 
predisposition and neurodegenerative syndromes linked to deficiencies in the DNA-
damage response (DDR). The role of ATM as a key regulator of signalling following 
DNA double-strand breaks (DSBs) has been dissected in extraordinary detail, but the 
impact of this process on DSB repair still remains controversial; while ATM-deficient 
cells and organisms are hypersensitive to DSB-inducing agents, they display only 
subtle repair defects. Here, we develop novel genetic and molecular tools to modulate 
the structure of DSB ends and demonstrate that ATM is indeed required for efficient 
and accurate DSB rejoining, but exclusively when the ends are irreversibly blocked. We 
therefore identify the nature of ATM involvement in DSB repair, presenting blocked 
DNA ends as a possible pathogenic trigger of A-T.
RESUMEN
La Ataxia telangiectasia (A-T) es un síndrome causado por mutaciones de pérdida de 
función en la kinasa ATM (Ataxia Telangiectasia mutated). A-T representa el paradigma 
de los síndromes caracterizados por predisposición a cáncer y neurodegeneración 
asociados a deficiencias en la respuesta a daño en el ADN. La función de dicha proteína 
como regulador principal en la señalización celular en respuesta a roturas de doble cadena 
en el ADN se ha definido en detalle, aunque aún se desconoce el impacto que provoca 
en su reparación. Mientras que la deficiencia de ATM causa una alta sensibilidad a 
agentes que inducen roturas de doble cadena, no se han detectado grandes defectos en 
la reparación de estas lesiones. En esta Tesis se desarrollan nuevos métodos moleculares 
y genéticos para modificar la estructura de los extremos de las roturas de doble cadena 
en el ADN. Mediante estas técnicas se demuestra que ATM es esencial para la correcta 
reparación de roturas de doble cadena, pero exclusivamente cuando los extremos de éstas 
están bloqueados. De esta manera identificamos la función de ATM en la reparación de 
roturas de doble cadena y sugerimos que los extremos bloqueados en el ADN pueden ser 
la causa de la Ataxia-telangiectasia.
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I. INTRODUCTION
1. DNA Damage 
The discovery of DNA as the cellular component responsible for the storage of 
genetic information marks a turning point in the molecular biology field. Initially, DNA 
was considered as a highly stable molecule. However, researchers promptly realised that 
DNA was largely susceptible to spontaneous decay and it frequently suffers damage 
(Lindahl 1993). It is estimated that each cell in the human body suffers tens of thousands 
of lesions per day (De Bont & van Larebeke 2004; Vilenchik & Knudson 2003). To 
overcome this threat, cells have developed complex mechanisms of repair, which efficiently 
revert DNA damage and minimize the adverse outcomes of these lesions (Lindahl & 
Wood 1999; Ciccia & Elledge 2010). Unfortunately, DNA repair is not always efficient, 
and unrepaired damage can accumulate under certain conditions (Altieri et al. 2008). For 
instance, when the DNA repair machinery is impaired, or when tissues confront high 
levels of damage, lesions in the DNA may scape cellular control. In consequence, these 
alterations in the genetic material threaten the correct functioning of cells by causing a 
large number of deleterious outcomes, ranging from mutations and epigenetic changes, 
to gross rearrangement of chromosomes. Eventually, accumulation of DNA damage can 
impair essential functions, leading to uncontrolled cell division, premature cell death and 
aging (Freitas & De Magalhães 2011; Surova & Zhivotovsky 2013; Jackson & Loeb 
2001). Therefore, DNA damage is considered as a key determinant in human disease, 
being a hallmark in cancer, neurodegenerative processes and several congenital syndromes. 
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1.1. DNA Double-strand Breaks  
DNA can suffer different types of damage (Figure 1). On one hand, the chemical 
structure of canonical nucleotides can be altered, either in the ribose or in the nitrogenous 
base. Indeed, we can find a plethora of these modifications; base hydrolysis, oxidation and 
alkylation of nucleotides or bulky adduct formation, pyrimidine dimers or interstrand 
covalent bonds, amongst others (Marnett 2000). On the other hand, the strand continuity 
of the DNA backbone can be interrupted. Within this type of lesion, the most frequent 
are single-strand breaks (SSBs), which are generated when one strand of the double 
helix is broken (Caldecott 2008). Thus, the continuity and structure of the molecule 
is not compromised, since an intact copy is maintained in the complementary strand, 
which is used as template for accurate repair. However, cells face situations in which both 
of the two strands of the helix are broken. Thus, double-strand breaks (DSBs) present 
Figure 1: Types of DNA damage. Different type of lesions can alter DNA structure. 
Alkylation and oxidation of nucleotides, hydrolysis of bases or interstrand crosslink 
and pyrimidine dimers are commonly found. Chemicals can also interact with the DNA 
molecule forming bulky adducts altering DNA structure. Single-strand breaks (SSBs) 
and double-strand breaks (DSBs) interrupt continuity of the DNA backbone.
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a huge threat to cells, since the continuity of the DNA molecule is lost. On top of this, 
cells cannot rely on a complementary strand to directly copy the genetic information, 
increasing the likelihood of mutations.
1.2. DSB repair in mammalian cells
To avoid DSB accumulation, there are two conceptually different ways in which these 
lesions can be repaired: by undergoing the direct ligation of the ends or by using a DNA 
template to copy and restore genetic information. Based on this, the two main pathways 
in mammals are non-homologous end joining (NHEJ) and homologous recombination 
5’
3’ 5’
3’
5’
3’ 5’
3’ 5’
3’
3’
3’
3’
5’
3’
3’
5’
5’
3’
3’
5’
NHEJ HR
5’
3’5’
3’
5’
3’
3’
Figure 2: Pathways for the repair of DSBs in mammalian cells. DSBs are repaired 
by non-homologous end joining (NHEJ) pathway by direct ligation of DNA ends (left). In 
the homologous recombination (HR) pathway (right), DNA ends are resected by 5’ strand 
degradation and newly formed 3’ protruding ends invade a homologous sequence, 
which is used as template for repair.
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(HR), respectively (Thompson 2012). As can be seen in Figure 2, while NHEJ directly 
ligates the ends of a DSB and is active throughout most of the cell cycle, HR requires 
a template to proceed, and preferentially uses sister chromatids which are only available 
during S/G2 cell cycle phases (Rothkamm et al. 2003). NHEJ machinery detects and 
tethers DSB ends, promoting their joining by a final step of ligation. Importantly, it can 
promote repair of numerous types of termini, but the use of homology is always restricted 
to 1-4 base pairs. Conversely, HR-repair requires a first step of resection, which trims the 
DNA-PK
MRN
γH2AX
ATM
KU70/80
MRN
γH2AX
p-Ser139
DNA Damage Response (DDR)
Transcriptional 
regulation
Cell cycle
arrest
DNA repair Apoptosis
p-Ser139
Figure 3: DNA damage response (DDR). DNA double strand-breaks are detected 
by KU70/80 heterodimer and the MRN complex. KU70/80 associated with DNA ends 
recruits DNA-PK catalytic subunit (DNA-PKcs) forming the DNA-PK holoenzyme. This, 
in collaboration with ATM activation triggers the DDR signalling cascade. MRN complex 
collaborate to tether DSB ends and to maintain ATM active in the vicinity of DSBs. 
This leads to H2AX phosphorylation in Ser139 (γH2AX), promoting the recruitment 
of downstream factors. The DDR modulates important cellular functions such as 
transcriptional regulation, cell cycle arrest, repair of the lesion, and apoptosis.
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5’ ends of DSBs to generate large 3’ protruding ends. This single-strand DNA (ssDNA) 
structure is essential for the steps of homology search and strand invasion of the template 
required for HR repair (for an extensive review see Mehte & Haber 2014). Alternatively, 
DSBs can be channelled through a backup pathway called microhomology-mediated end 
joining (MMEJ) (McVey & Lee 2008; Frit et al. 2014). For this, DSB ends are processed 
in a similar manner as in HR resection, but instead of using a homologous template to 
restore genetic information they are directly ligated. However, MMEJ uses larger regions 
of homology (5-25 bp), leading to deletions of the flanking sequence. MMEJ pathway 
is associated with complex chromosomal rearrangements and abnormalities such as 
deletions, inversions and translocations. Nevertheless, to which extent MMEJ pathway 
physiologically contributes to DNA repair and its relevance is still a matter of debate 
(Sfeir & Symington 2015). 
These repair pathways are integrated in the so-called DNA damage response 
(DDR), a network that orchestrates the direct repair of lesions, in coordination with the 
regulation of important cellular processes, such as cell cycle progression, gene transcription, 
and chromosome segregation (Figure 3) (Harper & Elledge 2007). This large-scale 
mechanism is associated with changes at all cellular levels, so a vast number of proteins 
and post-translational modifications are associated with the DDR (Polo & Jackson 
2011). Traditionally, they have been classified in different groups depending on their 
function (Harrison & Haber 2006). There are sensor proteins that efficiently recognize 
specific lesions in DNA. These early factors activate transducer proteins, which in turn 
recruit mediators that exponentially amplify the signal. Eventually, effector proteins have 
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the capacity to carry out the repair of the lesions, activate cell cycle checkpoint, remodel 
the chromatin or interfere with other cellular processes involved. It is worth noting that 
despite general factors are involved in all types of DNA damage, specific proteins are 
also required depending on the nature of the damage and the cellular status. In the 
particular case of DSBs, they are rapidly detected by the KU70/80 heterodimer and 
MRE11-RAD50-NBS1 (MRN) complex; two factors which display great affinity for 
DNA ends (Downs & Jackson 2004; Williams et al. 2007). After DSB recognition, 
DNA-PKcs, ATM and ATR, three kinases of the hosphatidylinositol 3-kinase-related 
kinases (PIKK) family, can be recruited to sites of damage serving as transducers of the 
signal (Falck et al. 2005). Importantly, while DSB induction robustly activates ATM 
and DNA-PKcs, ATR specifically requires ssDNA for its activation (Falck et al. 2005; 
Shiotani & Zou 2009a). For this, ATR is activated when DSBs are resected and ssDNA 
regions are formed, channelling repair toward HR (Shiotani & Zou 2009b). ATR 
activation is not restricted to DSBs, since it is also activated upon replicative stress during 
proliferative stages of the cell cycle, sensing damage in replication forks (Ward & Chen 
2001; Falck et al. 2005; Cimprich & Cortez 2008). Once they are active, ATR and ATM 
are crucial in the regulation of effector proteins such as CHK1, CHK2 and the tumour 
suppressor p53, which are crucial in the arrest of the cell cycle (Rouse & Jackson 2002). 
This allows cells to repair DNA before proceeding to the next stage in the presence of 
damage. Eventually, in the cases in which DNA damage proves to be irreparable, DDR 
participates in triggering apoptosis (Roos & Kaina 2013). This pathway is essential to 
remove potentially dangerous cells from the organism when DNA damage exceeds their 
repair capacity.
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A relevant characteristic of DDR factors is their local accumulation in the 
vicinity of DSBs (Polo & Jackson 2011). Taking advantage of specific antibodies against 
these factors, discrete foci within the nuclei can be observed under the microscope by 
immunofluorescence techniques (Costes et al. 2010). Historically, this approach has 
helped researchers to analyse DSB induction and disappearance in cells and tissues 
under several experimental setups. Specifically, one of the most upstream events in DSB 
signalling is the redundant phosphorylation in Ser139 of histone variant H2AX (known 
as γH2AX), which can be carried out by ATM, ATR and DNA-PKcs (Firsanov et al. 
2011). This post-translational modification has been used as a trustable DSB marker, 
since the amount of DSBs present in a particular cell has been proven to correlate with 
the number of discrete foci observed by immunofluorescence (Figure 4) (Kinner et al. 
γH2AX
DSB p-Ser139
γH2AX immunofluorescence
γH2AX
Figure 4: γH2AX immunofluorescence foci. Post-translational phosphorylation in 
Ser139 of histones H2AX, known as γH2AX, largely expands along megabases flanking 
DSBs. By performing immunofluorescence using γH2AX specific primary antibody and 
fluorochrome-conjugated secondary antibody, discrete foci can be observed under the 
microscope.
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2008; Löbrich et al. 2010). 
Beside its technical application in the study of DSB repair, γH2AX modification 
is physiologically relevant for the DDR. Indeed, this post-translational modification 
extends rapidly along megabases flanking both sides of a break, acting as a scaffold for 
a large number of downstream factors. Amongst them, MRN-complex member NBS1, 
53BP1 and BRCA1 are functionally relevant proteins that form irradiation-induced foci 
(Bekker-Jensen & Mailand 2010; Shroff et al. 2004; Ünal et al. 2004). These factors are 
critical for DSB repair even when they do not posses any enzymatic activity, since their 
recruitment would dictate the preferential repair pathway that will operate in a specific 
lesion (Chapman et al. 2012; Panier & Boulton 2014). The physiological importance 
of the recruitment of DDR factors is supported by a detailed dissection of numerous 
knockout mouse model and cells derived from human patients (Celeste et al. 2002; 
Barlow et al. 1996; Lou et al. 2006). These have unveiled several outcomes of an inefficient 
DDR, such as increased genome instability and hypersensitivity to DSB inducing agents 
(Franco et al. 2006; Craig H Bassing et al. 2002). Moreover, this can lead to infertility 
and immunodeficiency, two processes in which HR and NHEJ pathways have key roles 
respectively. Thus, these observations support the notion that DSB repair and the DDR 
are two closely adjusted mechanisms that rely on a large number of factors, and which 
have to be precisely controlled to avoid deleterious outcomes for cells and organisms. 
1.3. Non-homologous end joining (NHEJ)
In mammalian cells, the NHEJ is the major pathway for the repair of DSBs. 
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Indeed, it has been proven to operate throughout the cell cycle (Rothkamm et al. 2003), 
being specifically relevant during G0/G1, when HR is largely inactive (Huertas et al. 
2008). In addition, it contributes to a significant fraction of DSB repair even during S 
and G2 phases, when HR reaches its maximum activity (Mao et al. 2008). Typical NHEJ 
pathway can be divided into different steps (Figure 5) (Davis & Chen 2013). First of all, 
DSBs are efficiently recognized by the ring-shaped heterodimer formed by KU70 and 
KU80. Then, DSB ends are bridged and stabilized when DNA-PKcs is recruited to form 
the DNA-PK complex. This promotes the inward translocation of the KU70/80 ring 
and DNA-PKcs kinase becomes active, phosphorylating itself and other downstream 
factors.  The exact role that DNA-PKcs phosphorylation cascade plays in NHEJ is still 
a matter of debate, but DNA-PKcs autophosphorylation seems to be a required step 
DNA-PK
1)
2)
3)
KU70/80
LIG4
XRCC4/XLF XRCC4/XLF
4)
Figure 5: The Non-homologous end joining (NHEJ) pathway. First, DSBs are 
recognized by the ring-shaped KU70/80 heterodimer. DNA-PK catalytic subunit (DNA-
PKcs) is recruited and activated, translocating KU70/80 ring inward the break. This 
forms the DNA-PK holoenzyme that phosphorylates several downstream factors. 
Finally, DNA-PK suffers conformational changes allowing XRCC4/XLF filament to form 
and the recruitment of Ligase IV, which ligates DNA ends.
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for NHEJ to proceed (Lees-Miller & Meek 2003). Finally, helped by accessory factors 
such as XLF/Cernunnos, XRCC4 and PAXX proteins, DNA Ligase IV is recruited to 
catalyse the ligation of the (Mahaney et al. 2012; Ochi et al. 2015), how NHEJ factors 
disengage when DSB repair is completed or ligation is unfeasible is still unknown. It has 
been proposed that KU80 is polyubiquitilated and degraded by the proteasome to release 
the ring from the rejoined DNA molecule (Postow 2011; Feng & Chen 2012). However, 
recent work has described that p97/VCP can promote structural changes in KU70/80 to 
release the ring from DNA (van den Boom et al. 2016) 
Importantly, the precise chemical structure that terminal nucleotides of DSBs 
display are highly influential for NHEJ, since DNA Ligase IV enzyme requires 
compatible ends harbouring a 5’ phosphate and a 3’  hydroxyl groups for its activity 
(Lindahl & Barnes 1992). Thus, when DSB termini display aberrant structures that 
block DSB ends, they cannot be directly joined (Povirk 2012). There are to ways in which 
this can be bypassed (Figure 6). First, cells posses enzymatic activities that can directly 
convert these structures into ligatable ends. This does not compromise the nucleotide 
sequence, and we have termed this process as unblocking. Conversely, a more general 
pathway called processing can remove chemical modifications from DSB termini by 
nucleotide trimming. Beside the specific chemical structure, NHEJ is also influenced 
by the compatibility between DSB ends. Indeed, it is highly efficient in the rejoining of 
DSB ends with complementary ssDNA overhangs, but it can also proceed with DSBs 
harbouring incompatible overhangs and blunt ends (Smith et al. 2001; Raghavan & 
Raman 2004; Gu et al. 2007). For this, NHEJ accessory proteins carry out end processing 
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until ligatable termini are generated (Strande et al. 2012). Thus, single-stranded overhangs 
and blunt ends can be trimmed by nucleases, and ssDNA gaps that are newly formed 
can be filled by DNA polymerases (Budman et al. 2007). In this regard, the nuclease 
Artemis and Polymerases μ and λ have been demonstrated to contribute to the efficiency 
of NHEJ (Riballo et al. 2004; Ramsden 2011; Malyarchuk et al. 2013). Interestingly, 
biochemical characterization of Artemis has revealed different enzymatic activities that 
can support DSB end unblocking and processing, such as 5’-3’ exonuclease activity on 
single-stranded DNA and endonuclease activity in the ssDNA/dsDNA junction of 
single-strand overhangs (Chang & Lieber 2016). 
5’
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3’ 5’
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Figure 6: Unblocking and processing of DSBs. Unblocking pathways directly convert 
ends into 5’ phosphate and 3’ hydroxyl but the nucleotide sequence remains intact, 
promoting error-free repair (left). Processing can also facilitate blocked DSBs repair 
by removing aberrant structures from DNA ends by nucleotide trimming (right). This 
pathway can lead to error-prone repair when non-templated repair pathways such as 
NHEJ or MMEJ are used.
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1.4. Relevance of DSB end structure
As mentioned above, DSB repair mechanisms are conditioned by the chemical 
structure that DNA molecules present at their termini. Thus, if a DSB harbours clean 
ends, which are 5’ phosphate (5’ Pho) and 3’ hydroxyl (5’ OH), in theory, they can be 
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3’
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5’ phosphotyrosine
hairpin
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PNKP
PNKP
Artemis
Aprataxin
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Figure 7: Structure of DNA ends and unblocking enzymes. DSB termini can be 
blocked by numerous chemical structures in vivo. Several unblocking enzymes are 
present in mammalian cells and efficiently convert these structures in clean 5’ phosphate 
and 3’ hydroxyl DSB termini (left). These clean DSBs can be in theory, directly repaired 
with the only enzymatic activity of a ligase (right).
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rejoined with the only enzymatic activity of a ligase (Figure 7). In contrast to clean 
DSBs, there are some situations in which cells can encounter blocked DSBs harbouring 
aberrant structures at their ends (Povirk 2012). Indeed, a large number of different 
chemical structures have been described to impede efficient repair. Thus, as advanced 
previously, cells rely on two alternative pathways that can convert blocked ends into 
clean termini before they can be ligated). First of all, cells count on a wide variety of 
unblocking enzymes that directly catalyse the removal of specific aberrant structures 
from ends (Strande et al. 2012). Thus, each type of structure can count with one or several 
dedicated enzymatic activities to modify a particular type of blocked DSB. Importantly, 
the unblocking process does not compromise the nucleotide sequence. In contrast to 
this situation, when cells do not possess unblocking enzymes for a specific structure, 
DSBs have to be processed by nucleotide trimming upstream of the ends (Figure 6). 
If a non-templated repair pathway such as NHEJ is used, processing could lead to 
mutations and gain or loss of nucleotides in the joining site. Thus, unblocking activities 
are remarkably important when DSBs are channelled through NHEJ-dependent repair. 
Consistently, there are a vast number of unblocking enzymes that have been linked to 
DSB repair, including TDP1, TDP2, PNKP, Aprataxin, Ku and Artemis (Figure 6). 
Each of these factors efficiently detects and removes specific chemical blockages in 
DNA ends, facilitating DSB repair by NHEJ. Nonetheless, in contrast to NHEJ, HR 
invariably requires processing of 5’ strand to generate resected 3’ ends (Huertas 2010). 
Thus, blockages in the 5’ termini have negligible impact on this pathway (Liao et al. 
2016). 
14
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2. Sources of DNA Double-strand Breaks
It is estimated that an average human cell suffers around ten DSBs per day. The 
incidence of this type of damage in the DNA is largely minor if compared with other 
type of lesions. However, due to the great impact that DSBs display on cellular and 
physiological homeostasis is key to understand how they arise during human life. It is 
important to mention that despite DSBs being considered a serious threat for human 
physiology, there are crucial physiological processes such as gametogenesis and lymphocyte 
development that directly rely on the induction of endogenously programmed DSB for 
their correct function (Lam & Keeney 2015; Bednarski & Sleckman 2012; Stavnezer et 
al. 2008). Thus, in these special cases, organisms must activate enzymes that induce DSBs 
in a controlled environment. In addition to this, there are other multiple factors that can 
increase the incidental induction of DSBs (Mills et al. 2003).
2.1. Programmed DNA Double-strand Breaks
Gametogenesis generates haploid cells that are ready to form offspring. During this 
process, meiotic recombination is essential to increases genetic variation in populations 
and to ensure the efficient segregation of chromosomes (Baudat et al. 2013). For this, 
during prophase I stage of meiosis, homologous chromosomes associate forming 
a tetrad or bivalent, composed by four chromatids. Then, a precise number of DSBs 
are induced by the SPO11 recombinase in random sites along chromosomes. These 
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are blocked DSBs, since SPO11 protein remains covalently bound to the 5’ termini of 
the DNA. Importantly, these lesions are channelled through a HR-dependent repair 
(Lam & Keeney 2015). For this, DSBs are resected and 3’ protruding ends can invade 
homologous chromosomes that are in close proximity in the bivalent. This mechanism is 
key for meiotic recombination, since HR can be modulated to favour the formation of 
crossovers, which facilitates proper chromosome segregation and eventually promotes the 
interchange of genetic information between different parental chromosomes, generating 
unique combinations of gametes (Longhese et al. 2009). Consistently, human syndromes 
that are caused by mutations in genes involved in HR repair may display infertility, and 
polymorphisms in DSB repair genes carried by healthy individuals have been associated 
with impaired fertility (Cooke & Saunders 2002; Ji et al. 2013).
Another example of programmed DSBs in mammals is the induction of cleavage 
during T and B lymphocyte development. Induction of DSBs and their repair account 
for the highly diverse repertoire of immunoglobulins (Igs) and T cell receptors (TCR) 
that supports diversification of immune cells to recognize and adapt to new pathogens 
(Schatz & Swanson 2011). There are two different mechanisms in which programmed 
DSBs are induced, the rearrangement of TCR and Igs by V(D)J recombination in 
immature lymphocytes (Craig H. Bassing et al. 2002), and the isotype switching of the 
constant region of Igs in mature activated B-cells, induced by class switch recombination 
(CSR) (Stavnezer et al. 2008). In similar ways, both processes require DSB induction 
and a proficient NHEJ pathway for its completion. In fact, defects in c-NHEJ efficiency 
or a decrease in its accuracy, lead to immunodeficiency and/or lymphoma predisposition, 
16
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Figure 8: V(D)J recombination during lymphocyte maturation. A) T-cell receptor 
and Immunoglobulin genes contain arrays of different V, D and J coding segments, 
flanked by recombination signal sequences (RSS). B) RAG1/2 recombinase recognizes 
two different RSS sequences amongst the V, D or J segments. C) It brings genomic 
regions together forming the synaptic cleavage complex. D) It promotes DNA cleavage 
in each RSS, forming two DSBs. Each of them is formed by a hairpin structure in the 
coding end, and a blunt-end in the signal end. E) NHEJ pathway joins the two blunt-ends 
forming a circular extrachromosomal signal joint. Artemis endonuclease catalyzes the 
opening of the hairpin-ends, licensing them for NHEJ repair. This results in a lymphocyte 
precursor with a specific combination of single V, D and J regions rearranged together.
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respectively (Bassing & Alt 2004). T cell receptor (TCR) or Immoglobulin (Ig) genes 
contain an array conformed by several different coding variable (V), diversity (D) and 
joining ( J) segments, which are flanked by recombination signal sequences (RSS). In 
early stages of T and B lymphocyte maturation, V(D)J recombination rearranges a single 
combination of V, J, and in some cases, D segments in a random fashion (Craig H. 
Bassing et al. 2002; Zhang & Swanson 2008). At the molecular level, the mechanism that 
underlies V(D)J recombination is highly complex, but extensive multidisciplinary studies 
have been performed along decades to elucidate the steps involved (for an extensive 
review see (Craig H. Bassing et al. 2002)). To initiate the process RAG1/2 recombinase 
recognizes RSS sites adjacent to a pair of coding segments (Figure 8) (Schatz & 
Swanson 2011). Then, it brings these chromosomal sites together forming what is called 
the synaptic complex, and eventually promotes the cleavage of the DNA precisely in the 
RSS sequence. Due to its special catalytic mechanism, RAG1/2 recombinase generates 
two DBS, and each of them is formed by a hairpin-end, adjacent to the coding segment, 
and a blunt end, adjacent to the RSS site (McBlane et al. 1995). Therefore, two types of 
DSBs are induced, two blunt and clean ends and two blocked by a hairpin structure. The 
two blunt ends are joined together by core NHEJ machinery (KU70/80, DNA-PKcs, 
XLF, XRCC4 and DNA Ligase IV). This yields what is known as signal joints, forming 
extrachromosomal circles of RSS sequences ligated. The two hairpin-ends remaining 
are ligated together to form what is known as the coding join. In addition to c-NHEJ, 
repair of coding ends requires a previous step of hairpin opening.  This is carried out 
by the endonuclease Artemis, which beyond its general role in processing can act as 
an unblocking enzyme for this type of DSBs (Kurosawa & Adachi 2010; Moshous et 
18
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al. 2001). Thus, upon DNA repair by NHEJ, two different coding sequences out of the 
multiple possibilities are joined. Importantly, Artemis does not cleave at the hairpin-apex 
(Chang & Lieber 2016). Due to this, it generates overhangs in which nucleotides are 
added by terminal nucleotide transferase (TdT) and DNA polymerases μ and λ (Thai & 
Kearney 2005; Weill & Reynaud 2008). This step is key to introduce sequence variations 
that will be eventually transcribed and translated in the final protein product, resulting 
in the large variability in antigen-binding domains of Igs and TCRs (Gauss & Lieber 
1996). 
2.2. Incidental DNA Double-strand Breaks
Beside programmed physiological processes, there are numerous ways in which 
DSBs may arise in cells (Mills et al. 2003). They can be induced either by exogenous or 
endogenous sources. Probably, for its importance for cancer treatment and the study of 
DNA repair, ionizing radiation (IR) has been the paradigm of an exogenous source of 
DSBs. When IR passes through cells, it modifies the chemical structure of the molecules 
by inducing intermediary radical ions, free radicals and excited states. This affects several 
cellular components, such as lipid membranes, proteins, nucleic acids, etc. Nevertheless, 
due to the importance for cellular homeostasis, DNA molecule is especially vulnerable. IR 
induces multiple types of DNA damage, such as nucleotide modifications, SSB and DSBs, 
leading to oncogenic mutations and cell death (Ward 1988). However, due to its capacity 
to promote cell death specifically in highly proliferating cells, low energy radiation such 
as X- or γ-rays, are commonly used in radiotherapy for cancer treatment. There are other 
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types of radiation that present higher energy deposition rates, which is termed high LET 
(Linear Energy Transfer). For instance, α-particles present in outer space or produced by 
radon gas and uranium238 emitters are high LET. This type of radiation induces a larger 
number of complex and clustered damage in the DNA molecule, displaying a higher 
number of mutations and increasing its oncogenic potential (Hada & Georgakilas 2008). 
It is worth mentioning that DSBs induced by IR are largely heterogeneous. Terminal 
nucleotides can harbour a plethora of aberrant structures that differs from the canonical 
nucleotides, and clustered lesions can be present near DNA ends. The likelihood of the 
induction of more complex or blocked DSBs precisely correlates with increasing LET. 
On top of this, IR-induced DSBs can contain 5’ overhang, 3’ overhang, and rarely blunt 
ends. Besides IR, there are other important exogenous sources of DSB induction, such as 
the exposure to chemicals that directly interfere with the DNA molecule, or the presence 
of enzymes with endonuclease activity, such as restriction enzymes. In addition, agents 
that normally induce SSBs can produce DSBs when two of these lesions arise in close 
proximity in a random manner.
Endogenous processes also contribute in a large extent to the cellular formation 
of DSBs. For instance, DNA replication can indirectly generate DSBs when it proceeds 
through SSB lesions (Kuzminov 2001; Cortés-Ledesma & Aguilera 2006).  Therefore, 
there are important factors that largely contribute to SSB induction, and indirectly to 
DSB formation, such as the oxidative attack of reactive oxygen species (ROS) to the 
DNA molecule, or the abortive action of Topoisomerase 1. It is estimated that amongst 
the large number of SSB that are accumulated in human cells, at least 1% scape cellular 
20
INTRODUCTION  
control, being converted in DSBs in each cell division (Vilenchik & Knudson 2003). 
Additionally, other endogenous enzymatic activities that are key for DNA metabolism 
and cellular function present a direct source of DSB induction. Indeed, the catalytic 
action of topoisomerase 2 (TOP2) requires the cleavage of both strands of the double 
helix to promote topological changes. In normal conditions, the resealing of the cleavage 
is largely favoured. However, in certain situations, such as the presence of nearby DNA 
lesions, or the exposure to specific chemical agents, topoisomerase 2 normal activity is 
impaired and it can lead to the induction of DSBs (Deweese & Osheroff 2009). Since 
TOP2 abortive action is of the utmost importance to our work, this process will be 
dissected in detail. 
3. DNA Topoisomerases
DNA in its relaxed state assumes the B conformation; a right-handed helix in 
which each turn is 34 Å and it is formed by 10 base pairs (Richmond & Davey 2003). If 
stretched out, the 3 billions base pairs (bp) contained in each human cell would measure 
approximately two meters long. Since it has to be packed within the cellular nucleus, an 
intricate compartment of just around 6 μm of diameter, DNA has to wind tightly around 
histones and adopt different topological states (Cavalli & Misteli 2013). Furthermore, 
when DNA is subject to metabolic processes such as replication, transcription and 
chromosomal segregation, it suffers torsional stress or supercoiling, and it can usually 
be found tangled, knotted and catenated (Gilbert & Allan 2014). These constraints 
are normally removed by topoisomerases, enzymes that allow changes of topology by 
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inducing transient cleavages in the DNA (for an extensive review see (Pommier et al. 
2016). Indeed, topoisomerases are essential proteins that have been found in every form 
of life studied to date. Chemically, their catalytic activity is based on a nucleophilic 
attack performed by an oxygen molecule of a tyrosine residue, which cleaves DNA in 
the phosphate backbone. Importantly, this phosphate group remains transiently attached 
to the catalytic tyrosine of the protein by a covalent phosphotyrosine bond, and this is 
used to allow DNA topology to be conveniently changed. Based on the structure and 
their mechanism of action, they can be classified into type I and II, and each of them in 
subfamilies A and B.  While type I topoisomerases cleave only one strand of the DNA, 
type II requires ATP hydrolysis to promote the transport of an intact DNA molecule 
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Figure 9: Main topoisomerase activities in mammals. Topoisomerase 1 (TOP1) 
introduces a cleavage in a single strand of the double helix, allowing DNA to rotate along 
its axis. TOP1 remains covalently bound to the 3’ end of the DNA by its catalytic tyrosine 
(left). Topoisomerase 2 (TOP2) homodimer induces the simultaneous cleavage of both 
strands of the double helix. The gap formed is used to pass another segment of DNA. 
TOP2 remains covalently bound to 5’ DNA ends by the catalytic tyrosine residues (right).
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through a cleavage induced in both strands of another segment of DNA (Figure 9). Type 
IA topoisomerases display specific cleaving polarity, remaining attached to the 5’ end 
of the DNA, while type IB remain bound to 3’ ends. In the case of type IIA and IIB, 
they also display 5’ cleaving polarity, these subfamilies being differentiated by structural 
considerations.
Humans express several different topoisomerases, which carry out specific tasks 
during a large range of physiological processes, such as replication, transcription, 
chromosomal segregation and DNA repair. Representative members of the different 
families are TOP3α and TOP3β (type IA), TOP1 and mitochrondrial TOP1 (type IB) 
and two isoforms of type IIA topoisomerases, α and β (termed TOP2A and TOP2B). 
To point out the importance of these enzymes, deletions of any of their orthologous in 
rodents lead to lethality. Indeed, homozygous mutations in Top1, Top2a, and Top3a genes 
lead to defects in early stages of embryo development, and Top2b and Top3b mutant mice 
die shortly after birth (Morham et al. 1996; St. Pierre et al. 2002; Yang et al. 2000; Kwan 
& Wang 2001; Li & Wang 1998)
TOP2A and TOP2B share many similarities but they have separate nuclear 
functions. While TOP2A is essential for cell proliferation and it is almost absent in 
differentiated cells, TOP2B activity is important for the removal of topological constraints 
generated by the RNA polymerase machinery (Pommier et al. 2016). TOP2B is essential 
for neural differentiation and brain development. Increasing evidences suggest that 
TOP2B has alternative specific roles. TOP2B has been shown to regulate transcriptional 
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status of precise genes controlled by different stimuli. In this regard, its activity has been 
linked to the transcriptional regulation in response to hormones, such as estrogen and 
androgen (Haffner et al. 2010; Bong-Gun et al. 2006). Moreover, it has been described 
that TOP2B activity controls early response gene expression, which are key for synapse 
formation, neurite outgrowth and the maintenance of the balance between excitatory 
and inhibitory synapses in the adult central nervous system (Madabhushi et al. 2015).
3.1. Topoisomerase 2 and DNA Double-strand Breaks
Due to the singularities of type II topoisomerases, which cleave simultaneously 
in both strands of the double helix, their activity has been considered as a double-edged 
sword (Nitiss 2009). Thus, TOP2 catalytic cycle is a tightly regulated process. First of 
all, a TOP2 homodimer interacts with an intact region of DNA and then, it captures 
another DNA segment (Figure 10). TOP2 catalytic sites induce the simultaneous 
cleavage of both strands of the double helix in the first DNA molecule. The gap created 
is used to pass the previously captured DNA segment through, and after this transaction, 
TOP2 ensures the correct joining of the cleavage by religating DNA ends and releases 
the transported segment. Therefore, through this mechanism DNA molecules can be 
untangled, unknotted and decatenated. If the two segments of DNA involved in the 
process belong to the same molecule, this process also allows removal of supercoiling. 
Importantly, there is a crucial intermediate during this catalytic cycle termed the 
cleavage complex (TOP2cc), in which DNA is cleaved in both strands and each subunit of 
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TOP2 is covalently linked to the 5’ phosphate ends by the catalytic tyrosine. The cleavage 
complex is normally a short-term intermediate, since the topoisomerase rapidly joins the 
ends as the DNA segment has been passed through the gap. However, the exposure to 
chemicals known as TOP2-poisons, or the presence of nearby lesions in the DNA, can 
stabilize TOP2cc (Deweese & Osheroff 2009). These intermediates are considered an 
obstacle for DNA metabolism, since as long as the protein remains covalently attached 
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Figure 10: Catalytic cycle of Topoisomerase 2. TOP2 homodimer interacts with an 
intact DNA molecule and captures another segment. Then, it promotes the cleavage 
of both strands of the double-helix forming the cleavage complex (TOP2cc), in which 
each subunit of TOP2 is covalently linked to 5′ phosphate ends by the catalytic tyrosine 
residues. The gap created is used to pass through the captured DNA segment. Finally, 
TOP2 ensures the religation of the cleavage and the other fragment is released. TOP2-
poisons can stabilize the TOP2cc state.
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to the DNA molecule, genetic information cannot be accessed properly. Thus, if the 
transcription machinery and replication forks encounter a cleavage complex, TOP2 
protein is signalled for degradation by the 26S proteasome (Zhang et al. 2006) (Figure 
11). This leads to disassembly of the TOP2 homodimer, and in consequence a DSB is 
newly formed. It is important to remark that if TOP2-poison is removed before TOP2 
degradation proceeds, TOP2cc reverts and the enzyme can continue with its normal 
catalytic cycle. However, once that a DSB is in fact produced after TOP2 degradation, 
it is detected and signalled by the DNA damage response machinery. Transcription-
generated DSBs are more dependent on the proteasome for DDR signalling. In any 
case, DDR signalling cascade proceeds in an indistinguishable manner compared to 
DSB induced by IR or other known damaging agent (Sunter et al. 2010). Therefore, 
γH2AX histone modification expands in the regions adjacent to the lesion. Nevertheless, 
TOP2-induced DSBs are intrinsically different in structure, since they are characterised 
by harbouring a peptide adduct resulting of the proteosomal degradation of TOP2, 
which is covalently bound to each 5’ end of the DNA by a tyrosyl-phosphodiester bond. 
Therefore, they are considered blocked DSBs, and in consequence unblocking by a 5’ 
tyrosyl-DNA-phosphodiesterase (5’ TDP) activity or end processing must take place to 
ensure the repair of these lesions. 
It is worth noting that the amount of DSBs induced by TOP2 poisons depends 
on its activity, which is extremely high in proliferative cells (Heck et al. 1988). Based on 
this, TOP2-poisons have been commonly used as antineoplastic drugs in the treatment 
of a broad range of tumours, including malignant lymphomas, sarcomas, leukemias, and 
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lung, ovarian, breast and testicular cancers (Pommier et al. 2010).  However, similarly 
to other chemotherapeutic agents, TOP2-targeting drugs are only partially selective for 
tumour cells, resulting in unwanted toxicity in normal tissues. Thus, therapy-associated 
chromosome translocations linked to secondary leukemias have been described as a 
consequence of TOP2 induced DSB by these chemotherapeutical agents (Pendleton et 
al. 2014). Consistently, breakpoints in some of these translocations have been correlated 
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Figure 11: Induction of DSBs by the abortive activity of Topoisomerase 2. If on-
going replication or transcription encounters a TOP2cc, TOP2 homodimer is signalled 
and degraded by the 26S proteasome. Degradation of TOP2cc leads to the formation of 
a irreversible DSB characterized by peptide adducts covalently bound to 5’ DNA ends 
by a phosphotyrosine bond, which lead to the activation of the DNA damage response. 
TDP2 promotes the unblocking of 5’ phosphotyrosines, converting them into clean 5’ 
phosphate and 3’ hydroxyl DSBs. 
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with preferential sites of TOP2 activity (Lovett et al. 2001). Therefore, the study of the 
molecular mechanism underlying TOP2 activity and the repair of DSBs induced by its 
abortive action is essential, not just for the understanding of cellular mechanisms, but 
also for important issues in human health. 
Amongst the large number of TOP2-poisons that have been developed up to 
date, we can find etoposide (VP-16), teniposide (VM-26), and DNA intercalators such 
as doxorubicin and amsacrine (m-AMSA). These molecules inhibit DNA religation 
step of TOP2 catalytic cycle, after TOP2cc is formed. Additionally, other molecules 
such as quinolones, ellipticines, azatoxins, and the natural flavonoid genistein increase 
the likelihood of the formation of TOP2cc (Pommier et al. 2010). Remarkably, beside 
their clinical relevance in cancer treatment, these molecules have been widely used as 
DSB inducing agents in the study of DNA repair, since they have demonstrated a high 
capacity to induce breakage. Due to its specificity, fast kinetics in TOP2cc induction and 
solubility, etoposide has been probably the most used TOP2-poison in the DNA repair 
field up to date. Nevertheless, it is worth mentioning that on top of DSBs, etoposide has 
been described to generate SSBs (Muslimovic et al. 2011). 
3.2. Tyrosyl-DNA-phosphodiesterase 2 (TDP2)
The enzyme Tyrosyl-DNA-phosphodiesterase 1 (TDP1), a member 
of the Phospholipase D family, was described to remove 3’-phosphotyrosines, 
3’-phosphoglycolates and 3’-nucleosides from SSB termini (Connelly & Leach 2004). 
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TDP1 activity has been shown to account for the repair of TOP1-induced damage, 
since degradation of TOP1 cleavage complexes generates SSBs characterized by 3’ 
phosphotyrosines. Moreover, TOP1 activity can also induce DSB preferentially during 
S-phase, since DNA replication machinery converts 3’ blocked SSBs into DSBs. Under 
this condition, TDP1 has been proposed to promote efficient NHEJ of 3’ phosphotyrosine 
blocked DSBs (Heo et al. 2015). Moreover, 5’ TDP activity was described in Sacharomyces 
cerevisae TDP1 ortholog and human TDP1 overexpression conferred cellular resistance 
upon etoposide exposure, suggesting a possible role of TDP1 in the repair of TOP2-
induced damage. However, mammalian TDP1 showed a marked preferential polarity 
in 3’ over 5’ phosphotyrosines (Nitiss et al. 2006). Thus, whether TDP1 activity was 
physiologically relevant for the repair of TOP2-induced damage remained unclear. In 
2009, a genetic screening revealed Tyrosyl-DNA-phosphodiesterase 2 (TDP2) as a 
novel human enzyme that displayed a clear 5’ tyrosyl-DNA-phosphodiesterase activity. 
Consistently, the conversion of 5’-phosphotyrosyl DSB substrates into 5’-phosphate 
termini by cellular extracts, totally relied on the presence of TDP2 protein (Cortés-
Ledesma et al. 2009). For this, TDP2 was proposed as the only physiologically relevant 
human enzyme capable of unblock TOP2-induced DSBs. 
TDP2 is a protein of 47 kDa that belongs to Mg2+/Mn2+-dependent family of 
phosphodiesterases, and it seems to have appeared in higher eukariotes, since no yeast 
ortholog has been found. It has been proposed that TDP2 is a multitask protein, and 
its functions might go beyond DNA repair (Chunyang Li et al. 2011). Indeed, before 
its enzymatic activity was identified, TDP2 was known as TTRAP (TRAF and TNF 
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receptor-associated protein) (Xu et al. 2008; Zhou et al. 2013). Thus, it had been suggested 
that TDP2 could interfere with cell survival and immune response by inhibiting NFκB 
activation. Simultaneously, TDP2 was also named EAPII (ETS1-Associated Protein 
II) since it was identified as an interactor of ETS1, a transcription factor linked with 
tumorigenesis and metastasis (Pei et al. 2003; C. Li et al. 2011). Finally, TDP2 has 
been linked to viral infection by several independent laboratories. On one hand, TDP2 
has been reported to interact with HIV-1 integrase, which facilitates viral integration 
(Zhang et al. 2009). If this function of TDP2 relies on its enzymatic activity remains 
unclear. In the other hand, TDP2 activity has been described to impact on hepatitis 
B persistent reservoirs, by allowing the formation of closed circle circularization of 
the viral genome after the removal of the P protein, which is covalently attached by 
a tyrosyl-phosphodiester bond (Königer et al. 2014). In a similar manner, TDP2 has 
been identified as the responsible for the removal of the small viral protein (VPg) from 
picornavirus RNA genome (Virgen-slane et al. 2012). This enzymatic activity, termed 
VPg unlinkase, is essential during viral replication for the removal of VPg cap, which is 
covalently attached to the 5’-end of the viral genomic RNA via a phosphotyrosyl bond. 
In any case, the repair of TOP2-induced DSBs seems to be the leading function of 
TDP2, and extensive work has been performed at the cellular level to unveil its mechanism 
of action (Zeng et al. 2011; Gómez-Herreros et al. 2013; Ledesma et al. 2009; Gómez-
Herreros et al. 2014). In early experiments, TDP2 activity has been demonstrated to 
account for the unblocking of 5’ phosphotyrosines harboured by dsDNA using cellular 
extracts. In addition, purified recombinant TDP2 has shown to display 5’ tyrosyl-DNA-
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phosphodiesterase activity even at low protein concentrations. Consistently with these in 
vitro results, TDP2 has been described to facilitate the efficient repair of TOP2-induced 
DSBs in human and avian cells, preventing them from their deleterious consequences 
(Ledesma et al. 2009; Zeng et al. 2011; Gómez-Herreros et al. 2014). TDP2-depleted 
A539 human cell line and TDP2–deficient DT40 avian cells have been shown to be 
hypersensitive to TOP2-poison exposure, showing a negligible effect upon other DSB 
inducing agents, such as ionizing radiation and methylmethane sulphonate (Gómez-
Herreros et al. 2013; Zeng et al. 2011; Ledesma et al. 2009). Based on the epistatic relation 
between KU70 deletion over TDP2 deficiency in promoting survival upon etoposide 
exposure, it has been suggested that TDP2 participates in the NHEJ repair pathway 
(Gómez-Herreros et al. 2013). In addition to the cellular characterization, structural and 
biochemical details of TDP2 enzymatic activity have been precisely described in recent 
work (Schellenberg et al. 2012; Shi et al. 2012). Moreover, to address the physiological 
implications of TDP2 deficiency in the entire organism, a mouse model has been 
developed (Gómez-Herreros et al. 2013). Tdp2-/- mice are born in mendelian proportions 
and lack any gross spontaneous phenotype. Nonetheless, TDP2-deficient mice show 
a marked hypersensitivity upon etoposide injections, displaying lymphoid toxicity, 
intestinal damage, and increased genome instability in the bone marrow compared to 
wild-type mice.
Homozygous mutations in TDP2 have been described to be the cause of 
a newly identified cogenital syndrome, characterised by diverse neural defects 
encompassing mental disability, seizures and ataxia (Gómez-Herreros et al. 2014). 
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Blood extracts prepared from these patients showed a total absence of 5’ TDP activity, 
and lymphoblastoid cells displayed DSB repair deficiency and hypersensitivity upon 
etoposide exposure. Importantly, TDP2 absence has been proposed to impacts on 
TOP2-dependent transcriptional regulation. Consistently, depletion of TDP2 in human 
cellular model deregulates the expression of androgen-receptor target genes, which are 
normally regulated by TOP2 activity. Moreover, brains obtained from the TDP2 mouse 
model displayed transcriptional deregulation, particularly in a set of genes that are 
crucial for neural development and maintenance, a subset of which depend on TOP2B. 
However, the impact of TDP2 loss on rodent central nervous system is largely minor 
when compared to human. Nonetheless, taking these observations altogether, TDP2 
activity seems to contribute to the efficient TOP2-dependent transcriptional regulation 
in mammals. Thus, TDP2 can be considered a crucial factor in human physiology, but the 
extent of its implication would require further investigation. 
4. Double-strand Break Repair and Human Health
DSBs are one of the most dangerous types of lesions that can arise in DNA. 
Thus, considering the large number of physiological processes in which DSBs are 
involved, it is not surprising that when repair is suboptimal, it can directly leads to 
severe biological consequences such as sporadic cancer incidence, neurodegeneration and 
aging (Vilenchik & Knudson 2003; Jeppesen et al. 2011). In fact, if just a single DSB 
remains unrepaired, it can lead to cell death and apoptosis, being determinant in tissue 
homeostasis. For instance, considering that the human brain contains billions of neurons, 
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neural development requires high rates of cellular proliferation to achieve an adequate 
cellular mass. During this phase, cells are particularly sensitive to DSBs. If a high number 
of these cells present unrepaired breaks, massive cell loss leads to developmental delay 
or failures (Reynolds & Stewart 2013). In a similar manner, if significant cell loss due 
to unrepaired DNA damage occurs in adult tissues with low self-renewal capacity, cells 
are not efficiently substituted. Consistently, cell death due to unrepaired DNA damage 
in adult central nervous system (CNS) has been proven to be a hallmark of several 
neurodegenerative processes ( Jeppesen et al. 2011).
On top of this, if DBSs are not repaired properly, it increases the probability 
to generate mutations and chromosomal rearrangements (Mills et al. 2003). In each 
organism, cell death is precisely balanced with proliferation to preserve a constant number 
of cells in tissues and organs (Roos et al. 2015). However, a wide range of mutations, 
chromosomal fusions and translocations often alter gene expression, activating oncogenes 
or disabling tumour suppressors. This in turn can lead to uncontrolled cell proliferation, 
promoting neoplastic transformation (Khanna & Jackson 2001; Helleday et al. 2014). 
Thus, unfaithful DSB repair is considered one of the hallmarks of cancer. Additionally, 
genome instability produced by DSB repair malfunction directly contributes to tumour 
heterogeneity and clonal evolution, which are key steps in cancer metastasis and drug 
resistance. 
Mutations in DSB repair genes have been linked to a large variety of human 
syndromes (McKinnon & Caldecott 2007). Overall, they are congenital disorders 
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characterized by a combination of immune deficiency, developmental delay, infertility, 
central nervous system defects and/or cancer proneness. Importantly, each set of features 
displayed by individuals carrying mutations in a unique DNA repair gene gives us 
insights of the physiological function of the protein encoded. Extensive work has been 
done in mouse models to elucidate the link between DSB repair and disease (Nordstrand 
et al. 2007).  Nevertheless, rodent models do not always recapitulate every human feature 
and cellular approaches with cells isolated from patients have been key to dissect the 
molecular implications of these mutations.
4.1. c-NHEJ Syndromes
One of the most remarkable syndromes linked to DSB repair is the radiosensitivity 
and severe combined immunodeficiency (RS-SCID) (Christopher C. Dvorak 2010). 
These patients are characterized by reduced or absent circulating lymphocytes, combined 
with severe hypersensitivity to IR or radiomimetic agents. Individuals frequently present 
mutations in single genes, normally related to the NHEJ pathway. These mutations often 
result in the impairment at different stages of the NHEJ pathway, which correlates with 
the severity of the symptoms observed.
As mentioned above, NHEJ is essential for the efficient repair of IR-induced 
DSBs and RAG1/2-dependent cleavage during V(D)J recombination. Consistently, 
mutations in genes such as LIG4 (encoding DNA ligase IV), XLF (XLF), PRKDC 
(DNA-PKcs) and DCLRE1C (Artemis) have been found in patients suffering from 
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RS-SCID (Woodbine et al. 2014). Curiously, mutations in other c-NHEJ factors 
such as KU70/80 or XRCC4 have not been found up to date. Null mutations in genes 
such as LIG4 and XRCC4 in mice are embryonic lethal (Barnes et al. 1998; Gao et al. 
1998) and RS-SCID patients linked to LIG4 mutations are hypomorphic (Chistiakov 
2010), and mutations that totally abolish Ligase IV activity have not been found yet. 
Altogether, these observations suggest that mutations in c-NHEJ underlie the profound 
immunodeficiency of these patients, but curiously, only mutations that partially reduce 
NHEJ are compatible with embryonic development.
 Indeed, in addition to immune system defects, a fraction of RS-SCID patients 
display developmental or growth delay, dysmorphic facial characteristics and congenital 
microcephally (Buck et al. 2006; O’Driscoll et al. 2001; Woodbine et al. 2013). It has 
been suggested that a defective NHEJ repair during development can underlie these 
severe features. Importantly, these phenotypes are present when RS-SCID is caused 
by mutations in c-NHEJ genes but not in Artemis, which is key for V(D)J hairpin 
opening and end processing, but it is accessory for general NHEJ (Moshous et al. 2001). 
Supporting this notion, developmental defects are totally absent in non-radiosensitive 
SCID patients, a similar human syndrome characterised by mutations in RAG1/2 genes 
(Notarangelo et al. 2016). In these cases, individuals present defective V(D)J due to the 
absence of cleavage in TCR and Ig genes, but they show proficient NHEJ repair upon IR 
exposure. Therefore, these observations strongly suggest that defects in c-NHEJ are the 
underlying cause of the defects in CNS development in RS-SCID patients. Nonetheless, 
while the role of NHEJ in V(D)J recombination has been dissected in detail, the impact 
INTRODUCTION 
35
of defective NHEJ in neural development is less clear.
Despite the specific role of LIG4 in DSB repair by NHEJ, no other role in 
the repair of other type of lesions has been reported to date. Mouse models for LIG4 
syndrome display microcephaly, and they have served to provide insights in the role 
of NHEJ during neural development. Indeed, LIG4 null embryos die during E8-
16.5 due to a p53-dependent apoptotic pathway, which suggests that DSBs may be 
endogenously arising during brain development, and NHEJ pathway is required for its 
correct repair (Frank et al. 2000). Curiously, embryonic neuronal stem and progenitor 
cells that are located in the ventricular and sub-ventricular zones (VZ-SVZ) undergo 
rapid cell divisions from developmental stage E8 to E16.5, which are key to achieve an 
accumulation of enough stem cells to eventually differentiate to neurons (Sun & Hevner 
2014). It has been suggested that during this highly proliferative stage, DSBs are likely 
to arise in high amounts due to replicative stress. However, several other factors that can 
induce lesions during the critical stage of neuronal development have been proposed. 
On top of this, neural precursors have been shown to display hypersensitive apoptosis 
in response to DNA damaging agents, apoptosis being triggered with twenty-fold less 
DSBs than in adult brain cells (Barazzuol et al. 2015). Therefore, neural development is 
considered a critical process in which efficient repair mechanisms are highly required to 
avoid the deleterious outcomes of DSBs.
 
4.2. Other DNA Break-related Syndromes 
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Besides c-NHEJ factors, there are other human syndromes linked to DSB 
repair factors. Ataxia-telangiectasia (A-T) and ATLD (A-T like disorder) are two 
rare syndromes characterized by progressive cerebellar ataxia amongst other common 
features, such as radiosensitivity, immunodeficiency, cancer predisposition and infertility. 
For the importance to this work A-T will be dissected in further detail. ATLD syndrome 
is caused by mutations in the MRE11 gene, which encodes for MRE11, the nuclease 
component of the MRN complex (Taylor et al. 2004). Apparently, DSBs have been 
proposed to be the molecular trigger underlying ATLD, since the MRN complex is 
required for the repair of these lesions specifically. Nijmegen breakage syndrome, which 
is caused by a truncation in the NBS1 gene, other member of the MRN complex, displays 
microcephaly, dysmorphic cranium, growth retardation, impaired sexual maturation and 
immunodeficiency (Digweed & Sperling 2004). Seckel-syndrome, which is caused by 
mutations in the gene encoding for ATR displays microcephaly, facial dystrophy and 
growth retardation (Driscoll et al. 2004). Since ATR plays an essential role in cellular 
tolerance to replicative stress apart from DSB repair, defective replication seem to be the 
determinant factor for the development of this disease.  
Additionally, there are other syndromes linked to mutations in DNA repair genes 
characterized by microcephaly and other neural defects. Mutations in genes that have 
been described as accessory for the NHEJ pathway have been also linked to human 
syndromes. Mutations in APTX (Aprataxin) cause ataxia with oculomotor apraxia type 1 
(AOA1), characterised by childhood onset of slowly progressive cerebellar ataxia, followed 
by oculomotor apraxia and a severe motor neuropathy (Date et al. 2001). Mutations in 
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PNKP (PNKP) have been linked with a wider range of neurological disorders, ranging 
from congenital microcephaly to oculomotor apraxia type 4 (AOA4) (Shen et al. 2010; 
Bras et al. 2015). Furthermore, specific mutations in TDP1 gene are the cause of a 
neurodegenerative disorder known as spinocerebellar ataxia with axonal neuropathy 
(SCAN1) (Caldecott 2008). Interestingly, this set of diseases display a wide range of 
neurological features but with no overt immunodeficiency, neither phenotypes in other 
organs. Despite the fact that APRTX, PNKP and TDP1 can promote unblocking of 
DSBs, they display a primary role in SSB repair. For all of this, it has been suggested 
that blocked SSBs could be the molecular trigger underlying the neural features in these 
particular syndromes.  
These observations altogether suggests that defects in DNA break repair may 
trigger a wide range of neurological features, ranging from deficient neural development 
to progressive neurodegeneration. However, it is not still clear whether some of these 
syndromes are caused by the accumulation of DSB, or other type of damage contributes 
to them. It is important to remark that mutations that totally impair NHEJ or HR have 
not been found in humans, suggesting that these are essential pathways and their total 
lack leads to embryonic lethality.
5. Ataxia-telangiectasia (A-T)
Since its identification, Ataxia telangiectasia (A-T) has been the paradigm of 
human inherited disease related to the DDR (Lavin 2008; McKinnon 2012). Indeed, 
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spontaneous chromosomal instability and a profound hypersensitivity to DSB-inducing 
agents in cells derived from A-T patients, differentiate this syndrome from other 
spinocerebellar ataxias (Taylor et al. 1975). In 1995, positional cloning experiments 
defined mutations in ataxia-telangiectasia mutated (ATM) gene as the responsible for 
the A-T syndrome (Savitsky et al. 1995). Since then, several different mutations have 
been identified (Concannon & Gatti 1997; Sasaki et al. 1998; Chun & Gatti 2004). Up 
Ataxia
Immunodeficiency
Bronchopulmonary infections
Lymphoma and lymphoid leukemia
Radiosensitivity
Infertility
Figure 12: Ataxia Telangiectasia (A-T) syndrome. Individuals carrying homozygous 
mutations in ATM gene are characterized by multisystem failures such as, cerebellar 
ataxia, immunodeficiency, high incidence of bronchopulmonary infections, predisposition 
to lymphomas and leukemia, radiosensitivity and infertility.
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to date, whether defective DSB-repair is the trigger of the clinical pathology, or it resides 
in an alternative function of ATM is still a matter of debate.
5.1. A-T Human Syndrome
A-T disease is associated with multi-systemic features, affecting development and 
maintenance of the brain, gonads and immune system (Figure 12). Primarily, A-T is an 
early-onset progressive neurodegenerative disorder, in which patients are born with no 
overt symptoms (Chun & Gatti 2004). At an age of 2-3 years, progressive ataxia starts 
to develop. Extensive loss of movement control becomes observable as a loss of balance 
(ataxia), slurred speech (dysarthria), and difficulties to regulate fine eye movements 
(oculomotor apraxia) and voluntary muscle contraction (dyssynergia). As a consequence, 
patients normally require the use of a wheelchair in the first decade of life. Importantly, 
a wide range in the severity of these features has been observed, negatively correlating 
with the residual levels of ATM activity (Verhagen et al. 2012; Taylor et al. 2015). A-T 
neurodegeneration is mainly restricted to the cerebellum, in which Purkinje and granule 
cells seem to be specially affected (Thomas O. Crawford 1998). Why these cell-types are 
particularly sensitive to ATM-deficiency is still unknown, but it has been proposed that 
the lower apoptotic threshold in these cell-types upon DNA damage induction could 
partially account for their loss. Other possibilities such as the lack of compensatory repair 
pathways in these particular cells have been also considered (Barzilai 2010). 
During the last decades, supportive and symptomatic treatments have progressively 
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increased lifespan of patients with A-T during the last decades (Luciana Chessa 2016), 
which it varies greatly amongst individuals, presenting a median survival of 25 years, with 
some reported cases reaching the 50’s (Crawford et al. 2006). The major cause of death 
in A-T is pulmonary failure, which is often caused by sinopulmonary infections due to 
primary immunodeficiency (McGrath-Morrow et al. 2010). Indeed, individuals present 
lymphocytopenia, characterized by lower numbers of circulating CD4+ or CD8+ single 
RAG1/2
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Figure 13: Model to explain oncogenic translocations linked to lymphoid 
malignancies in A-T. During T-cell development programmed DSBs are induced by 
RAG1/2 in TCR loci. ATM is crucial for the correct repair of these lesions by the NHEJ 
machinery. If DSBs induced by RAG1/2 or by other sources arise during this process, 
ATM triggers cell cycle arrest to allow DNA repair. Loss of ATM increases the likelihood 
of lymphocyte proliferation in cells carrying persistent DSBs, which potentially generate 
gross chromosomal rearrangements and oncogenic translocations. 
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positive (SP) mature T-cells (Nowak-Wegrzyn et al. 2004). Cancer is the second cause 
of death, with roughly a third of the cases developing tumours, which are mainly (85%) 
lymphomas and lymphocytic leukemias, with a total absence of myeloid tumours (Taylor 
1996). Amongst them, acute T-cell lymphoblastic leukemia and adult T-cell leukemia 
are frequent. Nonetheless, the exact contribution of ATM loss to these processes is still 
under debate. It has been proposed that inaccurate repair of RAG1/2-induced DSBs can 
underlie T-cell neoplasia in A-T. Additionally, defective cell cycle checkpoint arrest in 
the presence of unrepaired damage can also contribute to oncogenic development. 
Recurrent chromosomal rearrangements in A-T lymphomas have been previously 
described in detail (Taylor 1996). Interestingly, clonal translocations clustering in TCR 
and immunoglobulin genes are frequently present. Typically, translocation and inversion 
involving chromosome 7 and 14, presenting breakpoints situated at ch.14q11 (TCRα/δ 
gene), ch.7q35 (TCRβ), and ch.7p14 (TCRγ) have been described. In fact, accumulation 
of unrepaired DSBs within these loci have been described to substantially contribute 
to the formation of oncogenic translocations (Figure 13) (Zheng 2013). Moreover, 
breakpoints in the TCR genes have been found in translocations with known oncogenes, 
such as TCL1 and MTCP. However, other recurrent clonal translocations that have been 
identified do not cluster in TCR or Ig genes, suggesting that a pathway independent of 
V(D)J recombination must underlie these rearrangements. Different mechanisms have 
been proposed to explain how DSBs can arise during T-cell development in sites that 
normally should not undergo RAG1/2 cleavage (Roth 2003). One possibility to explain 
DSBs arising in non-TCR sites is the erroneous RAG1/2-dependent cleavage in cryptic 
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recombination signal sequence (RSS) (Lewis et al. 1997). These cryptic RSS sites resemble 
a true RSS, in terms of sequence and chromatin status, but they are not adjacent to an 
antigen receptor or immunoglobulin gene. Therefore, RAG1/2 recombinase can cleave 
in these sites at a lower frequency compared to TCR and Igs loci. If they are located 
within oncogenes and tumour supressors, DSBs arising in these regions are dangerous, 
presenting a potential source of neoplastic changes in the genome. Indeed, cleavage of 
RAG1/2 in cryptic RSS has been observed along the genome, and it has been proposed 
to underlie some of the translocations found in other types of T-cell lymphomas. 
Another mechanism that can contribute to translocations is the occurrence of DSBs 
during periods of rapid cellular proliferation (Callen et al. 2007). ATM deficiency would 
contribute to accumulation of these replication-dependent DSBs within lymphocytes 
due to a defective cell cycle checkpoint arrest. In any case, other alternative mechanisms 
in which DSBs may arise in lymphocytes have not been addressed yet. 
5.2. A-T Mouse Model
ATM mouse models have served to understand important issues about the 
etiology of A-T. ATM-deficient mice recapitulate many features of the human 
syndrome, including susceptibility to lymphoid tumours, primary immunodeficiency, 
infertility, radiosensitivity and smaller body size (Barlow et al. 1996). However, this 
model does not recapitulate the striking neurodegenerative phenotype of A-T patients 
(Lavin 2013). Atm-/- mice present a median survival ranging from 100 to 350 days, 
depending on the genetic background (Genik et al. 2014). These animals normally 
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succumb to massive thymic lymphomas, which largely expand in the chest cavity, leading 
to breathing difficulties and eventually to death. These tumours are mainly composed 
by CD4+CD8+ double positive clonal T-cells, but also CD4+ or CD8+ single positives 
have been described. Translocations involving chromosome 14, with breakpoints in the 
Tcra/d genes with amplifications of its upstream region are frequently found, with a large 
number of tumours presenting the clonal translocation t(12:14) (Zha et al. 2010). This 
particular oncogenic translocation depends on the enhancer of the Tcrd gene (Eδ) for its 
formation, since they are absent in Atm-/-Eδ-/- mice ( Jiang et al. 2015). This suggests that 
it is specifically formed during recombination of the Tcrd  (TCRδ) gene. Other complex 
rearrangements involving chromosome 19, which contains Pten tumour suppressor, 
telomeric regions of chromosome 12, which includes Tcl1 oncogene and Bcl11b tumor 
suppressor, or chromosome 2, which contain Notch1 oncogene, have been also described 
in Atm-/- thymic lymphomas. 
One important observation is the fact that rodent models carrying ATM-deletion 
or C-terminal RAG2-deletion, display similar outcomes in terms of T-cell oncogenesis. 
Both mutations lead to genome instability and complex chromosomal rearrangements 
after RAG1/2 cleavage during V(D)J recombination. In fact, ATM and the C-terminus 
of RAG2 have been demonstrated to contribute to post-cleavage complex stabilization, 
restraining DSB repair to c-NHEJ in the coding joints (Deriano et al. 2011; Chaumeil 
et al. 2013). Indeed, Atm-/- lymphocytes tend to form illegitimate hybrid join formation, 
characterised by nucleotide loss and the addition of palindromic and non-templated 
nucleotides (Bredemeyer, Huang, et al. 2008). In any case, lymphoma incidence caused 
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by ATM deficiency does not seem to rely completely in V(D)J recombination process, 
since tumour predisposition in ATM-deficient mice is not supressed by Rag1 or Rag2 
deletion (Petiniot et al. 2002). Nevertheless, translocations involving TCRα/δ locus do 
depend on RAG1/2 cleavage, since they are not found in Atm-/-Rag1-/- or in Atm-/-Rag2-/-. 
This altogether, strongly suggests that rearrangements in the TCR, while increasing 
tumorigenic potential, are not the only requirement for thymic lymphoma development. 
For this, it is essential to explore alternative mechanisms that contribute to neoplastic 
development in A-T disease. 
5.3. Ataxia-Telangiectasia Mutated (ATM) protein
The Ser/Thr kinase ATM controls several cellular processes by modulating protein 
phosphorylation. This 360 kDa protein belongs to the PI3K-like kinases family (PIKKs), 
which includes DNA-PKcs, ATR, TRRAP, SMG1 and mTOR. These enzymes are 
usually involved in the cellular response to different stresses, being crucial in cellular 
homeostasis (Lempiäinen & Halazonetis 2009). Like ATR and DNA-PKcs, ATM 
preferentially phosphorylates specific targets on serine or threonine residues, followed 
by a glutamine, which is known as the S/T-Q motif (Kastan & Lim 2000). Up to date, 
numerous proteins have been defined as ATM substrates in vitro and in vivo. Proteomic 
screens revealed more than a thousand putative ATM substrates, encompassing different 
cellular processes such as gene expression, cell cycle control, chromatin organization, 
stress responses, cellular metabolism and DNA damage amongst others (Shiloh & Ziv 
2013). 
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Structurally, ATM presents its active PI3K-like domain, located in its carboxy-
terminus, a FAT domain (conserved in FRAP and TRRAP), a FATC domain (FAT 
C-terminal) and several HEAT domains, important for protein-protein specific 
interactions. ATM is normally found as inactive homodimers, which in response to 
specific stress, changes its spatial localization and become active in its monomeric form. 
In addition, numerous post-translational modifications have been described to modulate 
ATM activity (Paull 2015). It has been described three in trans autophosphorylation sites, 
Ser-367, Ser-1893 and Ser-1981, which are important for activation of human ATM. 
However, abrogation of these three sites showed to be dispensable for its activation in the 
rodent counterpart (Daniel et al. 2008). Other post-translational modifications, such as 
TIP60-mediated acetylation at Lys-3016, are particularly important for the early trigger 
of ATM activation. 
DSBs are probably the genotoxic lesion that activates ATM most robustly. However, 
after decades of study, the exact mechanism in which ATM senses these lesions remains 
elusive. Despite DNA ends being required for its full activation, other factors such as 
changes in chromatin status could be sufficient for the early stages (You et al. 2007; Kim 
et al. 2009). The MRN complex does not seem necessary for initial activation, but it 
has been described as crucial for maintaining ATM association to DSBs, since removal 
of any member of the complex or impeding ATM interaction with NBS1 impairs its 
retention in DSB-induced foci (Uziel et al. 2003). In addition to DSBs, ATM has been 
proposed to sense oxidative stress, since it becomes active after disulphide-crosslinked 
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dimer formation upon oxidation. Consistently, ATM-deficient cells have been described 
to display hypersensitivity to oxidative agents (Guo et al. 2010). However, the biological 
significance of this pathway and its impact in A-T disease remains elusive. 
The role of ATM in modulating the DDR upon genotoxic agents has been well 
dissected in the past (Iliakis et al. 2003). In fact, it is considered as an apical factor in the 
G1/S and G2/M checkpoints, which prevent cells from respectively undergoing replication 
of the DNA or proceeding into mitosis in the presence of damage. As mentioned above, 
in response to ionizing radiation, ATM phosphorylates Chk2 and p53. This event is key 
for the G1/S arrest, since activation of Chk2 promotes Cdc25A phosphorylation and 
its subsequent degradation by the 26S proteasome. Finally, reduced levels of Cdc25A 
results in the accumulation of the unphosphorylated form of Cdk2, which is incapable 
of initiating replication and promoting the firing of replication origins. Simultaneously, 
p53 is also activated by specific ATM-dependent phosphorylation in its Ser-15, and 
progressively, by Chk2-dependent phosphorylation in Ser-20, which contributes to 
the full activation of the pathway. These events promote p53 stabilization within the 
nucleus, by blocking its nuclear export and its subsequent proteasomal degradation in 
the cytoplasm. Increased levels of p53 in the nucleus favour its role as transcriptional 
activator, triggering the expression of several target genes, such as p21. These factors 
altogether inhibit Cdk2/CyclinE-dependent progression to S phase. On top of this, p21 
also contribute to maintain S phase-genes repressed by inhibiting Cdk4-CyclinD kinase 
activity. This reduces Retinoblastoma (Rb) phosphorylated form, which is key for the 
release of E2F, an important transcriptional activator of these S-phase genes. 
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Additionally, the G2/M checkpoint is an essential halt that avoid cells to enter 
mitosis when DNA is damaged (Löbrich & Jeggo 2007). Indeed, deficiencies in G2/M 
checkpoint lead to embryonic lethality in several mouse models. Moreover, cells lacking 
this arrest display chromosomal rearrangements and breaks upon DSB induction. 
Similar to the G1/S checkpoint, ATM is a keystone in the G2/M checkpoint arrest. 
ATM is strongly activated upon DSBs induction in G2, and its activity has been 
proposed to modulate end resection of the breaks. This step, which generates ssDNA 
patches, efficiently activates ATR kinase, which phosphorylates Chk1, another essential 
effector of the G2/M checkpoint. On top of this, in a similar manner as in G1, ATM 
phosphorylates Chk2. Finally phosphorylated forms of Chk1 and Chk2 interfere with 
Cdk1-CyclinB, avoiding mitotic entry. Therefore, the absence of ATM contributes 
to unregulated cell cycle progression in the presence of DSBs, potentially leading to 
mutations and chromosomal rearrangements that can lead to uncontrolled cell growth 
or cellular collapse. 
Nonetheless, besides the contribution of ATM to cell cycle checkpoint arrest, 
other functions have also been described. Indeed, one of the issues that remain most 
controversial is that, despite the profound radiosensitivity displayed by AT cells, the 
ATM role on the repair of DSBs is still unclear. Early works demonstrated that AT cells 
accumulate only a small fraction (≈15%) of persistently unrepaired DSBs induced by IR 
exposure (Foray et al. 1997; Kühne et al. 2004). This mild, but consistent, repair defect 
was observed in G1 and G2 cell cycle stages, ruling out a possible effect of checkpoint 
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deregulation. Importantly, Artemis endonuclease was described as the downstream factor 
of ATM responsible for this repair defect (Riballo et al. 2004). Since a fraction of the IR-
induced DSBs contains aberrant structures in their termini, it was proposed that ATM 
could specifically promote the repair of breaks with more complex structures. Therefore, 
Artemis-dependent nucleolitic trimming, controlled by ATM phosphorylation, would 
allow the processing of the breaks that cannot be directly ligated by c-NHEJ. However, 
due to the technical impossibility to induce homogeneous population of molecularly 
controlled blocked DSBs, the validation of the model was challenging at that moment. 
Ever since, alternative functions of ATM in DSB repair have been proposed.
IR induces DSBs randomly along the genome. Thus, a fraction of these lesions will 
be located in high dense heterochromatin regions. ATM has been proposed to contribute 
specifically to the repair of heterochromatin-associated DSBs. In this regard, ATM 
induces heterochromatin decompaction in the vicinity of these DSBs. For this, ATM 
kinase is required for KAP1 (KRAB-associated protein 1) phosphorylation (Goodarzi et 
al. 2010). This modification leads to KAP1-dependent changes in the chromatin status, 
allowing repair to proceed in these lesions. Other ATM downstream factors such as 
53BP1, RNF8, RNF168 and MDC1 have also been proposed to be essential for the 
repair of heretochromatin-associated DSBs (Noon et al. 2010). Curiously, according to 
the role of ATM in changing chromatin status, it has been suggested that ATM can 
deregulate gene expression through interfering with histone deacetylase 4 (HDAC4) (Li 
et al. 2012). This HDAC4-dependent regulation of gene expression seems to be essential 
for neuronal function, and could underlie to some extent A-T neurological features. It is 
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important to mention that this role of ATM in transcriptional regulation seems largely 
independent of DNA damage signalling or repair. Recent work has also linked ATM 
activity with the clustering of multiple DSB in repair foci upon AsiSI restriction enzyme 
cleavage (Caron et al. 2015a). Curiously, ATM inactivation has shown a negligible 
impact on the repair rate of these lesions. It is important to mention that AsiSI enzyme 
generates compatible and clean DSBs that can be easily religated by the repair machinery. 
5.4. Interplay of ATM and DNA-PKcs in the Repair of Double-strand Breaks
DNA-PKcs, with a molecular weight of approximately 460 kDa, is one of the 
largest kinases within the PI3K-like kinase family (Dobbs et al. 2010). Although DNA-
PKcs is not conserved in lower eukaryotes, the kinase activity of DNA-PKcs is required 
in mammalian cells for efficient NHEJ. Structurally, it shares several common features 
with ATM, such as the C-terminal kinase domain, which is flanked by a FAT and 
FATC domains, and numerous HEAT domains in its N-terminal region. Interestingly, 
several redundant roles have been described for ATM and DNA-PKcs kinases within 
the DNA damage response upon DSB induction. However, their regulation and the 
functional implications of their loss largely differ. In fact, while the role of ATM in 
DSB repair remains still unclear, DNA-PKcs has been described as a key member in 
c-NHEJ pathway. Consistent with this, mutations in DNA-PKcs and chemical agents 
that specifically inhibit its kinase activity have been described to cause marked DSB 
repair defects and radiosensitivity under several experimental conditions.
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The DNA-PK holoenzyme is formed when KU70/80 heterodimeric ring 
associates to DSB ends, promoting the recruitment and activation of the DNA-PK 
catalytic subunit (Gottlieb & Jackson 1993). Despite the fact that DNA-PKcs has 
been described to phosphorylate a high number of substrates in vitro and in vivo, the 
validation and relevance of these modifications under physiological conditions are still 
a matter of debate. Until present, the most characterized phosphorylation substrate has 
been by far DNA-PKcs itself (Stiff et al. 2004; Uematsu et al. 2007). Indeed, it has 
been described to suffer a large number of phosphorylations in in a large number of 
residues. The kinase activity and autophosphorylation have been demonstrated to be 
important for the efficient repair and cell survival upon the exposure to DSB-inducing 
agents. At the molecular level, it has been postulated that two DNA-PKcs molecules can 
autophosphorylate each other in trans when they are confronted in DSB end synapses 
during NHEJ (Reddy et al. 2004; Meek et al. 2007). This autophosphorylation leads to 
the dissociation of DNA-PKcs from DSB ends, resulting in decreased kinase activity 
of the DNA-PK holoenzyme (Chan & Lees-Miller 1996). Thus, inactive DNA-PKcs 
remains associated to DSB ends, preventing access to other required repair factors. 
Several phosphorylation clusters have been mapped in DNA-PKcs. Nonetheless, 
up to date, the most functionally relevant are the ABCDE and PQR (Meek et al. 2007). 
ABCDE phosphorylation cluster encompasses the residues Thr-2609, Ser-2612, Thr-
2620, Ser-2624, Thr-2638, Thr-2647, and the PRQ the serine residues 2023, 2029, 2041, 
2053 and 2056. Single alanine mutations in these residues displayed negligible effect in 
NHEJ capacity. However, combined mutations in all the residues of PQR or ABCDE 
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displayed different levels of radiosensitivity (Cui et al. 2005; Ding et al. 2003) Curiously, 
in contrast to the milder effect observed in the PQR mutant, combined mutations in the 
six residues of the ABCDE confer a profound sensitivity to IR exposure, which was even 
more pronounced than null mutations. At the molecular level, the major defect exhibited 
by ABCDE and PQR mutants was a disruption in DNA end processing capacity by 
the NHEJ pathway (Meek et al. 2008). In contrast, normal kinase activity, interaction 
with KU70/80 and recruitment to DSB sites were not affected. Nevertheless, while 
ABCDE phosphorylation seems to promote end processing, activation of the PRQ 
cluster leads to joining events with excessive nucleotide loss. Thus, it has been proposed 
that phosphorylation of these clusters are tightly regulated to modulate end protection 
and processing of DSBs. In this way, while ABCDE phosphorylation is key for end 
trimming, PQR phosphorylation limits end processing. Following DSB end synapse, 
multiple phosphorylation events can control DNA-PKcs conformational changes, 
allowing the recruitment of downstream processing enzymes and to the ligase complex 
(Meek et al. 2008). Structure of DSB termini condition DNA-PKcs activation, ranging 
from low by blunt-end and hairpin-end, to most active in the case of 3’ and 5’ overhangs 
(Hammarsten et al. 2000). Thus, different DSB ends would require specific DNA-PKcs 
phosphorylation steps to modulate end protection, processing and eventual repair by the 
NHEJ pathway.
Nevertheless, to which extent PQR and ABCDE clusters are exclusively 
phosphorylated by DNA-PKcs itself is unclear. In this regard, it has been suggested that 
Ser-2056 phosphorylation in the PQR cluster is indeed an autophosphorylation site, 
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while both DNA-PKcs and ATM seem to contribute to the phosphorylation of Thr-
2609 in the ABCDE cluster (Chen et al. 2007). Additionally, ABCDE phosphorylation 
was described to be essential for the Artemis-dependent endonuclease activity, important 
for end processing during NHEJ (Goodarzi et al. 2006). Thus, it has been proposed that 
the role of ATM in the repair of DSB could be mediated by the phosphorylation of 
DNA-PKcs to activate Artemis. 
II.   OBJECTIVES
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II. OBJECTIVES
Due to the relevance of DSBs for human physiology, the understanding of the 
molecular mechanisms that govern their repair is key. Importantly, the chemical structure 
present at DSB ends is highly influential for their repair, since it conditions the enzymatic 
activities and pathways required for an efficient repair. Nonetheless, the study of the repair 
of blocked DSBs has been largely impeded due to the technical incapacity to induce 
homogeneous populations of breaks. Based on previous work, we hypothesized that we 
can take advantage of TOP2-induced DSBs and TDP2 to control DNA end structure in 
cells and mouse models. For this, further characterization of the physiological activity of 
TDP2 in mammalian cells, and the validation of our theoretical approach, are required.
Mutations in the ATM gene cause the rare syndrome Ataxia-Telangiectasia. 
Despite the fact that ATM protein plays a central role in the DNA damage response 
upon DSB induction, and that several of the phenotypes have been linked to defects 
in DSB repair, the exact molecular trigger of this devastating disease remains elusive. 
Previous findings suggest the possibility of ATM being important for the repair of 
DSBs that present terminal blockages. Therefore, we aimed to demonstrate if the specific 
chemical structure present at DSB ends is a determinant factor in the requirement of 
ATM for their repair. This would put forward blocked DSBs as a possible trigger of A-T 
symptomatology.
56
OBJECTIVES  
Thus, the objectives of this Thesis are the following:
1. Determine how the chemical structure of DNA ends influences the repair of  
 DSBs
1.1. Characterize the biochemical activity of TDP2
1.2. Develop a genetic tool to induce homogeneous populations of blocked and    
 clean DSBs 
2. Determine the contribution of ATM to the repair of blocked DSBs in mammals 
2.1. Evaluate repair in ATM-deficient cells upon clean or blocked DSB-induction
2.2. Characterize the cellular impact of ATM loss upon clean or blocked DSB- 
 induction
3. Analyse the impact of TOP2-induced DSBs for the symptomatology of Ataxia-
Telangiectasia 
3.1. Study the contribution of ATM to the repair of blocked DSBs in a rodent 
model
3.2. Determine the impact of spontaneous TOP2-induced damage in an ATM 
mouse model
III.   RESULTS

RESULTS 
59
III. RESULTS
1. TDP2 is the major 5’-TDP activity and creates ligatable DSBs
The discovery of TDP2 as the first 5’-tyrosyl-DNA-phosphodiesterase (5’-TDP) 
activity raised the possibility of it being an important factor in the repair of TOP2-
induced damage and, therefore, in the clinical response to TOP2 poisons (Ledesma et 
al. 2009). To determine the impact of TDP2 loss on TOP2-induced DNA damage in 
mammals, we took advantage of a previously generated mouse in which the first three 
exons of Tdp2 plus the 5’-UTR were deleted. For this, primary mouse embryonic 
fibroblast (MEF) cells were isolated from wildtype and TDP2-deficient mice (Tdp2-/-).
To test if Tdp2 deletion abolishes 5’-TDP activity, radiolabelled oligonucleotide 
duplexes containing 5’ phosphotyrosine (5’-Tyr) moieties were incubated with protein 
extracts prepared from wildtype and Tdp2-/- primary MEFs. Then, samples were subject 
to polyacrylamide gel electrophoresis. Through this methodology, the conversion of 5’-Tyr 
to 5’ phosphate (5’-Pho) termini can be observed as a mobility shift. Wild-type samples 
showed a marked 5’-TDP activity in blunt-end 5’-Tyr substrates, as can be observed by 
the appearance of a lower band corresponding to 5’-Pho moieties (Figure 14A). On the 
contrary, TDP activity was totally abolished in Tdp2-/- extracts. This confirms the effective 
inactivation of TDP2 in mutant rodent cells. Consistently with previous work performed 
in avian DT40 and A549 TDP2-depleted cells, our result extends the conclusion of 
TDP2 being the only physiologically relevant 5’ -TDP activity in rodent primary cells.
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Previous work has described that TOP2 introduce two staggered nicks at 4 bp 
of distance (Pommier et al. 2016). Therefore, taking into consideration the biochemical 
mechanism of TOP2 cleavage, we anticipated that DSBs induced by this specific 
pathway would not harbour blunt-ends, but 5’ compatible overhangs. Thus, we speculated 
that if TDP2 account for the physiological unblocking of TOP2-induced damage, it 
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Figure 14: Deletion of Tdp2 in primary MEFs abolishes 5′-TDP activity. (A) DNA 
duplex substrate harbouring a 5′ phosphotyrosine blunt end was incubated during the 
indicated times with 1.5 µg cellular extracts from Tdp2+/+ or Tdp2-/- primary MEFs. (B) 
Duplex substrate harbouring a 5’ phosphotyrosine self-complementary overhang end 
was incubated with 10 µg cellular extract from Tdp2+/+ and Tdp2-/- transformed MEFs for 
2 h in the presence or absence of 50 mM EDTA. Migration of the 5′ phosphotyrosine (5’ 
Tyr) to 5’ phosphate (5’ Pho) is indicated. (C) 5′ phosphate (5’ Pho) and 5′ phosphotyrosine 
(5’ Tyr) substrates were incubated for 1.5 h with 3.3 µg cellular extract from Tdp2+/+ and 
Tdp2-/- transformed MEFs as in “A”, but in the presence of recombinant TDP2 and T4 
ligase. Migration of ligation (lig) product is indicated.
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would be highly active over this type of substrates. TDP2 activity would reconstitute 
complementary clean DSBs (5’ phosphate and 3’ hydroxyl termini), which would be an 
ideal substrate for ligation by NHEJ. For this, we recapitulated the previous experiment 
but using substrates harbouring 5’-Tyr in 4 bp overhangs. Consistently, cell extracts 
prepared from wild-type cells display high activity on these substrates, and was completely 
absent in Tdp2-/- (Figure 14B). EDTA-mediated chelation of Mg2+, which is essential for 
TDP2 function but dispensable for other unblocking enzymes such as TDP1, completely 
eliminated 5’-TDP activity in wild type MEF extracts (Gao et al. 2012). 
We could predict that upon TDP2 activity, repair of TOP2-induced lesions would 
accurately preserve DNA sequence, suggesting the possibility of error-free NHEJ. To test 
this hypothesis, we examined whether TDP2 action at 5’-Tyr substrates creates termini 
that can be directly joined with the single activity of a ligase. Indeed, addition of T4 
DNA Ligase in reactions containing wildtype MEF extracts resulted in the additional 
appearance of a product of 46-nt, indicative of the completion of repair without the loss 
of a single nucleotide. However, this product was not observed if reactions contained 
cell extract from Tdp2-/- MEFs, confirming that DNA ligation was dependent on TDP2 
activity (Figure 14C).
Furthermore, to analyse ligation of DSBs directly catalysed by cell extracts, we 
generated linear plasmids by PCR amplification with primers harbouring 5’  phosphate 
(5’-Pho) or 5’ phosphotyrosine (5’-Tyr) moieties. This linear dsDNA simulates 
chromosomal DSBs, due to the larger length (6.7 kb) compared with substrates 
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Figure 15: Recombinant TDP2 facilitates NHEJ by reconstituting ‘clean’ DSBs 
in vitro. (A) Scheme of the in vitro plasmid circularization assay. (B) Circularization 
efficiency of linear 5’ Tyr and 5’ Pho plasmids catalysed by nuclear extracts prepared 
from Tdp2-/- transformed MEFs in the presence and absence of recombinant human 
TDP2. Average ± s.e.m. of three independent experiments is shown. Statistical 
significance by Two-way ANOVA test with Bonferroni post-test is indicated (*P≤0.05; 
**P≤0.01; ***P≤0.001). (C) Same as in “B”, but substrates were pre-incubated in the 
presence or absence of Shrimp Alkaline Phosphatase (rSAP). After heat-inactivation of 
rSAP, circularization was performed by T4 ligase.
RESULTS 
63
employed previously (27 bp) (Seluanov et al. 2004). The incubation of these substrates 
with NHEJ-competent nuclear extracts results in plasmid circularization events, which 
were scored as kanamycin-resistant colonies following bacterial transformation (Figure 
15A). Nuclear extracts from Tdp2-/- MEFs efficiently circularized linear plasmids with 
5’-Pho ends, but not 5’-Tyr counterparts (Figure 15B). This difference was lost upon 
addition of recombinant human TDP2 (hTDP2) to the reaction, confirming the TDP2–
dependent nature of the repair by NHEJ of this type of lesions. Additionally, in order to 
test whether TDP2 activity reconstitutes clean DSBs, both plasmids were pre-incubated 
with Shrimp Alkaline Phosphatase (rSAP). In order to avoid dephosphorylation of the 
newly formed 5’-Pho by TDP activity, rSAP was heat inactivated prior to TDP2 and 
T4 ligase addition to the reactions. Since 5’-Pho termini are required for ligation, pre-
incubation with rSAP abolished circularization of the 5’-Pho plasmid (Figure 15C). On 
the contrary, 5’-Tyr moieties protected ends from dephosphorylation by rSAP, licensing 
plasmids for ligation when hTDP2 was specifically present in the reactions.
Collectively, our data suggest that TDP2 supports the only physiologically relevant 
5’-TDP activity in mammalian cells. Its activity facilitates the accurate repair of 5’ 
phosphotyrosine blocked DSBs, by generating 5’ phosphate termini that can proceed to 
direct ligation, supporting the notion that TDP2 can allow error-free NHEJ of TOP2-
induced DNA damage.
2. TDP2 promotes efficient repair of TOP2-induced DSBs by removing 
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covalently bound peptides.  
Based on the fact that TDP2-deficiency abolishes 5’-TDP activity in cells, we 
speculated that upon exposure to TOP2-poisons, tyrosine residues or peptide adducts 
would remain covalently linked to DNA at the sites of TOP2-induced lesions that have 
not been unblocked or processed yet. Indeed, we aimed to develop a methodology to 
specifically measure protein-blocked DSBs, which we have termed SLOPE (Selective 
Labelling Of Protein-blocked Ends). SLOPE is based on a previously described assay 
that has been used to identify genomic regions of TOP2 cleavage (Haffner et al. 2010). 
Essentially, following isolation of genomic DNA after extensive Proteinase K treatment, 
TOP2-blocked DSBs will harbour covalently bound tyrosines. Biotin is then conjugated 
to these residues by a specific chemical reaction. Based on the selective reactivity of 
activated N-Hydroxysuccinimide (NHS) esters of biotin with primary amino groups 
(-NH2) contained in side chain of lysine (K) residues and the N-terminus of polypeptides. 
Finally, the amount of biotin conjugated is measured in dot-blot assays, and used as an 
indicator of protein covalently linked to DNA. To detect irreversible TOP2-blocked 
DSBs resulting from etoposide treatment but not cleavage complexes, cells are incubated 
in the absence of the drug to allow cleavage complex reversal before DNA isolation. 
As can be seen in Figure 16A, incubation of wildtype MEFs with etoposide did not 
detectably change the amount of protein covalently linked to DNA compared with 
untreated samples, while a clear and significant increase was observed in Tdp2-/- cells. 
These results demonstrate that, upon etoposide treatment, protein-blocked DSBs 
accumulate in TDP2-deficient cells.
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Figure 16: TDP2 removes peptide adducts and promote efficient repair of TOP2-
induced DSBs. (A) Representative image of SLOPE assay (left) and quantification (right) 
performed in Tdp2+/+ and Tdp2-/- confluency-arrested primary MEFs. Average±s.e.m. 
Signal from three independent experiments and statistical significance by two-way 
ANOVA test with Bonferroni post-test is shown (right) (*P≤0.05; **P≤0.01; ***P≤0.001). 
(B) γH2AX foci induction after 30 min 10 µM etoposide treatment and repair at different 
times following drug removal in confluency arrested Tdp2+/+ and Tdp2-/- primary MEFs. 
Average±s.e.m. signal from three independent experiments and statistical significance 
by two-way ANOVA test with Bonferroni post-test is shown (*P≤0.05; **P≤0.01; 
***P≤0.001). (C) Same than in B but cells were exposed to 2 Gy γ-irradiation.
Our previous results suggest that TDP2 can facilitate error-free NHEJ by removing 
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5’- phosphotyrosines from DSBs. Thus, we next analysed the importance of TDP2 in the 
repair of DSBs generated by TOP2 poisons in mammalian cells. To address this, we 
measured DSB repair at different time-points after 30 min of etoposide treatment in 
wild-type and Tdp2-/- primary MEFs. For this we performed immunofluorescence of 
the Ser139-phosphorylated form of H2AX (γH2AX), which forms foci that accurately 
correlate with the amount of DSBs present in cells. Since TOP2 activity is subject to 
cell cycle variations, cells were confluency arrested in G0 to avoid discrepancies in DSB 
induction. On top of this, NHEJ is the only active pathway operating in quiescent cells. 
Interestingly, the rate of DSB repair was diminished in Tdp2-/- MEFs upon etoposide 
treatment (Figure 16B), consistent with the anticipated TDP2 function in the repair of 
TOP2-induced DSBs by NHEJ. In contrast to treatment with etoposide, which generates 
DSBs in which 5’-TDP activity is required, the rate of DSB repair was indistinguishable 
in  Tdp2-/- compared to wildtype cells following γ-irradiation (Figure 16C). In summary, 
these results demonstrate that TDP2 is required for the efficient repair of TOP2-induced 
DSBs in mammalian cells.
3. ATM facilitates repair of TOP2-blocked but not clean DSBs
As mentioned above, we can use TOP2 poisons such as etoposide to induce DSBs 
that are homogeneous in structure. Therefore, we can modulate the ends of these DSBs 
by working in different genetic backgrounds (Figure 17A).  3’  hydroxyl and 5’ phosphate 
clean ends will be formed in cells containing TDP2 activity, while breaks with a peptide 
block on 5’ ends will accumulate in TDP2-deficient cells. Following this rationale, we 
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can use this genetic system to control the chemical structure present in DSBs, being 
extraordinarily adequate for the study of the repair of blocked DSBs.
Since ATM was previously proposed to have a role in DSB-end processing (Riballo 
et al. 2004), we decided to apply the experimental setup described above to analyse the 
impact of its loss on the repair of either clean or blocked DSBs. For this, we measured 
DSB repair following the time course of γH2AX foci disappearance in G0 primary MEFs 
after etoposide treatment (See Figure 16B). We observed that the absence of ATM 
caused a marked reduction in the intensity of etoposide-induced γH2AX foci (Figure 
18A, upper). This is not surprising given the key role of ATM in H2AX phosphorylation 
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Figure 17: TDP2 determines end structure of TOP2-induced DSBs. Scheme of the 
strategy used to generate DSBs with specific structure. Etoposide exposure induces 
TOP2-mediated DSBs that are blocked by 5’ peptide adducts. In wildtype cells, TDP2 
activity can efficiently unblock these lesions. Conversely, in TDP2-deficient background 
all DSBs are blocked, requiring DNA cleavage and processing by nucleases for their 
repair.  
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in response to DSBs (Kastan & Lim 2000). However, in contrast to the intensity, the 
number of γH2AX foci induced was not affected, validating the use of this parameter as 
a DSB-scoring tool in our particular setup (Figure 18A, lower). As can be seen in Figure 
19A, the absence of ATM did not affect the rate of DSB repair in Tdp2+/+ background, 
consistent with previous observations, suggesting that ATM does not influence repair 
of clean DSBs. In contrast, a striking decrease in the repair rate was observed in the 
combined mutant Tdp2−/− Atm−/−, with ~40% of the breaks remaining unrepaired even 
24 h after damage induction (Figure 19B). This strongly suggests that ATM is crucial for 
the repair of DSB, specifically when they are blocked. Remarkably, it is the first time that 
such a severe repair defect is reported in ATM-deficient cells. Since Tdp2+/+ cells were 
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Figure 18: ATM does not affect the induction of DSBs generated by TOP2. (A) 
Average number per cell (upper) and intensity (lower) of γH2AX foci after 30 min 10 µM 
etoposide treatment in the indicated confluency arrested primary MEFs. Average±s.e.m. 
of three independent experiments and statistical significance by Mann-Whitney test is 
indicated (*P≤0.05; **P≤0.01; ***P≤0.001). (B) Representative images of γH2AX foci 
(green) and DAPI counterstain (blue) are shown.
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indistinguishable from Tdp2+/- in ATM-deficient background, we can conclude that a 
single copy of Tdp2 is sufficient to unblock TOP2-induced DSBs (Figure 20). Moreover, 
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Figure 19: ATM facilitates repair of TOP2 blocked DSBs in confluency arrested 
MEFs. (A) γH2AX foci induction and disappearance upon 30 min treatment with 10 µM 
etoposide and different repair times in the indicated confluency arrested primary MEFs. 
Total number of foci (left) and percentage remaining (right) is shown. Average ± s.e.m. 
of at least three independent experiments is shown (left). Statistical significance by two-
way ANOVA test with Bonferroni post-test is indicated (*P≤0.05; **P≤0.01; ***P≤0.001) 
(right). (B) Representative images of γH2AX foci (green) and DAPI counterstain (blue) for 
the 24 h repair time point. (C) Same as in ‘A’ but cells were exposed to 2Gy γ-irradiation.
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the synergistic defect of TDP2 and ATM deletion was specific to TOP2-induced breaks, 
not being observed with ionizing radiation (Figure 19C). Consistent with previous work, 
repair of only ~10% of the breaks relies on ATM upon IR exposure, independently of 
the TDP2 status. 
Based on this end structure-specific function of ATM, we tested whether there 
was differential activation upon clean or blocked DSB-induction. For this we monitored 
autophosphorylation of ATM in Ser-1981 (Bakkenist & Kastan 2003). Interestingly, 
ATM was activated to similar extent in wildtype and TDP2-deficient background 
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Figure 20: A single copy of TDP2 can promote efficient repair of TOP2-induced 
DSBs. (A) Comparison of DSB-repair efficiency between Tdp2+/+ and Tdp2+/- cells 
in ATM-deficient background. γH2AX foci induction and disappearance upon 30 min 
treatment with 10 µM etoposide and different repair times in the indicated confluency 
arrested primary MEFs. Total number of foci (left) and percentage remaining (right) 
is shown. Average ± s.e.m. of at least three independent experiments is shown (left). 
Statistical significance by two-way ANOVA test with Bonferroni post-test is indicated 
(*P≤0.05; **P≤0.01; ***P≤0.001) (right).   
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upon increasing doses of etoposide exposure (Figure 21A). Next, we addressed if its 
downstream factors involved in the DNA damage response (DDR) were differentially 
activated in similar conditions. We previously observed that γH2AX signalling in 
response to etoposide strongly relies on ATM (Figure 18), but its deficiency only has an 
impact on repair in the absence of TDP2. Consistently with this independence between 
signalling and repair, ATM and downstream checkpoint factors, such as p53, CHK1 and 
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Figure 21: Equivalent DDR signalling in wild-type and TDP2-deficient cells. 
(A) ATM activation monitored by immunoblot of S1981 phosphorylation, after 30 min 
incubation with etoposide of Tdp2+/+ and Tdp2-/- confluency arrested primary MEFs. Total 
ATM was used as a loading control. (B) p53, CHK2 and CHK1 activation, was monitored 
by immunoblot of phosphorylation in the indicated residues, after 30 min incubation of 
Tdp2+/+ and Tdp2-/- confluency arrested primary MEFs with 100µM etoposide. α-Tubulin 
was used as a loading control.
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Chk2 were equally activated in Tdp2+/+ and Tdp2−/− cells upon etoposide exposure (Figure 
21).
To confirm the synergism between TDP2 and ATM in the repair of etoposide-
induced DSBs, we repeated the analysis using chemical inhibition of ATM, instead 
of deletion (Figure 22). Consistently, incubation with the ATM inhibitor KU55933 
diminished the repair rate of TOP2-induced DSBs, but specifically in Tdp2−/− background. 
Since chemical inhibition abolishes ATM activity but the protein is still present, this 
result demonstrates that the role of ATM in the repair of blocked DSBs depends on its 
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Figure 22: ATM kinase activity is important for the repair of TOP2 blocked DSBs (A) 
γH2AX foci induction and disappearance upon 30 min treatment with 10 µM etoposide 
and different repair times in the indicated confluency arrested primary MEFs incubated 
or not with 10µM ATMi. Total number of foci (left) and percentage remaining (right) is 
shown. Average ± s.e.m. of at least three independent experiments is shown (left). 
Statistical significance by two-way ANOVA test with Bonferroni post-test is indicated 
(*P≤0.05; **P≤0.01; ***P≤0.001) (right).  
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Figure 23: ATM facilitates repair of TOP2 blocked DSBs in human cells (A) γH2AX foci 
induction and disappearance upon 30 min treatment with 20 µM etoposide and different 
repair times in primary fibroblast derived from A-T patients (AT) and wildtype controls 
(BJ1) depleted (shTDP2) or not for TDP2. Total number of foci (left) and percentage 
remaining (right) is shown. Average ± s.e.m. of at least three independent experiments 
is shown (left). Statistical significance by two-way ANOVA test with Bonferroni post-test 
is indicated (*P≤0.05; **P≤0.01; ***P≤0.001) (right). (B) A duplex substrate harbouring a 
5’ phosphotyrosine blunt end was incubated for 2h with increasing concentration of the 
indicated cellular extracts. Migration of the 5’ phosphotyrosine (5’ Tyr) and 5’ phosphate 
(5’ Pho) is shown. 
function as kinase. On top of this, it rules out possible artefacts caused by heterogeneity 
in MEFs.
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Figure 24: ATM facilitates repair of TOP2 blocked DSBs in G1 cells. (A) γH2AX foci 
induction and disappearance upon 30 min treatment with 20 µM etoposide and different 
repair times in the indicated G1 primary MEFs. Total number of foci (left) and percentage 
remaining (right) is shown. Average ± s.e.m. of at least three independent experiments 
is shown (left). Statistical significance by two-way ANOVA test with Bonferroni post-test 
is indicated (*P≤0.05; **P≤0.01; ***P≤0.001) (right). 
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Figure 25: ATM facilitates repair of TOP2 blocked DSBs in G2 cells. (A) γH2AX foci 
induction and disappearance upon 30 min treatment with 20 µM etoposide and different 
repair times in the indicated G2 primary MEFs. Total number of foci (left) and percentage 
remaining (right) is shown. Average ± s.e.m. of at least three independent experiments 
is shown (left). Statistical significance by two-way ANOVA test with Bonferroni post-test 
is indicated (*P≤0.05; **P≤0.01; ***P≤0.001) (right).
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Next, we extended our results to human by using confluency-arrested primary 
fibroblasts derived from A-T patients. A similar DSB-repair defect was observed when 
AT cells were depleted for TDP2, and not in neither wild type nor non-depleted controls 
(Figure 23A). However, in this case the effect was milder compared to previous results 
figure 19A, perhaps due to an incomplete knockdown of TDP2, as determined by a 
~10% residual 5’-TDP activity (Figure 23B). Finally, as can be seen in Figure 24 and 
Figure 25, the synergistic repair defect observed between TDP2 and ATM deficiency 
upon etoposide, was not restricted to quiescent cells, since it was also observed in cycling 
cells (both in G1 and G2). Overall, this set of results constitutes strong evidence for 
an involvement of ATM in DSB repair, but specifically when DSBs are blocked, being 
extensive to rodent and human cells. Moreover, we can conclude that the mechanism 
underlying this phenotype directly relies on ATM kinase activity. 
4. ATM function in blocked DSB repair on the chromatin status
In the currently accepted model, ATM is specifically required to repair DSBs 
associated to heterochromatin regions. It has been proposed to promote heterochromatin 
decompaction, facilitating access to the repair machinery. Despite TOP2 activity being 
enriched in highly transcribed euchromatin regions, we aimed to test if ATM function 
in the repair of blocked lesions was related with its role in heterochromatin-associated 
DSBs. For this, we decided to analyse by three-dimensional confocal microscopy, the 
location of etoposide-induced γH2AX foci with respect to heterochromatin in Tdp2−/− 
Atm−/− confluency-arrested primary MEFs (Figure 26). As expected, none of the γH2AX 
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Figure 26: Unrepaired TOP2-blocked DSBs are not associated with 
heterochromatin. Confluency-arrested Tdp2−/−Atm−/− primary MEFs were treated 
30 min 10µM etoposide. (A) Percentage of γH2AX foci that are located within 
heterochromatin (Het) or euchromatin (Eu) following 0 and 24 h repair after treatment. 
A cut-off distance of 0.4 μM from the centroid of each focus to the nearest euchromatin/
heterochromatin boundary was applied. Statistical significance by Chi Square test is 
indicated. (B) Distribution of distances between γH2AX foci and heterochromatin as 
determined above. Bins of 0.4 μm centred on the indicated distance were used for 
representation. (C) Example of the automatic calculation of distances between γH2AX 
foci (green) and densely DAPI-stained chromocenters (blue) used for the data shown 
above. Both a z-stack projection (left) and a 3D reconstitution (right) are shown.
foci induced with etoposide colocalized within highly dense chromocenters and only 
15.45% (34 out of 220 foci scored) were located at less than 0.4 μm from its boundaries 
(Figure 26A), which we considered to be heterochromatin associated. In these same 
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conditions, a significantly higher percentage of the breaks (~40%) required ATM activity 
for their repair (see Figure 19A), indicating that the chromatin status of a TOP2-
induced DSB is not a major determinant of ATM requirement for repair. Furthermore, 
if ATM loss would impair just heterochromatin-associated DSBs repair, an increase in 
the percentage of foci in close proximity to this regions would be expected as repair 
proceeds. However, the overall distribution of heterochromatin-associated foci was not 
significantly changed following 24 h of repair (Figure 26B), with the vast majority of 
unrepaired foci (81.92%) being located within euchromatin (Fig.26A). Therefore, we 
conclude that the involvement of ATM in the repair of TOP2-blocked DSBs is largely 
independent of its role in facilitating repair of heterochromatin associated-DSBs.
5. ATM facilitates repair of blocked-DSBs preserving DNA sequence
TOP2-blocked DSBs represent only one type of many possible blockages 
occurring in vivo. We therefore aimed to confirm the involvement of ATM in the repair 
of blocked DSBs using a TOP2-independent system, in which structure of DNA ends 
could be molecularly controlled. We started by searching for a 5’ modification that could 
block DNA ends in vitro. We found that 5’ biotin (5’-Bio) was not removed from duplex 
oligonucleotides in vitro by HEK293T cellular extracts, while a clear 5’-TDP activity was 
observed under the same conditions (Figure 27). Therefore, we decided to use this 5’-Bio 
modification to block ends of the pEGFP-Pem1 system. This system has been widely 
used as a measure of NHEJ repair, since reconstitution of GFP expression occurs when 
linear plasmids are recircularized after transfection in mammalian cells (Figure 28A). 
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Using PCR-mediated amplification using primers with different 5’ termini, we were 
able to generate DNA substrates that harboured either clean 5’-phosphates (5’-Pho) or 
blocked 5’-biotins (5’-Bio). This was confirmed by streptavidin-mediated pull-down, in 
which only the linear plasmids containing 5’ biotin termini were isolated (Figure 28B). 
Taking advantage of this experimental setup, as can be seen in figure 29A, repair 
of pEGFP-Pem1 plasmids containing clean 5’-Pho was not significantly affected by 
incubation of HEK293T cells with an ATM inhibitor, as measured by either percentage 
of GFP-expressing cells (Figure 29A, left) or the total accumulated fluorescence intensity 
(Figure 29A, right). In contrast, repair of 5’ biotin linear DNA was significantly decreased 
by ATM inhibition, regardless of the quantification method used. As an additional control, 
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Figure 27: 5’-biotin blocks DSB ends. (A) Scheme of the structure of the 5’-biotin 
modification used. (B) Duplex substrates harbouring a 5’-biotin (5’Bio) or a 5’-tyrosine 
(5’Tyr) blunt end were incubated with the indicated concentration of HEK293T cellular 
extracts for 2 h. Migration of the 5’ biotin, 5’ tyrosine and 5’ phosphate (5’Pho) is indicated.
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we found that ATM was not required to repair a 5’  hydroxyl (5’-OH) modification, that 
should not result in end blockage due to the presence of PNKP enzyme, which convert 
5’-OH into 5’-Pho (Figure 29B). Therefore, by using a molecularly defined system, 
we confirmed that the absence of ATM kinase activity impedes the efficient repair of 
blocked DSBs. 
Additionally, we analysed not just the quantity, but also the quality of repair. For 
this, we amplified a minimum of 46 individual events for each condition by bacterial 
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Figure 28: pEGFP-Pem1 system can be modified to measure blocked DSB repair. 
(A) Scheme of the system harbouring 5′ phosphate or 5′ biotin ends (left) and a truncated 
form of the GFP gene. The expected repair product yields GFP expresion (right). Pem1 
intro allows insertions and deletions in the joining site without disrupting GFP expression. 
(B) Validation of the substrates used. Each substrate was incubated with streptavidin-
coated magnetic particles. Input (I), unbound (UB) and bound (B) fractions are shown.
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cloning. Single repair events were subject to restriction analysis to measure losses in the 
DNA sequence (Figure 30). It is important to mention that blockage in DSB termini 
decreased repair accuracy per se, independently of ATM status. However, ATM inhibition 
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Figure 29: :  ATM facilitates repair of biotin-blocked DSBs (A) HEK293T cells were 
transfected in the presence or absence of 10  μM ATM inhibitor with the substrates 
described in figure 28, and analysed by FACS for GFP-positive cells (left) and average 
GFP intensity (right). In both cases, data are relative to transfection with a control 
pEGFP-Pem1 circular plasmid. Average±s.e.m. of four independent experiments and 
statistical significance by two-way ANOVA with Bonferroni post-test is shown (*P≤0.05; 
**P≤0.01; ***P≤0.001). (B) Same as “A” but cells were transfected with linear plasmids 
containing 5′ phosphate or 5′ hydroxyl ends.
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had negligible impact on the quality of 5’-Pho DSB repair. On the contrary, when 5’-Bio 
plasmids were assayed, a marked decrease (from 20% to 5%) in the percentage of repair 
events not carrying detectable loss of sequence was observed (Figure 31A). Nonetheless, 
in the clones showing DNA loss, the average size of deleted sequence was unchanged by 
ATM inhibition (Figure 31B). This demonstrates that ATM prevents excessive sequence 
loss from DNA ends, which suggest an involvement in the regulation of blocked DSB 
end processing. 
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Figure 30: Deletion analysis of plasmids rescued from transfected HEK293T 
cells (A) DraI restriction map of re-circularized pEGFP-Pem1 plasmid. The DSB site 
is indicated (arrow). (B) Representative repair events rescued from cells treated with 
ATMi and transfected with 5’ biotin substrates previously used in Figure 29. Single 
repair events were analysed by agarose gel electrophoresis after DraI endonuclease 
enzyme digestion. Deletion size calculated for each individual clone is indicated. Control 
of pEGFPPem1 re-circularized plasmid is shown (lane 1). Asterisk indicates a clone 
without detectable deletion.
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6. ATM function on blocked DSBs has consequences for the cell
The incapacity to properly repair even a single DSB can lead to cell death and/or 
genome rearrangements. It is therefore conceivable that the ATM loss could have a drastic 
impact in cells upon TOP2-induced DSBs, aggravated when DSBs are blocked. To test 
this hypothesis, we exploited our genetic approach to address the cellular implications of 
ATM loss upon ‘clean’ against ‘blocked’ TOP2-induced damage. 
For this, cell survival in response to increasing doses of etoposide was measured by 
clonogenic assay. We observed that Atm deletion in transformed MEFs had a negligible 
effect on etoposide sensitivity in Tdp2+/+ background. In contrast, sensitivity of Tdp2−/− 
cells, which was mild at low doses of etoposide, was significantly increased by ATM 
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Figure 31: ATM protects degradation of biotin-blocked DSB ends (A) Percentage 
of plasmid-repair events not associated with detectable sequence loss. Statistical 
significance by Chi Square test is shown (*P≤0.05; **P≤0.01; ***P≤0.001). (B) 
Distribution of the size in single repair events that contained deletions. Average±s.e.m. 
and statistical significance by Kruskal-Wallis test with Dunn’s post-test are indicated.
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loss, correlating with the observed synergistic repair defect of combined TDP2 and 
ATM loss (Figure 32A). An even larger effect was observed if ATM inhibition was used 
instead of deletion (Figure 32B), confirming the requirement of the kinase activity of 
ATM, and ruling out differences caused by heterogeneity intrinsic to the MEFs or the 
cellular transformation process. Furthermore, the difference observed between deletion 
and chemical inhibition suggests a possible negative effect of inactive ATM, consistent 
with previous observations of the lethality of the catalytic dead ATM knock-in mice 
compared to Atm complete deletion (Yamamoto et al. 2012).
Furthermore, we addressed the impact of ATM deficiency on genome integrity 
following etoposide treatment in Tdp2+/+ and Tdp2−/− transformed MEFs. First, we 
monitored micronuclei formation, which arise from the missegregation of chromosomes 
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Figure 32: ATM promotes survival upon induction of blocked DSBs. (A) Clonogenic 
survival of the indicated transformed MEFs following acute treatment with the indicated 
concentrations of etoposide. Average±s.e.m. of at least three independent experiments 
is shown. (B) As above, with or without incubation with 10 μM ATM inhibitor.
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or acentric chromosomal fragments, and it is a well-established indicator of genome 
instability (Fenech 2000). To restrict our analysis to micronuclei arising due to the 
etoposide treatment applied, cytokinesis was blocked with cytochalasin B and only 
binucleated cells were scored (Figure 33). Independent deletion of either Atm or Tdp2 
caused an increase in etoposide-induced micronuclei. Interestingly, the levels were 
further increased when both genes were simultaneously deleted, doubling the frequency 
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Figure 33: ATM promotes the maintenance of genome integrity upon induction 
of blocked DSBs. (A) Micronuclei scored in the indicated binucleated transformed 
MEFs following acute treatment with 2.5 μM etoposide (30 min). Histogram bars (left) 
represent the average±s.e.m. of n≥600 cells from three independent experiments. 
Statistical significance by one-way ANOVA with Bonferroni post-test is indicated 
(*P≤0.05; **P≤0.01; ***P≤0.001). (B) Representative image of a treated Tpd2−/−Atm−/− 
cell containing multiple micronuclei. Tubulin (green), vinculin (red), DAPI (blue) and 
merge staining are shown. 
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observed in either single mutant. It is worth noting that the frequency observed 
corresponds to extremely high levels of instability, with many of the cells displaying 
multiple micronuclei, a qualitative difference compared with single mutants. To extend 
the analysis on genome instability, we scored chromosomal aberrations in metaphase 
spreads (Figure 34). Following etoposide treatment, Tdp2−/−Atm−/− cells displayed a 
marked increase in the number of chromosomal aberrations observed. A wide variety of 
aberration types were observed, including breaks, radial chromosomes and fusions. On 
average, these cells showed a striking 15% aberrant chromosomes, which represent a 7.5-
fold and 3-fold increase when compared to single Tdp2−/−Atm−/− mutants, respectively. 
Altogether, these results demonstrate that ATM promotes cell survival and maintains 
genome integrity upon blocked DSBs. 
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Figure 34: ATM protects cells from chromosomal abnormalities induced by blocked 
DSBs. (A) Chromosomal aberrations (both break and exchange type) following acute 
treatment with 2.5 μM etoposide (30 min). Plot shows the number of aberrations per 100 
chromosomes from individual metaphase spreads obtained in at least 6 independent 
experiments. Average±s.e.m. and statistical significance by Kruskal-Wallis test with 
Dunn’s post-test is indicated (*P≤0.05; **P≤0.01; ***P≤0.001). (B) Representative image 
of a Tpd2−/−Atm−/− metaphase containing multiple chromosomal aberrations (arrows).
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Tdp2−/− Atm−/− mice recapitulate the cellular phenotype 
Considering that ATM deficiency has a striking impact on cells upon blocked 
DSBs induction, we hypothesized that this type of lesions could have severe physiological 
consequences in a complex organism such as mouse. To test this, mice originated 
from Tdp2 and Atm double heterozygote crosses (Tdp2+/−Atm+/− x Tdp2+/−Atm+/−) were 
generated. They were born with no detectable gross abnormality and in normal mendelian 
proportions (Figure 35A).
In order to determine the impact of TDP2 and ATM loss upon TOP2-induced 
damage, adult mice (8 wk) homozygous for Tdp2 and Atm deleted alleles were subject to 
a single intraperitoneal injection of etoposide (25 mg/kg). As can be seen in Figure 35B, 
Tdp2−/−Atm−/− double-knockout mice showed a severe hypersensitivity upon etoposide 
exposure, suffering a progressive weight loss reaching a 15% loss after 6 days, when 
animals were sacrificed.  Histopathological analysis revealed marked villous atrophy in 
the small intestinal mucosa as the likely cause of the drastic weight loss (Figure 35C). In 
contrast, etoposide injections have negligible effect in either wildtype or ATM-deficient 
mice, and only a mild weight loss and intestinal atrophy was observed in Tdp2−/− animals. 
These results suggest a protective role of ATM against adverse effects of etoposide in 
vivo, but just when TDP2 is absent. For this, we can conclude that the phenotype of 
etoposide sensitivity observed in cells is consistently recapitulated in mice. 
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Figure 35: ATM loss confers hypersensitivity to blocked DSB induction in mice. 
(A) Genotypes of the progeny of crosses between Tdp2/Atm double-heterozygote mice 
expected by mendelian proportions and observed are shown. (B) Body weight of 8-week 
old mice cohorts intraperitoneally injected with a single dose of etoposide (25mg/kg). 
Average ± s.e.m. of the percentage of initial body weight from 5 mice and statistical 
significance by Two-way ANOVA with Bonferroni post-test are shown (*P≤0.05; **P≤0.01; 
***P≤0.001). (C) Representative images of hematoxylin-eosin stained jejunum slices 
obtained 6 days after etoposide exposure.
In previous work, in addition to intestinal damage, etoposide injections resulted 
in elevated splenic and thymic atrophy in Tdp2−/− mice compared to wildtype (Gómez-
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Figure 36: ATM loss does not affect thymus or spleen upon blocked DSB induction  
(A) Weight of thymus from mice sacrified in Figure 21 was measured (left). Average ± 
s.e.m. is indicated. Representative images of hematoxylin-eosin stained tissue slices 
are shown (right). (B) Same as in “A” but for spleen tissue was analysed.
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Herreros et al. 2013). Consistently, histological analysis of thymus and spleen in TDP2-
deficient animals revealed a reduction in weight and cellular content (Figure 36).  This 
effect was milder compared to higher etoposide dose and remarkably more pronounced 
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in thymus than in spleen (note the low density of dark-stained nuclei (Figure 36A, right). 
However, we observed a negligible effect of ATM inactivation in these particular tissues.
7. Tdp2-/-Atm-/- mice display elevated mortality due to an increased incidence of 
thymic lymphoma 
Based on our previous results, we can propose blocked DSBs as a potential threat 
to ATM-deficient animals. Indeed, we wondered whether this type of damage could 
underlie some of the symptoms of the A-T syndrome. We reasoned that if TOP2 damage 
underlies any of the phenotypes observed in ATM mouse model, inactivation of TDP2 
would largely aggravate it.
Mice carrying homozygous deletion of Atm alleles were previously reported to be 
smaller in size (Barlow et al. 1996). For this, the body weight of male mice was measured 
4 weeks after birth. As expected, Atm-/- mice showed a significant decrease in size 
compared to wildtype. On the contrary, deletion of Tdp2 did not aggravate the decreased 
size characteristic of Atm mice (Figure 37A). Nonetheless, when cellular growth index 
was measured in primary MEF cultures, Tdp2−/−Atm-/- cells showed a marked reduction 
in proliferation compared with single mutants (Figure 37B), suggesting that TOP2-
damage arises spontaneously, impacting on cell growth ex vivo.
Since inactivation of both genes has negligible effect during development, we 
decided to analyse their life span. For this, weight and general health status was monitored 
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weekly in a minimum of 20 mice per genotype, until reaching the experimental endpoint 
of 720 days (Figure 38A). ATM-deficient mouse model is characterized by an acute 
mortality within the first year of life, with a large number of animals developing massive 
thymic tumours. They succumb to disease since fast-growing T-cell lymphomas lead to 
lung collapse (Figure 38B, right). Consistent with this, we observed that ATM-deficient 
animals showed an increased death rate compared to wildtype. Strikingly, this was 
largely aggravated by Tdp2 inactivation, since Tdp2−/−Atm-/- showed a median survival 
of 140 days, contrasting with 307 days in the case of Tdp2+Atm-/- mice (Figure 38A). 
Furthermore, Tdp2 and Atm double-knockout mice showed an increased incidence of 
thymic lymphoma compared with Atm single mutants, increasing from 43 % to 72 % the 
likelihood of developing this type of tumour during the first year of life (Figure 38B). 
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Figure 37: The effect of TDP2 and ATM deficiency on cellular and mouse growth. 
(A) Weight of at least 20 male mice of the indicated genotypes 4-weeks after birth. (B) 
Cellular growth index was measured hourly during 3 days in the indicated genotypes of 
primary MEFs. 
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Figure 38: Tdp2 Atm homozygous mutant mice suffer increased incidence 
of thymic lymphoma. (A) Kaplan-meier survival curve of wild-type, Tdp2+Atm-/-,             
Tdp2-/-Atm-/- and Tdp2-/-Atm-/- mice. At least 20 animals per genotype were included in 
the analysis. (B) Representation of the cumulative risk to develop thymic lymphoma of 
the indicated mice (left). Statistical significance by Wilcoxon test of survival or thymic 
lymphoma risk is indicated (*P≤0.05; **P≤0.01; ***P≤0.001). Representative image of a 
thymic turmour compared to a healthy thymus (right).
Thus, we considered the possibility of TOP2 induced damage being a major determinant 
during A-T lymphomagenesis.  
92
RESULTS  
A 
0
20
40
60
80
100
CD
4+
CD
8+
 
Th
ym
ic
 ly
m
ph
om
a 
(%
) Tdp2+/+ Atm-/-
Tdp2-/- Atm-/-
100
101
102
103
104
100 101 102 103 100 101 102 103
CD4 CD4
C
D
8
C
D
8
WT thymus DP Thymic lymphoma
CD4-CD8- 1.98 ± 0.90 1.74 ± 0.54
CD4+CD8- 3.36 ± 1.54 3.20 ± 0.59
CD4-CD8+ 1.22 ± 0.22 1.30 ± 0.40
DP 93.44 ± 0.22 93.76 ± 2.48
Tdp2+ Atm-/- Tdp2-/- Atm-/-
B 
C 
Figure 39: Characterization of Tdp2-/-Atm-/- lymphomas. (A) Representation of 
the mean ± s.e.m of the percentage of precursors (double negative, DN), immature 
CD4+CD8+ (double-positive, DP), or mature CD4+CD8- and CD4-CD8+ (simple-
positive, SP) T-lymphocytes.  (B) FACs profile of T-lymphocytes extracted from a 
representative normal thymus (left) or a thymic tumour (right). X and Y axis represent 
CD4 and CD8 signal respectively. (C) Representation of the percentage of tumours 
composed by immature CD4+CD8+ lymphocytes in the indicated genotypes.
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Atm-/- mice were reported to display decreased number in mature CD4 and CD8 
single positive T-lymphocytes. Thus, we first tested if TDP loss affects the distribution. We 
found that double-knockout mice did not show differential distribution of T-lymphocyte 
populations in healthy thymus compared to Tdp2+Atm-/- mice. Then, thymic lymphomas 
were further characterized. Fundamentally, tumours isolated from double-knockout and 
Atm-/- mice were formed by immature double-positive (DP) T-lymphocytes (Figure 39). 
In order to evaluate genomic instability in these tumours, we analyse copy number variation 
in the genome of cancerous cells by performing a Comparative Genomic Hybridization 
(CGH). Through this assay, deletions and duplications along the genome of tumour cells 
can be detected (Michels et al. 2007), and these regions of instability have been proven to 
correlate within breakpoints of oncogenic translocations. Thus, we compared instability 
hotspots along the genome of 6 double-knockout and 2 Atm-/- thymic tumours (Figure 
40). Interestingly, we found several recurrent hotspots of instability along the genome 
of Tdp2−/−Atm-/- mice. A marked instability in the telomeric region of chromosome 12 
was observed in 6 out of 6 mice. In a similar manner, trisomy of chromosome 15 was 
also observed in every tumour analysed. Consistently with the contribution of V(D)
J recombination to clonal translocations previously described in A-T malignancies,  4 
out of 6 displayed instability along the chromosome 14, with breakpoints located in the 
Tcrad gene. Other genomic regions displaying increased instability were found, such as 
chromosome 19 (2 out of 6), in which Pten tumor suppressor is located, telomeric region 
of chromosome 5 (2 out of 6) and chromosome 2 and 6, with breaking points mapping 
in Notch1 tumour suppressor or immunoglobulin genes respectively (1 out of 6). ATM-
deficient tumours showed instability in the same regions that were observed in double-
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Figure 40: CGH analysis of Tdp2-/-Atm-/- thymic lymphomas. (A) Each tumor sample 
was hybridized and analyzed using kidney DNA as control. The Y axis represents 
amplification/deletion index (sum of Log2 tumor/kidney ratio of all tumors analyzed). 
Significant copy number variations are defined by Log2 tumor/kidney > 0.66 (black 
dashed line). The amplification score at each probe location is plotted in red and deletion 
score is plotted in blue. Location of important genes in which copy number variation has 
been previously described is indicated.
knockout tumours. Importantly, every breakpoint and instability hotspot observed in our 
analysis were described in previous characterization of the ATM-deficient mouse model 
(Zha et al. 2010). Thus, our result suggests that TDP2 loss does not alter the location and 
distribution of chromosomal breakage that induces oncogenic translocations of thymic 
malignancies in Atm-/- mice. This, together with the marked increase in the incidence of 
thymic lymphomas observed in double-knockout mice compared to single Atm deletion, 
suggests that TOP2 could participate in the neoplastic changes described in A-T. 
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ATM-deficient mice recapitulate the majority of A-T symptoms, with the 
exception of the progressive Purkinje cell loss leading to cerebellar ataxia. It is important 
to mention that the lack of an adequate animal model for this particular feature has 
traditionally impeded the study of the most debilitating symptom of A-T. Therefore, 
we tested whether TDP2 inactivation influences cerebellum integrity in 8-week mice. 
We did not observe any reduction in Purkinje cell density in cerebellar tissues when 
double-knockout were compared with single ATM-deficient animals (Figure 41). 
Moreover, animals that were subject to lifespan analysis (Figure 38A) did not show any 
gross deficiency in motor skills at any point of the experiment. It is important to remark 
that TOP2-induced damage as a trigger of cerebellar ataxia in A-T disease cannot rule 
out by these results, since the mouse model has proved to be an inadequate model for 
neurodegeneration in numerous DDR-related diseases.  
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Figure 41: Tdp2-/-Atm-/- mice do not show cerebellar neurodegeneration. (A) Purkinje 
cellular density observed by calbindin immunohistochemistry on sagital vibratome 
sections of cerebellums obtained from Tdp2+Atm-/- and Tdp2-/-Atm-/- 8-weeks old mice. 
At least three independent individuals per genotype were analyzed. (B) Representative 
images of cerebellum.
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8. DNA-PKcs activity and ATM redundantly promote repair of blocked-DSBs. 
DNA-PKcs and ATM are enzymes that belong to the same PI3K-like kinase 
family. They have been reported to modulate the DNA damage response upon DSB-
induction, and redundant and non-redundant functions have been described. Therefore, 
we decided to test if DNA-PKcs was implicated in the repair of blocked DSBs. For this, 
we decided to test how inactivation of DNA-PKcs would impact TOP2-induced DSB 
repair in wildtype and TDP2-deficient backgrounds. As above, we followed the time 
course of γH2AX foci disappearance after etoposide treatment in G0 primary MEFs 
(Figure 42). As previously reported, wildtype cells showed accumulation of unrepaired 
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Figure 42: DNA-PKcs activity mediates repair of TOP2-induced DSBs (A) γH2AX 
foci induction and disappearance upon 30 min treatment with 10 µM etoposide and 
different repair times in the indicated confluency arrested primary MEFs incubated or 
not with 10 µM DNA-PKi. Total number of foci (left) and percentage remaining (right) 
is shown. Average ± s.e.m. of at least three independent experiments is shown (left). 
Statistical significance by two-way ANOVA test with Bonferroni post-test is indicated 
(*P≤0.05; **P≤0.01; ***P≤0.001) (right).  
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foci when DNA-PKcs activity was inhibited, according to its general role in NHEJ. 
Interestingly, DNA-PKcs inactivation showed a further DSB repair defect in Tdp2−/− cells 
compared with the wildtype. These points out the specific requirement of DNA-PKcs 
in blocked DSB repair, suggesting an additional role in processing beyond its general 
function in NHEJ.
Since these kinases have been reported to be responsible for the redundant 
phosphorylation of H2AX (Burma et al. 2001; Stiff et al. 2004), we analysed γH2AX foci 
induction upon irradiation and etoposide exposure in the presence of ATM and DNA-
PKcs inhibitors (Figure 43). Consistently with previous results, we observed that γH2AX 
formation is largely dependent on ATM kinase, since foci intensity was largely reduced 
by ATM inhibition. Nevertheless, DNA-PKcs inhibition by itself or in combination 
Figure 43: Induction of γH2AX foci upon ATM and DNA-PKcs inactivation 
(A) Average foci intensity of γH2AX foci after 30 min 10 µM etoposide treatment in 
confluency arrested primary MEFs incubated with ATMi, DNA-PKi and the combination 
of both inhibitors (left). 
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with ATM inactivation, showed a negligible impact on γH2AX foci intensity. Therefore, 
we validated the use of γH2AX foci scoring to measure DSB repair in conditions in 
which both kinases are inactivated. 
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Figure 44: ATM and DNA-PKcs kinase activities redundantly promote the repair of 
TOP2-induced blocked DSBs (A) γH2AX foci induction and disappearance upon 30 
min treatment with 10 µM etoposide and different repair times in wild-type confluency 
arrested primary MEFs incubated or not with 10 µM ATMi, DNA-PKi or the combination of 
both inhibitors. Total number of foci (upper) and percentage remaining (lower) is shown. 
Average ± s.e.m. of at least three independent experiments is shown (left). Statistical 
significance by two-way ANOVA test with Bonferroni post-test is indicated (*P≤0.05; 
**P≤0.01; ***P≤0.001) (right). (B) Same in “A” but with Tdp2-/- MEFs. 
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To determine the interaction between ATM and DNA-PKcs in the repair of 
TOP2-induced damage, we followed the time course of γH2AX foci disappearance after 
etoposide treatment, combining ATM and DNA-PKcs chemical inhibition. As can be 
seen in Figure 44A, inhibiting ATM had a negligible effect in the repair of clean DSB, even 
when DNA-PKcs was inactivated. Strikingly, in TDP2-deficient cells, the combination 
of both inhibitors showed a marked repair defect compared with single inactivation 
(Figure 44B). Moreover, in cells carrying deletions in Atm and inactive DNA-PKcs, 
TDP2 deficiency results in the complete abrogation of DSB repair (Fig.45A). Curiously, 
under Atm deletion and the chemical inhibition of DNA-PK, γH2AX foci formation 
was absent at 30 min after etoposide exposure (Fig.45B), but foci could be proficiently 
scored at 9h after etoposide removal. 
In any case, to avoid artefacts due to the indirect measure of DSBs in conditions 
in which γH2AX foci induction was impaired, we performed the neutral comet assay 
(Figure 45C). This approach is based in the direct measure of DSBs, by comparing the 
electrophoretic mobility of the DNA contained in the nuclei of single cells embedded in 
agarose (Olive & Banath 2006). We did not observe differential comet signal in Tdp2−/− 
Atm-/- MEFs when they were incubated or not with DNA-PKcs inhibitor, confirming 
that similar number of DSBs are induced by etoposide exposure. This result validates 
γH2AX foci scoring performed in Figure 45A as an efficient measure of DSB repair. On 
top of this, after 12 hours of etoposide withdrawal, inhibition of DNA-PKcs combined 
with ATM-deficiency totally impaired DSB repair, consistent with our previous result. 
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Based on our observations, we anticipated that impairment of both, ATM and 
DNA-PKcs activity, would lead to severe consequences for cell integrity upon blocked 
DSB exposure. Thus, cell survival was monitored by clonogenic assay in response to 
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Figure 45: DNA-PKcs inactivation aggravates ATM deletion repair defect to TOP2-
induced blocked DSBs. (A) γH2AX foci after 9 h following drug removal (30 min 10 µM 
etoposide) in the indicated genotypes of confluency arrested primary MEFs incubated or 
not with 10 µM of DNA-PKcs inhibitor. (B) Representative images of γH2AX foci (green) 
and DAPI counterstain (blue) for the induction (0 h) and 9 h repair time point in Tdp2-/-
Atm-/- cells upon DNA-PKcs inhibition are shown. (C) Neutral comet assay in confluency 
arrested primary MEFs incubated 1 h 100 µM etoposide treatment and 12 h repair point 
(left). A representative image is shown (right).
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increasing doses of etoposide in wildtype and Tdp2−/− transformed MEFs (Figure 46). 
Combined ATM and DNA-PKcs inactivation resulted in etoposide sensitivity compared 
to single inhibition, even in wild-type background (Figure 46A). Nevertheless, a largely 
aggravated hypersensitivity to etoposide was observed in TDP2-deficient background 
when ATM and DNA-PKcs were simultaneously inactivated, even at lower doses of 
etoposide (Figure 46B). This altogether suggests that ATM and DNA-PKcs encompasses 
two redundant pathways to protect cell integrity upon DSBs, but they are especially 
important for the survival upon blocked DSBs. 
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Figure 46: ATM and DNA-PKcs redundantly promote survival upon induction of 
blocked DSBs. (A) Clonogenic survival of wild-type transformed MEFs following acute 
treatment with the indicated concentrations of etoposide. Cells were incubated or not 
with 10 µM ATM, DNA-PKcs or the combination of both inhibitors. (B) As above, but 
Tdp2-/- transformed MEFs were used.
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IV. DISCUSSION
The study of the mechanisms that repair damaged DNA and safeguard the 
genetic information has provided essential knowledge of how living cells function. Since 
researchers pointed out the inherent instability in the chemistry of DNA, and its reactivity 
with numerous chemical and physical agents, the study of DNA repair has served to make 
a qualitative leap in scientific, clinical, technological and even social issues. Of particular 
interest, we can mention the contribution to unveil the cause of important human diseases 
(McKinnon & Caldecott 2007). In this regard, defective DNA repair mechanisms have 
been demonstrated to predispose individuals to aging, cancer proneness or to suffer 
congenital syndromes. In addition, since DNA repair capacity largely affect the response 
to cytotoxic treatments commonly used against cancer, discerning how repair pathways 
can be modulated to specifically induce tumour death is decisive (Melorose et al. 2008). 
On top of this, besides the contribution in disease treatment, it is worth mentioning that 
DNA repair field has also helped to develop important biotechnological advances, ranging 
from daily-used laboratory techniques, to the most innovative procedures of genome 
editing and next generation sequencing. Therefore, understanding at the molecular level 
the rules that govern DNA repair attaches the utmost importance. 
1. Molecular role of TDP2 and its physiological implications 
TOP2 activity is keystone in DNA metabolism, since it removes topological 
constraints generated by transcription and replication, and facilitates chromosomal 
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segregation. Importantly, previous work has also linked TOP2 with transcriptional 
regulation of important genes during human development. On top of this, TOP2 activity 
and its trapping in cleavage complexes promoted by TOP2-poisons has been an effective 
approach to treat several types of oncogenic malignancies over decades. For all of this, the 
mechanisms of how TOP2 induces DNA damage and how these lesions are repaired are 
of particular interest for cellular and molecular biologist, as well as clinicians. 
In this work, we have dissected the enzymatic activity of TDP2, confirming that 
it is the only relevant 5’-tyrosyl-DNA-phosphodiesterase activity in mammalian cells, 
consistently with previous results obtained in avian DT40 cells and human cell lines. 
However, TDP1 had been proposed to undergo the removal of 5’ phosphotyrosine 
blockages from DNA ends, collaborating in the repair of TOP2-induced DSBs. This 
was based on a weak 5’-TDP activity of human TDP1 recombinant protein, resistance 
of TDP1 overexpressing cells to etoposide treatment and the physiological 5’-TDP 
activity described in Saccharomyces cerevisiae TDP1 (Nitiss et al. 2006). Nonetheless, 
we have not detected any residual 5’-TDP activity in Tdp2−/− cellular extracts or in 
wildtype extracts in the presence of Mg2+ chelator EDTA, suggesting that TDP1 activity, 
which is Mg2+-independent (Murai et al. 2012), cannot compensate TDP2 deficiency. 
Moreover, alternative work has not found evidence for an increased etoposide sensitivity 
or repair defect of Tdp1/Tdp2 deleted cells compared to single TDP2-deficient cells 
(Zeng et al. 2012). It is important to mention, that in contrast to TDP1, there is no 
obvious TDP2 ortholog in yeast. Hence, we can speculate that while Saccharomyces 
cerevisiae TDP1 can display both activities efficiently, TDP2 could have appeared later in 
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evolution, restricting TDP1 to a more specialized 3’ TDP activity in higher eukaryotes. 
Furthermore, previous work has proposed that TDP2 activity promotes the repair of 
TOP2-induced DSBs in mammalian cells, based on its preference for 5’-phosphotyrosyl 
termini in blunt dsDNA, compared to single-stranded 5’ termini or 5’ termini at single-
strand breaks (Ledesma et al. 2009).  It is worth mentioning that TOP2 cleavage is 
characterized by four-based staggered nicks in the DNA backbone, that can potentially 
produce DSBs harbouring 5’ phosphotyrosine overhangs (Liu et al. 1983). Consistently, 
we have observed that TDP2 promotes the efficient cleavage of 5’ phosphotyrosines 
harboured in 4 bp overhangs, consistent with a physiological role of TDP2 in the repair 
of TOP2-induced lesions. On top of this, our data strongly suggests, that the biochemical 
mechanism of TDP2 unblocks TOP2-induced DSBs without loss of a single nucleotide, 
generating 5’ phosphate complementary overhangs. The result of this reaction largely 
facilitates the direct ligation of these DSBs by the NHEJ machinery. Consistent with a 
role of TDP2 in NHEJ pathway, KU70 has been described to be epistatic over TDP2 for 
etoposide sensitivity. Nevertheless, whether TDP2 can act independently or it requires 
the association with NHEJ factors under physiological conditions is still unclear. In this 
regard, direct interaction between c-NHEJ proteins and TDP2 have not been described 
so far. In any case, TDP2 displays the most adequate enzymatic activity to ensure error-
free ligation of TOP2-induced DSBs. In theory, it was anticipated that TDP2 activity 
would be crucial when NHEJ is the only active pathway. 
Although TDP2 loss slows down the repair of DSBs, they are eventually 
repaired even in quiescent cells when NHEJ is the only active pathway. This suggests 
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that alternative mechanisms must be operating. In theory, the absence of TDP2 forces 
TOP2-induced DSBs to undergo processing, since this is the only mechanism that can 
remove 5’-peptide adducts to allow ligation. In consequence, DSB ends must be trimmed 
by nucleases. It is important to keep in mind that 5’ overhang trimming potentially leads 
to sequence loss, since DNA polymerases cannot reconstitute the original sequence, 
due to its characteristic 5’ to 3’ polymerization polarity (Ramsden 2011). Thus, despite 
TDP2-independent pathways must be operating to repair TOP2-induced lesions, they 
are potentially mutagenic. Indeed, it has been described that TDP2-deficient cells suffer 
increased genome instability upon TOP2-poison exposure (Gómez-Herreros et al. 2013). 
It would be essential to analyse in the future at the nucleotide level, the consequence of 
TDP2 loss upon TOP2-induced damage. Nonetheless, this is technically challenging, 
since TOP2 activity is normally enriched in certain regions of the genome, but it does 
not cleave in a sequence specific manner (Madabhushi et al. 2015). In consequence, the 
lack of TOP2-induced DSB specific sites has impeded this analysis under physiological 
conditions. Thus, new approaches should be developed to address this issue.
Mutagenic DNA repair has been proven to contribute to cancer development 
and progression. Therefore, it is tempting to think that TDP2 loss would present a 
potential source of genome instability and neoplastic changes. Thus, TDP2 is a factor 
that must be taken into account in cancer development, progression and treatment. To 
address the implication of TDP2 in cancer, incidence of tumours in lifespan experiments 
should be carried out in TDP2 mouse model. In addition, TDP2 must be considered a 
determinant factor in cancer treatment, especially when patients are treated with TOP2-
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poisons (Pommier et al. 2010). We can anticipate that TDP2 inactivation will sensitize 
tumour cells to TOP2-poison chemotherapy. Indeed, to explore this possibility, catalytic 
inhibitors that block TDP2 activity have been described recently and they are under 
characterization for their adequateness for clinical trials (Marchand et al. 2016; Kossmann 
et al. 2016; Kankanala et al. 2016; P. Hornyak et al. 2016) However, it is important to 
consider that based on our findings, inactivation of TDP2 could channel DSB-repair to 
error-prone pathways, which can potentiate the development of treatment-associated 
secondary leukemias (Pendleton et al. 2014).
TOP2B plays an essential role in the removal of topological constraints allowing 
efficient transcription, being determinant for the expression of neural development and 
long genes (Li et al. 2014; Lyu et al. 2006; Nur-E-Kamal et al. 2007; King et al. 2013). 
Beside its role in topological modulation, increasing evidence supports the notion that 
human TOP2B also modulates the expression of specific genes in response to certain 
stimuli. Indeed, TOP2B activity in promoters has been proposed to regulate the 
expression of certain genes in response to hormones, such as estrogen and androgen, 
amongst other stimuli (Haffner et al. 2010; Bong-Gun et al. 2006). In a similar manner, 
recent work has proposed that TOP2B activity mediates the expression of early-response 
gene in neurons (Madabhushi et al. 2015). Curiously, it has been proposed that the 
transcriptional regulation mediated by TOP2B relies on the induction of physiological 
DSBs (Bunch et al. 2015). Nevertheless, how this mechanism is regulated in order to 
modify gene transcriptional status is still unknown. In any case, efficient DSB repair 
machinery would be crucial for maintaining genome integrity in transcribed regions. 
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Interestingly, depletion of TDP2 was shown to greatly reduced gene expression of 
AR-regulated genes in a cellular system, suggesting that TDP2 contributes to this 
mechanism (Gómez-Herreros et al. 2014). However, further work needs to be performed 
to measure the extent of TDP2 contribution in early-response genes regulation in adult 
brain. Another important issue is that recent work has linked mutations in TDP2 that 
abolish the enzymatic activity with a congenital syndrome characterized by severe 
neural deficiencies (Gómez-Herreros et al. 2014). These neural features seem to be 
caused by deregulation of TOP2-dependent transcription of important genes for neural 
development and homeostasis. Altogether, these observations points toward TDP2 as a 
crucial factor for TOP2-mediated regulation of the transcriptional landscape, and which 
loss may have severe consequences in human health. 
Finally, it is worth mentioning that the exact contribution of TDP2 to HR pathway 
remains unclear. Nonetheless, we can anticipate that the presence of 5’ blockages would 
have a negligible impact on HR pathway, since in this repair pathway DSBs normally 
undergo processing of the 5’ strand. In this regard, it has been reported that TDP2 loss 
lead to channelling TOP2-induced DSBs through HR repair, suggesting that TDP2 
activity is restricted to NHEJ pathway (Gómez-Herreros et al. 2013). Consistently, the 
combination of TDP2 depletion and BRCA2 deficiency, a factor that promotes HR 
repair, displayed synergistic hypersensitivity upon etoposide exposure, suggesting that 
TDP2 operates in a HR-independent manner.  Curiously, Spo11 initiates meiotic 
recombination by inducing DSBs in a similar manner as Topoisomerase 2, remaining 
attached by a covalent phosphotyrosine bond to the 5’ ends (Lam & Keeney 2015; 
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Neale et al. 2005). During this process, homologous chromosomes are confronted in the 
bivalent and DSBs are channelled towards HR repair (Gao et al. 2014). Whether TDP2 
can cleave SPO11 complexes in vivo is still unclear. We can speculate that based on the 
requirement of TOP2cc degradation to allow TDP2 unblocking activity, intact Spo11 
would be refractory to TDP2 activity. Importantly, this would ensure that processing of 
5’ strand and repair by HR is the preferential pathway operating during gametogenesis. 
In any case, it is tempting to think that TDP2 activity would be modulated in different 
physiological processes, depending on the requirement for 5’ end unblocking. 
2. Molecular role of ATM in the repair of blocked DNA double-strand breaks
Historically, the study of how the chemical structure of DSB ends affects the 
repair process has been impeded by the inability to induce homogeneous lesions. The 
majority of DNA damaging agents used for this purpose generates a vast number of 
heterogeneous chemical structures. IR has been widely used as a tool for the study 
of DNA repair, but it produces a plethora of nucleotide and base modifications, and 
generates a combination of SSBs and DSBs (Ward 1988; Hagen 1994). By chance, a 
small fraction of these breaks would harbour a damaged base blocking the termini. On 
top of this, higher-energy radiation has been also used for the study of blocked DSB, 
since it increases the likelihood to generate clustered DSB with aberrant structures at 
their termini (Brenner & Ward 1992). However, the heterogeneity of lesions generated 
in the DNA molecule impedes the interpretation of the results obtained through this 
approach. There are more molecularly controlled systems that have shed some light on 
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the process of blocked DSB-repair. For instance, V(D)J recombination, which relies on 
the cleavage of RAG1/2 recombinase in specific loci during lymphocyte development, 
generates at the same time two types of DSBs, a hairpin blocked DSB in the coding 
end, and a clean blunt-ended DSB in the signal end. This has allowed researchers to 
analyse the contribution of NHEJ factors in the repair of each type of DSB. Several 
in vitro and in vivo systems have been developed for the study of this process, being 
determinant in immunology research (Ramsden et al. 1997; Bredemeyer, Helmink, et al. 
2008). However, tools that rely on RAG1/2 cleavage have also shown disadvantages for 
the study of blocked DSB repair, since they only operate in G1 lymphocytes and display 
characteristic and peculiarities that are specific of the V(D)J recombination process. 
For all these reasons, we aimed to develop a novel approach to analyse the 
contribution of different factors to the repair of blocked DSBs. In the present work, we 
have successfully defined genuine methodology to induce homogeneous population of 
blocked or clean DSBs depending on the genetic background (Figure 17). Importantly, 
we have proven that several experimental setups can be proficiently assayed in different 
cells and animal models. Nonetheless, it stands to reason that this system relies on TOP2-
activity, and therefore, TOP2 singularities and modulation along different conditions 
must be taken into consideration. 
Since ATM identification, numerous laboratories have carried out extensive research 
to elucidate its molecular role and impact on human pathology. Presumably, due to the 
overwhelming number of processes in which it is involved and the numerous proteins that 
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are regulated by its kinase activity, it has been extremely complex to integrate every facet 
of ATM. In any case, its deficiency has been consistently demonstrated to impact just on 
a small fraction of DSB repair in cells. Therefore, two subpopulations of DSBs, according 
to their ATM dependency or independency, could be considered. Our work demonstrates 
that to some extent, this division might be based on the structural heterogeneity of the 
ends induced by DNA-damaging agents. Indeed, we have demonstrated that ATM 
does not influence the repair of clean DSBs, which present 5’ phosphate and 3’ hydroxyl 
termini, or in DSBs that can be directly unblocked. Consistently, alternative studies with 
different approaches such as the cleavage with restriction enzymes in certain regions 
of the genome have described similar results (Caron et al. 2015b). In contrast to clean 
DSBs, ATM activity is crucial to facilitate the repair of blocked DSBs, preventing from 
their deleterious outcomes. Therefore, we have contributed to the understanding of the 
molecular role of ATM in the repair of DSBs.
Curiously, ATM inhibition seems to sensitize cells to blocked DSBs to a greater 
extent than ATM deletion. This suggests that the presence of inactive ATM could 
inhibit DSB repair, probably in a dominant negative fashion, while ATM loss allows 
the repair by redundant pathways. This is consistent with the observation that Atm-/- 
mice are viable, in contrast to the embryonic lethality displayed by mice expressing a 
kinase-dead mutant form of ATM (Yamamoto et al. 2012). In addition, our data strongly 
suggests that ATM action in blocked DSBs is largely independent on the previously 
reported role of ATM in facilitating repair of heterochromatin-associated lesions. Our 
results, while they can be interpreted as conflicting with the previous model, are indeed 
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a demonstration of a broader role of ATM in the repair of any kind of complex lesion in 
which repair is suboptimal. In this context, ATM would be crucial for any DSB that is 
not directly ligated by the DSB repair machinery. Beside this, recent work has suggested 
that ATM also promotes higher-order chromatin organization, ensuring association in 
repair clusters of multiple DSBs induced by restriction enzymes, but this not seem to 
affect the repair process (Caron et al. 2015b). 
Unfortunately, the exact molecular mechanism of ATM in blocked DSBs still 
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Figure 47: Model for ATM involvement in blocked DSB repair. ATM promotes 
processing and inhibits excessive degradation of blocked DSBs to ensure correct repair. 
Processing is essential to remove blockages from DNA ends and to avoid cell death 
induced by unrepaired DSBs. At the same time, ATM ensures that end trimming is the 
minimum necessary for repair, avoiding excessive degradation. This protects cells from 
genomic instability associated to deletions and gross chromosomal rearrangements. 
In the absence of ATM, increased cell death and genome instability can trigger the 
development of A-T symptomatology.
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remained elusive. Nevertheless, our results allow us to propose two possibilities that are 
not mutually exclusive (Figure 47). On one hand, ATM kinase activity may promote 
end processing by regulating the action of factors required for this process, such as 
endonucleases or DNA polymerases. On the other hand, beyond its role in facilitating 
the processing of blocked DSBs, it may preserve genome integrity, by ensuring that DSB 
ends undergo the minimum processing required for repair. This controlled processing 
would be crucial to avoid excessive end degradation that can lead to error-prone repair 
and gross chromosomal rearrangements.  
In theory, there are several possible known nucleases that can be taken into 
consideration. However, it is important to remark that multiple enzymes might be 
downstream of ATM and account for DSB processing when they cannot be efficiently 
unblocked. For instance, Artemis and the MRN complex have been previously shown 
to contribute to the repair of TOP2-induced DSBs (Quennet et al. 2011; Kühne et al. 
2004). Consistently, Artemis has been shown to promote processing of DSB during 
NHEJ pathway by its endonuclease activity, operating on 5’ single-stranded overhangs 
(Chang & Lieber 2016; Goodarzi et al. 2006). Interestingly, its endonuclease activity 
preferentially cleaves on the ssDNA/dsDNA junction. Thus, in theory, it would be 
capable to trim 5’ blocked ends generated by TOP2-abortive activity with a minimum 
loss of nucleotides. On top of this, Artemis has proven required for fully efficient NHEJ 
repair, using diverse damaging agents. Importantly, fibroblasts carrying mutations 
in Artemis, display a similar repair defect compared to ATM-deficient cells upon IR 
exposure (Riballo et al. 2004). Indeed, ATM deficiency was shown to be epistatic over 
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Artemis-deficiency, suggesting that ATM could be in some way modulating its activity. 
Nonetheless, ATM has been proven to phosphorylate Artemis, but this seems to be 
dispensable for DSB repair (Goodarzi et al. 2006). For all of these, it would be crucial 
to analyse the exact contribution of Artemis in the repair of blocked DSBs under our 
specific experimental conditions.
In addition to Artemis-dependent processing, which is restricted to a few 
nucleotides away from the ends, the MRN complex can act hundreds of nucleotides 
upstream of the DSB termini (Garcia et al. 2012). MRN complex activity is crucial for 
HR repair, since it can initiate resection of DSBs generating 3’ protruding ends. For 
this, it promotes endonuclease cleavage upstream of the DSB termini, followed by a 3’ 
to 5’ exonuclease activity. Thus, in principle, the MRN complex could also facilitate the 
removal of a 5’ blockage. Consistent with this possibility, the interplay between the MRN 
complex and ATM in regulating DSB repair has been widely reported. Indeed, every 
single component of the MRN complex can be phosphorylated by ATM, and ATM full 
activation upon DSB-induction seems to require its interaction with the MRN complex 
through NBS1 (Lavin et al. 2015; Difilippantonio et al. 2007). On top of this, ATM has 
been proposed as a modulator of the processing activity of MRN (Kijas et al. 2015). Thus, 
it would be essential to test if the ATM-dependent pathway for the repair of blocked 
DSBs relies on the MRN complex nuclease activity. In any case, it will be necessary to 
carry out further work to elucidate to which extent Artemis or the MRN complex are 
contributing to the repair of TOP2-induced DSBs in the absence of TDP2, and how 
they are regulated by the ATM kinase activity. 
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As mentioned above, it is also tempting to speculate that ATM could inhibit 
excessive degradation of DSBs. In quiescent cells (G1/G0), processing activity must be 
closely regulated to avoid long-range resection of DSB ends, since sister chromatids 
are not present during these cell cycle stages to be used as template for HR. Under 
these conditions, NHEJ is the preferential repair pathway, but MMEJ pathway, which 
requires MRN processing, could also contribute to the repair of this type of lesions in 
the absence of an unblocking activity (Sfeir & Symington 2015). It is tempting to think 
that ATM could be responsible for the inhibition of long-range resection when the 
MRN complex initiates degradation of DNA ends. A possible candidate would be Exo1 
exonuclease, which promotes extensive degradation of ends to channel DSBs to a HR-
dependent repair (Bolderson et al. 2010). Nevertheless, there are other possible factors in 
the DDR that are controlled by ATM activity and could prevent long-range resection. 
ATM-dependent formation of γH2AX has been demonstrated to be essential for the 
recruitment of downstream factors, such as MDC1, 53BP1 and BRCA1 (Bekker-Jensen 
& Mailand 2010). They have been suggested to be crucial choice of repair pathway, 
controlling to which extent DSBs are processed. Since ATM is the major contributor to 
the early wave of γH2AX phosphorylation upon DSB induction, a decrease in γH2AX 
formation adjacent to the lesions could lead to unprotected DSB ends. Consistent with 
this hypothesis, cells and mice lacking H2AX present increased genome instability 
upon DSB-induction in numerous experimental setups (Celeste et al. 2002). Indeed, 
blocked DSBs generated during V(D)J recombination are largely degraded in a MRN-
dependent manner in the absence of Artemis and H2AX (Helmink et al. 2011). In a 
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similar manner, we can propose that, TDP2-deficiency would force TOP2-induced 
DSBs to be processed and in the absence of ATM-dependent formation of large γH2AX 
regions, MRN complex and other nucleases could promote excessive degradation of 
ends, leading to error-prone repair, gross chromosomal rearrangements or accumulation 
of unrepaired DSBs. Nevertheless, future experiments must be performed to clarify the 
exact contribution of each of these factors to the increased genomic instability linked to 
ATM-deficiency upon the induction of blocked DSBs.
Up to date, several redundant and non-redundant roles of ATM and DNA-PKcs 
have been reported. However, the precise function of these kinases in DSB repair is 
still a matter of debate. Both are efficiently activated by DSB induction, and they share 
numerous common substrates. However, they also support distinct functions and their 
impairment implies different outcomes for cells and organisms. While ATM deletion 
leads to nearly normal repair rate, and an accumulation of a fraction of permanently 
unrepaired DSBs, DNA-PKcs absence largely slows down repair but not completing 
repair (Goodarzi et al. 2010). Notably, in both cases, DSB induction leads to the 
accumulation of illegitimate joining events that are highly deleterious. Strikingly, we have 
found that ATM and DNA-PKcs encompass two pathways that redundantly promote 
blocked DSB repair in mammalian cells. In the absence of both activities, cells show a 
marked sensitivity upon this type of lesions, probably due to a total lack of repair. Indeed, 
such a striking repair defect has been only observed in Lig4-/- quiescent cells upon IR 
exposure. Further dissection of downstream factors that function in each pathway would 
be particularly interesting. 
While we have observed a negligible effect of ATM absence in clean DSB repair, 
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DNA-PKcs inactivation has shown a significant accumulation of unrepaired DSBs. This 
is consistent with previous evidence of DNA-PKcs kinase activity being important for 
NHEJ. Nevertheless, the repair defect was exacerbated when the termini were blocked, 
suggesting that DNA-PKcs kinase activity, in addition to the role in the end joining 
process itself, is specifically required for the correct processing of blocked lesions. 
Our experiments have been performed using chemical inhibition of DNA-PKcs and 
dominant negative effects due to the presence of inactive protein attached to DSB ends 
cannot be ruled out. Thus, it would be important in the future to carry out experiments 
in DNA-PKcs-deficient background. In any case, two distinct pathways seem to operate 
in cells for the repair of blocked DSBs, differentially regulated by ATM or DNA-PKcs 
kinase activities. Therefore, it is tempting to speculate that in conditions in which ATM 
is absent, DNA-PKcs would compensate for the removal of these lesions. Interestingly, 
combined absence of ATM and DNA-PKcs have been shown to lead to embryonic 
lethality in mice (Gurley & Kemp 2001). This has been explained as a synthetic lethality 
effect produced by the accumulation of DSBs characteristic of a DNA-PKcs deficiency, 
on top of the impairment in cell cycle checkpoints caused by Atm deletion. However, 
since these two proteins distinctly control the only two pathways for the repair of blocked 
DSBs, we hypothesize that accumulation of blocked DSBs could to some extent underlie 
the severity the phenotype observed in the combined absence of ATM and DNA-PK. 
The formation of the DNA-PK complex at DSBs has been described as a key 
step for end tethering and protection, end processing and repair pathway choice. In 
this regard, the modulation of DNA-PKcs activity and its structure is key during the 
120
DISCUSSION  
repair process. For this, DNA-PKcs suffers conformational changes that are modulated 
by the phosphorylation of functionally different clusters, such as the ABCDE and the 
PQR (Meek et al. 2008). Previous work has described the importance of the kinase 
activity of DNA-PKcs and its posttranslational changes upon the exposure to DSB-
inducing agents. Thus, it is tempting to think that a tightly adjusted phosphorylation 
status along the repair process is essential. In the present work we have described the 
importance of ATM and DNA-PKcs activities in the repair of DSBs that specifically 
harbour a blockage in their termini. Thus, we can hypothesize that ATM and DNA-
PKcs modulate precisely the status of DNA-PK phosphorylation, and this is key for the 
correct repair of blocked DSBs, since they rely on processing to ensure ligation. It has 
been proposed that the PQR cluster is autophosphorylated in trans, and this leads to end 
protection, reducing nucleotide loss in joining events. Additionally, this phosphorylation 
seems to contribute to an open conformation of DNA-PKcs, allowing the access of 
the ligase complex to complete the NHEJ process. Conversely, phosphorylation in the 
ABCDE cluster seems to be carried out by DNA-PKcs or ATM redundantly (Chen et 
al. 2007), facilitating end processing. In this regard, Artemis endonuclease activity seems 
to rely on the phosphorylation of the ABCDE cluster (Goodarzi et al. 2006). Therefore, 
we can hypothesize that in the presence of blocked DSBs generated by TOP2 abortive 
action, redundant phosphorylation of the ABCDE could be key to promote limited end 
processing by Artemis or other downstream nucleases. Consistent with this, ATM and 
DNA-PKcs kinase activities display redundant roles for the repair of blocked DSBs in 
our particular experimental setup. It will be crucial to dissect the specific contribution of 
each phosphorylation events that facilitate the repair of blocked DSBs.
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3. Physiological implications of ATM function in the repair of blocked double-
strand breaks
Our results strongly support the notion that ATM is critical in minimizing the 
deleterious outcomes of blocked DSBs, not just in cells, but also in the context of the 
entire organism. Consistent with this, ATM has been described to contribute to different 
processes in which blocked DSB repair is crucial, and which have a direct impact in 
A-T. First, during V(D)J recombination in lymphocyte development, ATM promotes 
the stability and correct repair of RAG1/2 induced DSBs. Importantly, the impairment 
of the correct joining of coding ends leads to DSB accumulation during lymphocyte 
development, underlying the immunodeficiency and increased lymphoma incidence 
observed in A-T patients. Specifically, ATM activity is key for protecting coding ends, 
which are hairpin blocked, from degradation and promoting their faithful joining. In 
contrast, ATM loss does not affect the joining of signal ends, which are clean blunt ends 
(Bredemeyer et al. 2006). Secondly, meiotic recombination involves the repair of DSBs 
harbouring SPO11 protein covalently bound to its 5’ end. Indeed, the impairment of 
this process has been reported to be the cause of sterility in A-T individuals, since ATM 
directly influence SPO11-dependent DSB induction and repair during gametogenesis 
(Lange et al. 2011; Garcia et al. 2015).
Several alternative roles that are independent of TOP2 abortive activity have 
been attributed to TDP2 in the past (Chunyang Li et al. 2011). Nevertheless, no gross 
spontaneous phenotypes have been observed until present in TDP2-deficient mice. Thus, 
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based on the specificity of TDP2 in the unblocking of DSB blocked by 5’ peptide adducts, 
we anticipated that any aggravation of the features displayed by the ATM mouse model 
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Figure 48: Model for the molecular trigger of thymic lymphomas in A-T. During 
lymphocyte maturation DSBs arise by RAG1/2 cleavage in order to promote V(D)J 
recombination. c-NHEJ machinery in collaboration with Artemis and ATM ensures the 
repair of these lesions. In addition, TOP2-dependent transcriptional regulation can 
induce DSBs, which requires TDP2 and ATM for their correct repair. In the absence 
of both, persistent DSBs accumulate. ATM is also required for cell cycle arrest and 
apoptosis upon DSB-induction. In the absence of ATM, immature lymphocytes can 
proliferate with persistent chromosomal breakage induced by RAG1/2 and TOP2 
activity, increasing the likelihood of unfaithful repair of DSBs that underlie the induction 
of oncogenic translocation. 
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by the absence of TDP2, would uncover TOP2 abortive action as a possible trigger of 
A-T symptoms. Remarkably, we have found that Tdp2/Atm double-knockout mice are 
more likely to suffer thymic malignancies, compared to ATM-deficient animals. Thus, 
it is tempting to speculate that TOP2 could be a potential source of chromosomal 
breakage during lymphocyte development, increasing the likelihood of the appearance 
of oncogenic translocations in A-T patients. This spontaneous source of DSBs, combined 
with an increase of unfaithful repair, cell-cycle arrest impairment and defective DDR 
characteristic of ATM deficiency would alllow lymphocytes with a high number of 
mutations and oncogenic translocations to develop, leading to a higher incidence of 
thymic lymphoma. 
These findings opened two possible scenarios. On one hand, TOP2 abortive 
action could increase chromosomal breakage in sites that are distinct to the break 
points described in ATM tumours. On the other hand, TOP2 cleavage could directly 
increase the likelihood of breakage in specific sites that spontaneously occurs in A-T 
malignancies. Based on the analysis of the spatial distribution of instability sites along the 
genome in Tdp2+/+Atm-/- and Tdp2-/-Atm-/- tumours, we can conclude that chromosomal 
breakage is occurring in similar regions in both genetic backgrounds. This suggests that 
oncogenic translocations previously described in A-T could be, at least in part, triggered 
by mechanisms that are dependent on TOP2. Thus, we propose a model in which TOP2-
abortive activity is a determinant factor in the appearance of lymphoid leukemia in A-T 
(Figure 48). 
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Interestingly, ATM-deficient mice that cannot undergo V(D)J recombination still 
develop thymic malignancies but translocations do not involve TCR or immunoglobulin 
genes. Therefore, other source of DSBs, alternative from RAG1/2 cleavage, must be 
driving this oncogenic translocation. In this regard, TOP2 abortive action could account 
for chromosomal breakage that is not dependent on RAG1/2 cleavage. However, it is 
also possible that TOP2 activity influences V(D)J recombination, since this process relies 
on structural rearrangement of the chromatin, RAG1/2 cleavage complex formation and 
post-cleavage stabilization to ensure DNA repair. Thus, this process could generate high 
levels of topological stress, increasing TOP2 activity and the likelihood to be trapped in 
TCR and Ig genes. 
It is important to mention that, to our knowledge, lymphocytes are the only 
cell lineage suffering the consequences of TDP2 and ATM combined deficiency in 
our experimental setup. This could be explained by the incapacity of other phenotypes 
to arise due to the early mortality of these mice. Nonetheless, double-knockout mice 
reaching above 520 days did not show any gross feature. Up to date, the determinant 
factor that underlies neurodegeneration in A-T, the most devastating characteristic of 
the syndrome, remains elusive. In this regard, ATM-deficient mouse models do not 
recapitulate the profound neural phenotype observed in A-T patients, which has greatly 
impeded its study. Remarkably, a recent porcine model of ataxia telangiectasia has been 
shown to reproduce neurological features and motor deficits of human A-T (Beraldi 
et al. 2015). This suggests that important interspecies differences may exist concerning 
the homeostasis of the neural system. We can also hypothesize that the likelihood of 
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appearance of lesion that underlie A-T neural defects are lower in mice, or independent 
pathways could efficiently compensate for their repair in the central nervous system. 
In addition, intrinsic differences during neural development, increased longevity of 
humans, or exposure to environmental sources of DNA damage, may account for these 
differences. Nevertheless, we aimed to analyse a possible role of blocked DSBs as the 
molecular trigger of neurodegeneration in A-T syndrome. Therefore, we tested if loss of 
TDP2 could uncover a possible effect of TOP2-induced damage in the central nervous 
system of ATM-deficient mice. Despite the fact that no overt neurological phenotype 
was observed in Tdp2 and Atm double-knockout mice, we cannot rule out the possibility 
of TOP2-induced damage as a determinant factor in triggering A-T neurodegenerative 
symptoms in human, since there are multiple examples of rodent models that do not 
recapitulate neural defects. Moreover, it is important to bear in mind that TOP2-abortive 
activity represents just a single example of how blocked DSBs may arise in vivo, and there 
are several alternative sources of DSB carrying different blocking structures in their ends. 
Thus, further work must be performed to elucidate if blocked DSBs are indeed the cause 
of the progressive neurodegeneration of A-T disease.

V.   CONCLUSIONS
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V. CONCLUSIONS
1. TDP2-deficient mouse cells lack observable 5’-tyrosyl-DNA-phosphodiesterase 
activity in vitro
2. TDP2 activity facilitates the religation of 5’ phosphotyrosine DNA substrates in 
vitro
3. Covalently-bound peptides accumulate on the DNA upon the exposure to TOP2 
poisons in TDP2-deficient primary MEFs 
4. ATM facilitates repair of TOP2-induced DSBs in human and rodent cells, 
specifically in the absence of TDP2 
5. ATM function in the repair of TOP2-induced DSBs is heterochromatin 
independent
6. ATM function promotes cell survival and genome integrity in TDP2-deficient 
MEFs upon TOP2-induced DSBs 
7. ATM function prevents loss of DNA sequence in extrachromosomal 5’-blocked 
DSBs in human cells 
8. DNA-PKcs function in the repair of TOP2-induced DSBs is increased in the 
absence of TDP2
9. DNA-PKcs activity and ATM redundantly promote repair of TOP2-induced 
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DSBs in the absence of TDP2
10. ATM confers resistance to TOP2-poison exposure in mice, specifically in the 
absence of TDP2
11. Tdp2-/- Atm-/- mice display elevated mortality due to an increased incidence of 
thymic lymphoma compared to ATM-deficient mice
12. Lymphomas in Tdp2-/- Atm-/- double mutant mice are characterized by genome 
instability events that are similar to Tdp2+/+ Atm-/- single
VI.   MATERIALS AND 
METHODS
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VI. MATERIALS AND METHODS
1. Cell culture procedures
1.1. Cell lines and primary cell culture
Cells were maintained in HEPA class 100 incubators (Thermo) at 37 ºC and 5% 
CO2.
Primary MEFs were isolated from embryos at day 13 p.c. and cultured at 3% 
O2 in Dubelcco’s Modified Eagle’s Medium (DMEM) supplemented with penicillin, 
streptomycin, 2 mM L-Glutamine, 15% FCS and non-essential aminoacids. All 
experiments were carried out between P1 and P5.
Transformed MEFs were maintained in DMEM supplemented with penicillin, 
streptomycin, 2 mM L-Glutamine and 10% FCS. MEFs were transformed by retroviral 
delivery of T121, a fragment of the SV40 large T antigen that antagonizes the three 
Rb family members but not p53 (Saenz Robles et al. 1994). After 20 passages under 
puromycine selection single clones that efficiently grew were selected. 
HEK293T and U2OS cells were maintained at 37 °C, 5% CO2 in DMEM 
supplemented with penicillin, streptomycin, 2 mM L-Glutamine and 10% FCS. 
A-T (Coriell’s Repository GM05823D) and BJ1 primary fibroblasts were cultured 
at 37 °C, 5% CO2, in DMEM supplemented with penicillin, streptomycin, 2mM 
L-Glutamine and 15% FCS. Cells were maintained in HEPA class 100 incubators 
(Thermo) at 37 ºC and 5% CO2.
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1.2. Lentivirus production and infection
To produce lentiviral particles containing vector expressing shRNA, 3.5x106 
HEK293T cells growing in 100-mm plates were transfected by calcium phosphate 
protocol with a mixture composed by 15 μg of either pLKO.1-puro-Tdp2-2 (clone 
TRCN0000003072, SIGMA) or empty control pLKO.1-puro (SIGMA), 10 μg of 
p8.91 (plasmid containing viral capsid genes) and 5 μg of pVSVG (plasmid containing 
viral envelope genes). Growing medium was recovered after 48 h, and viral particles were 
isolated from cells using 0.45 µm polyvinylidene difluoride (PVDF) filters (SLHV035RS, 
Millex®-HV, Millipore). Then, viral particles were concentrated by centrifugation 
for 1 hour and 30 min at 22.000 rpm at 4 ºC in a Beckman-coulter Optima L-100K 
Ultracentrifuge. Finally, viruses were resuspended in DMEM and stored at -80 ºC.
For infection, lentiviral particles were added to cells in DMEM supplemented 
with 4 μg/ml hexadimethrine bromide (H9268, Sigma). For titration U2OS cells were 
infected with serial dilutions of lentiviral particles. After 72 h, 2x103 cells were seeded for 
duplicate in 100 mm dishes and selected in puromycine (1 μg/ml). Multiplicity of infection 
(MOI) was calculated based on the amount of puromycine resistant cells measured by the 
clonogenic survival assay. Finally, 0.5x106 A-T human primary fibroblasts and wild-type 
BJ1 primary fibroblasts growing in 100 mm dishes were infected with MOI-1. After 3 
days cells were selected in puromycin (1 μg/ml) for 7 days before assays were performed. 
2. Molecular biology procedures
2.1. 5’-TDP activity in vitro
2.1.1. Radiolabeled substrates production
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Substrates were generated by mixing 5’Y-blunt and Blunt.Rev.Comp. 
oligonucleotides for blunt-ended, and 5’Y-overhang and Overh.Rev.Comp. for 4 bp 5’ 
overhang. 40 pmoles of oligonucleotides containing 5’ phosphotyrosines and 20 pmoles 
of Blunt.Rev.Comp or Overh.Rev.Comp. were mixed in a total volume of 50 μl, heated at 
95 ºC and cool down at 2 ºC/min rate.
Annealed DNA duplexes contained 5’-AG-3’ overhangs. This was used for 3’ fill 
in by Klenow polymerase (Takara) for 1 h at 37 ºC in the presence of [α-32P]-dCTP for 
radiolabelling, and 50 μM ddTTP that protect 3’ ends from degradation by exonucleases. 
5’-Y-AATT-3’ overhangs could not be filled in, since dATP was not present in reactions. 
Unincorporated [α-32P]-dCTP was removed by illustra MicroSpin G-25 Columns 
(GE Healthcare).
2.1.2. Cell extract for in vitro reactions 
The indicated cells were grown in 100 mm dishes and were collected by 
trypsinization. They were washed twice in PBS and the pellet was lysed by mild sonication 
in Lysis Buffer (40 mM Tris–HCl, pH 7.5, 100 mM NaCl, 0.1% Tween-20, 1 mM DTT) 
supplemented with 1 mM PMSF and protease inhibitor cocktail (Sigma). Extracts were 
clarified by centrifugation 10 min at 16500 g 4°C. Finally, protein concentration was 
measured with Bradford reagent (Sigma) and samples were aliquoted, frozen in liquid 
nitrogen and transferred to -80ºC for long-term storage. 
2.1.3. 5’ TDP reactions
Reactions contained 50 nM substrate, 80 μM competitor single-stranded 
oligonucleotide and the indicated amount of protein extract in a total volume of 6 μl 
Reaction Buffer (50 mM Tris-Cl, pH 7.5, 50 mM KCl, 1 mM MgCl2, 1 mM DTT, 
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100 μg/ml BSA). Additionally, to analyze ligation of substrates, reactions contained 5 
units of T4 DNA ligase (Fermentas) and 1 mM ATP (Sigma). Reactions were stopped 
by the addition of Formamide Loading Buffer and boiling for 5 min at 95°C. Samples 
were resolved in 7M Urea denaturing 20% polyacrylamide gel electrophoresis in 0.5x 
TBE buffer. Gels were analysed by phosphorimaging in a Fujifilm FLA5100 device (GE 
Healthcare). 
2.2. Linear plasmid circularization assays
2.2.1. Substrate production
Substrates were generated by PCR-mediated amplification of plasmid pEGFP-
Pem1-Ad2 with 5’P-NHEJ-Fw and 5’P-NHEJ-Rv primers, which harboured phosphate, 
or 5’Y-NHEJ-Fw and 5’Y-NHEJ-Rv containing phosphotyrosine moieties at 5’ ends.
A high fidelity KOD Hot Start DNA Polymerase (Merck-Millipore) was used 
for PCR reaction. Template used for PCR was 0.2 ngr/μl of ScaI disgested pEGFP-
Pem1-Ad2 (Seluanov et al. 2004). Primers were added at final concentration of 0.2 μM, 
dNTPs 2mM each, MgSO4 2mM, 2% DMSO (PCR grade) and 1U of HotStart KOD 
polymerase (Merck-Millipore) in 1x KOD polymerase buffer. PCR amplification was 
performed as following: 1x (95ºC 2 min), 35x (95ºC 20 s, 57.9ºC 10 s, 70ºC 3 min), 1x 
(70ºC 5 min). Substrates of the expected size were purified using Gel/PCR Purification 
Kits (Favorgen) in agarose 0.4% gel electrophoresis.
2.2.2. NHEJ-competent nuclear extracts
NHEJ-competent nuclear extracts were prepared from transformed MEFs in 
3xT150 flasks at 90% of confluency. Cells were harvested and whased three times in 
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ice-cold PBS, and twice in buffer A (10 mM HEPES, pH 7.9; 1.5 mM MgCl2; 10mM 
KCl; 0,5 mM DTT and 0,2 mM PMSF) for 10’. Cells were lysed by homogenization (10 
strokes with a type B pestle) and the nuclei were pelleted by centrifugation for 5’ at 1500g 
at 4ºC. Nuclei were resuspended in one pellet volume of buffer C (20 mM HEPES, pH 
7.9; 1.5 mM MgCl2; 0,42 M NaCl; 25% Glycerol; 0,6 mM KCl; 0,5 mM DTT and 
0,2 mM PMSF) and incubated in rotation for 30’ at 4ºC. Extracts were cleared by high 
speed centrifugation at 18000 g for 15 min at 4 ºC and supernatant was transfered to 
an Amicon Ultra-4 3k (Millipore) and spined at 4000 g for 30’ at 4 ºC. Concentrated 
nuclear extracts were dyalized against 500 ml of buffer D (20 mM HEPES, pH 7.9; 20% 
Glycerol; 0,1 M Kcl; 0,2 mM EDTA; 0,2 mM PMSF and 0,5 mM DTT) for 4h at 4 ºC. 
Protein concentration was measured with Bradford reagent (Sigma) and extracts were 
finally fast-frozen in liquid nitrogen and stored at −80 °C.
2.2.3. In vitro plasmid circularization assay
For in vitro plasmid circularization using cellular nuclear extracts, reactions were 
performed by incubating 100 ng of each substrate with 7 μg of NHEJ-competent nuclear 
extracts for 6 h at 16°C in NHEJ Buffer (50 mM Tris-HCl pH 7.5, 50 mM KCl, 1 mM 
DTT, 2 mM MgCl2, 1 mM ATP, 100 μg/ml BSA) in the presence or absence of 50 nM 
hTDP2 recombinant protein. Reactions were stopped by addition of EDTA (to a final 
concentration of 100 mM) and treated 30 min with Proteinase K (0.2 mg/ml). DNA was 
purified using FavorPrep GEL/PCR Purification Mini Kit (Favorgen) and transformed 
into MegaX DH10B T1 Electrocompetent Cells (Invitrogen). Positive transformants 
were selected by plating on LB agar plates containing kanamycin (25 μg/ml) and single 
colonies were manually counted to estimate religation efficiency. 
For in vitro plasmid circularization using T4 Ligase, reactions were performed by 
incubating 400 ng of the indicated substrates in the presence or absence of 2 U of rSAP 
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(NEB) in 15 μl of 1x Cutsmart buffer (NEB) at 37 ºC for 1 h. To inactivate rSAP samples 
were incubated for 5 min at 65 ºC. The samples were incubated with 5 U of T4 Ligase 
(Fermentas) in the presence or absence of 50 nm hTDP2. The reaction was incubated for 
6 h at 16 ºC in a buffer containing 50 mM Tris-HCl, 50 mM KCl, 1 mM DTT, 1 mM 
ATP, 5 mM MgCl2 and 100 μg/ml BSA. A final step of 30 min at 37 ºC adding EDTA 
to a final concentration of 100 mM and 0.2 mg/ml proteinase K, stopped the reaction. 
DNA was purified using FavorPrep GEL/PCR Purification Mini Kit (Favorgen) eluted 
in 20 μl of mili-Q water. 1 μl was used for DH5α transformation and transformants were 
selected by plating on LB agar plates containing kanamycin (25 μg/ml). Single colonies 
were manually counted to estimate religation efficiency. 
2.3. Selective labelling of protein-blocked DNA ends (SLOPE)
Cells arrested in G0 were treated 30 min with 100 μM etoposide or vehicle 
(DMSO), and 30 min after drug removal (to allow reversal of cleavage complexes) 
genomic DNA was isolated with the DNeasy Blood and Tissue Kit (Qiagen), including 
the steps of proteinase K and RNAseA treatment as described by the manufacturer. 
Peptide residues that remain covalently linked to DNA were labelled with biotin by 
incubating 4 μg of gDNA with 1 μg/μl EDC (Sigma) and 6 mM amine-PEG3-biotin 
(Thermo Scientific) in 100 mM MES buffer pH 5.5 for 2 h rotating at room temperature. 
Then, in order to eliminate unreacted amine-PEG3-biotin DNA was purified by standard 
ethanol precipitation and resuspended in TE buffer. Finally, DNA was quantified using 
Nanodrop, and 500 ng were boiled and dotted on a Hybond-H+ (Amersham Bioscience) 
membrane and cross-linked with 70,000 μJ cm−2 UV. The membrane was blocked with 
Odyssey blocking buffer (LI-COR Biosciences) with 1% SDS, incubated with IRDye 
Streptavidin 800CW, 1/10,000 (LI-COR Biosciences) in the same buffer and washed 
(three times in TBS-0.1% Tween20). Dots were analysed and quantified in Odyssey CLx 
with ImageStudio Odyssey CLx Software. For the representation, the total signal in each 
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sample was related to an internal control using plasmid DNA.
2.4. DDR analysis by Western blot
Confluency-arrested primary MEFs were treatmed 30 min with the indicated 
concentration of etoposide, and resuspended on ice using a cell scraper. Cells were washed 
twice in cold PBS and the pellets were directly lysed in Laemli buffer by incubating them 
at 96 °C for 5 min. Protein concentration was measured by Pierce 660 nm Protein Assay 
with Ionic detergent compatibility reagent (Thermo Scientific). Thirty micrograms of 
sample were run in NuPAGE Tris-Acetate Mini gels 3–8% (Novex) and transferred 
to Immobilon-FL Transfer Membranes (Millipore) in a Mini-PROTEAN Tetra Cell 
System (Biorad) overnight applying 30 V at 4 ºC.
Membranes were blocked in Odyssey Blocking Buffer (LI-COR Biosciences) 
incubated with the indicated primary antibodies in Odyssey Blocking Buffer-0.1% 
Tween20 and washed (three times in TBS-0.1% Tween20). They were then incubated 
with the corresponding IRDye-conjugated secondary antibodies in Odyssey Blocking 
Buffer-0.1% Tween20 and washed (three times in TBS-0.1% Tween20 and 1 × in TBS 
buffer). Finally, membranes were analyzed in Odyssey CLx with ImageStudio Odyssey 
CLx Software. 
The following primary antibodies were used at the indicated dilution: ATM 
(Sigma, MAT3-4G10/8), 1/1,000; ATM pS1981 (Cell Signaling, #4526), 1/1,000; 
p-CHK2 Thr68 (Cell Signaling, #2661), 1/1,000; p-p53 Ser15 (Cell Signaling, #9284), 
1/1,000; p-CHK1 Ser345 (Cell Signaling, #2341), 1/1,000; α-tubulin (Sigma, T9026), 
1/50,000.
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3. Cell biology procedures
3.1. Immunofluorescence
Cells were grown on coverslips and treated as indicated. For DSB induction cells 
were treated with 10 μM etoposide for 30 min (Sigma) or exposed to 2 Gy of γ-radiation 
using a BIOBEAM GM 8000 (Gamma-Service Medical GmbH) emitter. For ATM 
and DNA-PK chemical inhibition, cells were incubated with 10 μM ATM inhibitor 
KU55933 (Tocris) or/and 10μM DNA-PKcs inhibitor NU7441 (Tocris) 30 min before 
DSB-induction until the experimental endpoint. 
Cells were fixed 10 min in ice-cold methanol in the case of MEFs or 4% PFA-
PBS in A-T and BJ1 human fibroblasts. Cells were then permeabilized (2 min in PBS-
0.2% Triton X-100), blocked (30 min in PBS-5% BSA) and incubated with the required 
primary antibodies (1–3 h in PBS-1% BSA). Cells were then washed (three times in 
PBS-0.1% Tween 20), incubated for 30 min with the corresponding AlexaFluor-
conjugated secondary antibodies (1/1,000 dilution in 1% BSA-PBS) and washed again 
as described above. Finally, they were counterstained with DAPI (Sigma) and mounted 
in Vectashield (Vector Labs). Primary antibodies were used at the indicated dilution: 
γH2AX (Millipore, 05-636)), 1/1,000; α-Tubulin (Abcam, ab18251), 1/2,000; Vinculin 
hVIN-1 (Sigma, V9131) 1/2,000.
When necessary to identify replicating cells, 5’-ethynyl-2’-deoxyuridine (EdU, 
Invitrogen) was added throughout treatment and repair at a final concentration of 10 mM. 
Click chemistry reaction was performed before standard Cyclin A immunofluoresncence 
and DAPI staining by incubating (30 min r.t.). For clickchemistry, 1 mM AlexaFluor-
conjugated azide (Invitrogen) in reaction cocktail (100 mM TrisHCl pH 8.5, 1 mM 
CuSO4, 100 mM ascorbic acid) was added to the samples. For the analysis of G0/G1 
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confluency-arrested cells only Cyclin A negative cells were scored. For G2, as EdU was 
present (10 mM) during and after treatment, only Cyclin A positive cells without EdU 
incorporation were scored.
3.2. Microscopy analysis
Standard immunofluorescence assays were visualized using Leica DM6000 
microscope and images were acquired using a Leica AF6000 image processing station. 
For DSB repair kinetic, γH2AX foci were manually scored (double-blind) in at least 40 
cells preselected by DAPI staining for showing regular and standard nuclear morphology. 
At least three independent experiments were performed. 
For heterochromatin and γH2AX foci spatial analysis a series of Z-sections 
(0.21mm step) were obtained using a Leica TCS-SP5 confocal microscope with a HCX 
PL APO 63x/ 1.40lBL objective. For image processing an in-house MATLAB R2012a 
based application was designed to segment nuclei images. For each nucleus, these series 
were segmented to obtain the number, position, intensity and volume values of γH2AX 
foci and heterochromatin (G and B components of the RGB image, respectively). 
The segmentation from the different sections was integrated to reconstitute the 3D 
information of each entire nucleus. Using this reconstitution, the distance between each 
focus and the nearest euchromatin/heterochromatin boundary in the 3D space was 
determined.
3.3. Plasmid circularization assays
Linear plasmids harbouring phosphate, hydroxyl or biotin (Sigma) moieties at 
5’ ends, were generated as described previously for in vitro circularization assays. For 5’ 
phosphate linear plasmids 5’P-NHEJ-Fw and 5’P-NHEJ-Fw, for 5’ biotin 5’B-NHEJ-
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Fw and 5’B-NHEJ-Fw, and for 5’ -hydroxyl 5’OH-NHEJ-Fw and 5’OH-NHEJ-Fw, pairs 
of primers were used. 1 μg of substrates were transfected into 0.25x106 HEK293T cells 
by using GeneJuice (Novagen) reagent following recommendations of the manufacturer. 
Cells were preincubated for 30 min with 10 μM ATMinhibitor KU55933 (Tocris) or 
vehicle (DMSO) before transfection. Cells were collected by trypsinization 16 hours 
later, and number of GFP positive cells, as well as GFP intensity was analysed using a 
BD FACSCalibur Flow Cytometer (342975, BD Biosciences). 
To analyse individual repair events, DNA was isolated using QIAmp DNA 
mini kit (Qiagen) from cells treated as previously. Total DNA purified from these cells 
was transformed in MAX Efficiency DH10B Competent Cells (Invitrogen Positive 
transformants were selected by plating on LB agar plates containing kanamycin (25 μg/
ml) and plasmid DNA was purified from single colonies. Sequence of single repair events 
were analysed by agarose gel electrophoresis after digestion with the restriction enzyme 
DraI (Takara).
To validate the presence of 5’ biotin in substrates, they were analysed by 
streptavidin-mediated precipitation. Dynabeads (10 μg) M-270 Streptavidin magnetic 
beads (Invitrogen) were prewashed (3 × in 5 mM Tris–HClpH 7.5, 0.5 mM EDTA in the 
presence of 1 M NaCl) and incubated with 100 ng of substrates for 1 h. Beads were then 
washed 4 times gradually decreasing NaCl concentration to 0. Finally, DNA fragments 
were eluted by 2 h incubation with BglII restriction enzyme (NEB). Input, unbound and 
bound DNA was analysed by agarose gel electrophoresis.
3.4. Clonogenic survival assays
Survival assays were carried out seeding 2,000 transformed MEFs in 100 mm 
dishes, in duplicate for each experimental condition. Cells were preincubated with 10 μM 
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ATM inhibitor KU55933 (Tocris), 10μM DNA-PKcs inhibitor NU7441 (Tocris) or 
vehicle (DMSO) for 1 h. The indicated concentration of etoposide (Sigma) was added 
and cells were incubated for additional 3 h. After a wash with PBS, fresh medium was 
added and cells were incubated for 10–14 days. Dishes were fixed and stained for colony 
scoring in Crystal Violet solution (0.5% Crystal violet in 20% ethanol). The surviving 
fraction at each dose was calculated by dividing the average number of visible colonies in 
treated versus untreated dishes.
3.5. Cytogenetic analysis
Micronuclei were analysed in transformed MEFs previously seeded onto coverslips. 
Following etoposide treatment, cytochalasin B (Sigma) was added at 4 μg/ml. 22 h post 
treatment, cells were fixed 10 min in methanol at -20ºC, and immunofluorescence was 
performed as previously described using antibodies against Tubulin and Vinculin, and 
stained with DAPI. To restrict the analysis to etoposide-induced micronuclei, only 
binucleated cells selected by visualization of the cytoplasm by Tubulin and Vinculin 
staining. They were manually scored for the presence of micronuclei by DAPI visualization. 
Chromosomal aberrations were scored in Giemsa-stained metaphase spreads. 
Following treatment, recovery in fresh medium was allowed for 2 h, and demecolcine 
(Sigma) was added at a final concentration of 0.2 μg/ml. Four hours later, cells were 
collected by trypsinization, subjected to hypotonic shock for 1 h at 37 °C in 0.3 M sodium 
citrate, and fixed in 3:1 methanol:acetic acid solution. Cells were dropped onto acetic 
acid-humidified slides and stained 20 min in Giemsa-modified solution (5% v/v in H2O, 
Sigma). Samples were analyzed after permanent mounting in DEPEX. 
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3.6. Cellular index assay
Three independent sets of primary MEFs cells were analysed. 4000 cells were 
plated in E-plates 16 in duplicates and analised by the xCELLigence® RTCA DP 
(ACEA Bioscences). The instrument measures cellular proliferation by changes in 
impedance-based signals in real time. 
4. Animal procedures
4.1. Ethics statement
All animal procedures were performed in accordance with European Union 
legislation and with the approval of the Ethical Committee for Animal Experimentation 
of the University of Seville and local Committee of Cabimer.
4.2. Animal maintenance
Double heterozygotes Tdp2+/- Atm+/- were obtained by the crossing of Tdp2+/- of 
an outbred 129Ola, CD1 and C57BL/6 background with 129/SvEv × NIH Black Swiss 
background Atm+/- mice. The colony was maintained by crossing double-heterozygotes, 
and littermates were used for experiments. Animals were housed in isolated cages with 
controlled ventilation trough HEPA-filters, kept under standard housing conditions 
(21±1°C with a photoperiod of 12:12 h), and manipulated in flow cabins. Sterile food 
pellets and water were available ad libitum.
Mice were genotyped using Phire Animal Tissue Direct PCR Kit (Thermo) 
following manufacturer instructions. For Tdp2, the indicated TDP2-1, TDP2-2 and 
TDP2-3 primers were used. This results in amplification of a 429 bp fragment from the 
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wild-type allele or 561 bp fragments from the mutant allele. In the case of Atm, ATM-1, 
ATM-2 and ATM-3 primers were used, resulting in amplification of a 160 bp fragment 
from the wild-type allele or 300 bp fragments from the mutant allele.
4.3. In vivo etoposide sensitivity
At 8 weeks of age, mice underwent intraperitoneal injection with 3 μl/g of body 
weight of either DMSO (vehicle control) or etoposide at 25 mg/ml in DMSO for a 
final dose of 25 mg/kg. Weight and general health status was monitored daily from 
the day of injection (inclusive). 6 days post-treatment mice were sacrificed by cervical 
dislocation and dissected for histopathological analysis. For this, organs were fixed in 
4% paraformaldehyde for 2 days, embedded in paraffin, cut in 6 μm slices by microtome, 
stained with Hematoxylin-Eosin and visualized under the microscope.
4.4. Lifespan analysis
Minimum 20 mice per experimental condition were included in the analysis. 
Weight and general health status was monitored weekly. Animals were sacrificed by 
cervical dislocation and dissected for histopathological analysis in the case of showing a 
20% loss of the maximum weight, the presence of a detectable tumor or signs of evident 
pain. 
4.5. Lymphocyte analysis
Healthy thymus (4 weeks-old) or thymic lymphomas were extracted from mice, 
disgregated to single cells into EDTA-buffer and immunostained with anti-CD4-
FITC (eBioscience, 17-0081-81, 1/500) and anti-CD8-APC (eBioscience, 11-0081-41, 
1/500). Samples were fixed 10 min in 4%-paraformaldehyde for storage at 4 ºC. Intensity 
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was analysed using a BD FACSCalibur Flow Cytometer (342975, BD Biosciences). 
4.6. Comparative Genomic Hybridization (CGH) analysis
For CGH, genomic DNA was purified from thymic tumours and kidney from 
Tdp2+/+ Atm-/- or Tdp2-/- Atm-/- mice using DNeasy Blood and Tissue Kit (Qiagen) 
following recommendations of the manufacturer. 1 μg of genomic DNA from thymic 
lymphoma was profiled against 1 μg of matched normal kidney DNA from the same 
mouse. Processing, labelling and hybridization to Mouse Genome CGH Microarray 
2x105K (G4425B-014699, Agilent) was performed at the Cabimer Genomic Facility. 
Data was processed using the package snapCGH within R (version 3.3.1) (Ewy & Sean 
2016). Background correction was applied to fluorescence ratios of scanned images using 
the method ‘minimum’. To compare hybridizations, normalization between arrays by the 
method ‘scale’ was performed. Finally, data was processed and ordered by the function 
‘processCGH’, and fluorescence ratios were plotted using the R function ‘plot’ and the 
package Gviz (Smith et al. 2009). Thresholds for copy number alterations were set at log2 
= ±0.6 for trisomy or hemizygous deletion.  
4.7. Cerebellum histological analysis
Cerebellums were fixed in 4% paraformaldehyde, embedded in paraffin, and sagital 
50 μm slices were obtained by vibratome. Immunohistochemistry was performed using 
anti-calbindin (D28K rabbit, CB-38a Swant, 1:5,000) primary antibody and Biotin-SP 
AffiniPure Goat Anti-Rabbit IgG ( Jackson; 1:1,000) secondary antibody. Signal was 
developed using VECTASTAIN Elite ABC HRP Kit (Pk-6100, Vector Laboratories) 
and DAB (D4418-50SET, Sigma).
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5. Statistical analysis 
Statistical analysis was performed using GraphPad Prism software (GraphPad, 
San Diego, CA, USA).
Table 1: Cells used in this Thesis. 
6. Tables of materials 
Cell name Specie Origin
primary MEFs Mus musculus Embryonic fibroblasts
BJ1 Homo sapiens Primary skin fibroblasts
AT Homo sapiens Ataxia-telangiectasia primary fibroblasts
Transformed MEFs Mus musculus SV40-transformed embryonic fibroblasts
HEK293T Homo sapiens Embryonic kidney transformed cell line
U2OS Homo sapiens Osteosarcoma cell line
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 Name Sequence 5’ end From
5’Y-blunt CTTCTCTTTCCAGGGCTATGT 5’-P-Y MCRC
Blunt.Rev.Comp AGACATAGCCCTGGAAAGAGAAG 5’-OH Sigma
5’Y-overhang AATTCTTCTCTTTCCAGGGCTATGT 5’-P-Y MCRC
Overh.Rev.Comp AGACATAGCCCTGGAAAGAGAAG 5’-OH Sigma
5’P-NHEJ-Fw AATTCTTCTCTTTCCAGGGCTATGT 5’-P Sigma
5’P-NHEJ-Rv AATTCATCCCCAGAAATGTAACTTG 5’-P Sigma
5’Y-NHEJ-Fw AATTCTTCTCTTTCCAGGGCTATGT 5’-P-Y MCRC
5’Y-NHEJ-Rv AATTCATCCCCAGAAATGTAACTTG 5’-P-Y MCRC
5’B-NHEJ-Fw AATTCTTCTCTTTCCAGGGCTATGT 5’-B Sigma
5’B-NHEJ-Rv AATTCATCCCCAGAAATGTAACTTG 5’-B Sigma
5’OH-NHEJ-Fw AATTCTTCTCTTTCCAGGGCTATGT 5’-OH Sigma
5’OH-NHEJ-Rv AATTCATCCCCAGAAATGTAACTTG 5’-OH Sigma
TDP2-1 CCTTCATTACTTCTCGTAGGTTCTGGGTC 5’-OH Sigma
TDP2-2 ACCCGCTCTTCACGCTGCTTCC 5’-OH Sigma
TDP2-3 TACACCGTGCCATAATGACCAAC 5’-OH Sigma
ATM-1 GACTTCTGTCAGATGTTGCTGCC 5’-OH Sigma
ATM-2 CGAATTTGCAGGAGTTGCTGAG 5’-OH Sigma
ATM-3 CCAGCTCATTCCTCCCACTCA 5’-OH Sigma
Table 2: DNA Oligonucleotides used in this Thesis. 5’-P-Y (5’ phosphotyrosine); 5’-
OH (5’ hydroxyl): 5’-P (5’ phosphate) 5’-B (5’ biotin); MCRC (Midland Certified Reagents 
Company)
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Primary antibodies Dilution Obtained from Specie
ATM 1/1,000 Sigma, MAT3-4G10/8 Mouse
ATM pS1981 1/1,000 Cell Signaling, #4526 Mouse
p-CHK2 Thr68 1/1,000 Cell Signaling, #2661 Mouse
p-p53 Ser15 1/1,000 Cell Signaling, #9284 Rabbit
p-CHK1 Ser345 1/1,000 Cell Signaling, #2341 Rabbit
α-tubulin 1/50,000 Sigma, T9026 Mouse
γH2AX 1/1,000 Millipore, 05-636 Mouse
α-Tubulin 1/2,000 Abcam, ab18251 Rabbit
Vinculin hVIN-1 1/2,000 Sigma, V9131 Mouse
anti-calbindin 1/5,000 D28K, CB-38a Swant Rabbit
Cyclin A 1/500 Santa Cruz, sc-751 Rabbit
anti-CD4-FITC 1/500 eBioscience, 17-0081-81 Mouse
anti-CD8-APC 1/500 eBioscience, 11-0043-81 Mouse
Secondary
IRDye 680RD goat anti-mouse IgG (H+L) 1/15,000 LI-COR, 926-68070 Goat
IRDye 800RD goat anti-rabbit IgG (H+L) 1/15,000 LI-COR, 926-32211 Goat
goat anti-mouse-AlexaFluor488 1/1,000 Jackson Goat
goat anti-mouse-AlexaFluor594 1/1,000 Jackson Goat
Biotin-SP AffiniPure Goat Anti-Rabbit IgG 1/1,000 Jackson, 111-065-003 Goat
Table 3: Antibodies used in this Thesis. 
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Ataxia telangiectasia is caused by mutations in ATM and represents a paradigm for cancer
predisposition and neurodegenerative syndromes linked to deﬁciencies in the DNA-damage
response. The role of ATM as a key regulator of signalling following DNA double-strand
breaks (DSBs) has been dissected in extraordinary detail, but the impact of this process on
DSB repair still remains controversial. Here we develop novel genetic and molecular tools to
modify the structure of DSB ends and demonstrate that ATM is indeed required for efﬁcient
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D
eﬁciencies in the DNA-damage response (DDR) are the
cause of several human genetic syndromes1. Common
hallmarks of these disorders include neurodegeneration
and/or cancer predisposition, which are a probable consequence
of deﬁcient and inaccurate repair of DNA damage. Ataxia
telangiectasia (A-T), a rare autosomal recessive syndrome that
results from inactivation of the PIKK family Ser/Thr protein
kinase ATM (A-T Mutated), is perhaps the paradigm for diseases
of this type2,3. It is characterized by a symptomatology
that includes progressive cerebellar ataxia, immunodeﬁciency,
radiosensitivity, hypogonadism and increased cancer incidence
(mainly leukaemia and lymphoma). Multiple functions have been
assigned to ATM and its list of phosphorylation substrates is
extensive4. Despite this versatility, its main function, or at least
the best understood, is to trigger the initial phosphorylation wave
of the DDR to double-strand breaks (DSBs). This fact, together
with the exquisite radiosensitivity displayed by ATM-deﬁcient
cells and individuals and the symptomatological overlap of A-T
with other break repair-defective human syndromes, strongly
suggests a link between DSBs and pathology in A-T patients3,5.
On the basis of all of this, one could anticipate that ATM would
be essential, or at least important, for the repair of DSBs. Strikingly,
this is not the case, as ATM loss does not result in obvious defects
in the DSB repair rate. It has therefore been proposed that the
radiosensitivity and chromosomal instability observed in ATM-
deﬁcient cells more likely arises from deﬁcient checkpoint allowing
cell cycle progression in the presence of damaged DNA6. However,
there is a subset of DSBs, 10–20% depending on the DNA-
damaging agent used7,8, which do require ATM. The current
understanding is that these DSBs correspond to damage occurring
in heterochromatin, where ATM is required to open the chromatin
structure, allowing access of the repair machinery9. Interestingly, in
addition to this, ATM is involved in specialized DSB-repair
mechanisms that are not heterochromatin associated, such as
V(D)J, class-switching and meiotic recombination10–12. These
processes are related to important aspects of A-T pathogenesis
such as immunodeﬁciency, increased incidence of lymphoma and
sterility. Fully understanding the nature of DSBs that speciﬁcally
require ATM for repair could therefore provide important clues
into disease pathogenesis.
DSBs can harbour different types of chemical moieties that differ
from the canonical 50 phosphate and 30 hydroxyl at the ends13.
Cells are therefore endowed with a wide variety of enzymatic
activities that can ‘unblock’ DSBs preparing them for repair.
However, under certain circumstances, such as the presence of
complex or staggered lesions, these activities may be compromised
or overwhelmed, resulting in breaks that are ‘blocked,’ in which
case the only possibility to allow repair involves the action of
nucleases to ‘process’ the ends by cleaving DNA sequence. It is
therefore conceivable that clean and blocked DSBs can have
different repair requirements and consequences. However, the
study of how DNA-end complexity inﬂuences the DDR and repair
has been traditionally impeded by the heterogeneity in the breaks
induced by most DNA-damaging agents.
A particular source of DNA breaks is the abortive activity of
DNA topoisomerase II (TOP2, a and b isoforms)14, which are
essential homodimeric enzymes that relax, unknot and/or
decatenate DNA molecules15. The a isoform is speciﬁc to cycling
cells, having essential functions during replication and
chromosome condensation and segregation. In contrast, the
TOP2b is the main TOP2 isoform in quiescent cells and acts
mainly in transcription. Despite the important function of TOP2 in
essential processes of chromosome metabolism, its mechanism of
action can be dangerous, as it involves the passage of duplex DNA
through a transient DSB created by the enzyme. This key
intermediate of TOP2 activity (termed cleavage complex), in
which two topoisomerase subunits are covalently linked to each
50-terminus of a DSB via a phosphodiester bond between the
active-site tyrosine and the 50-phosphate, is normally very short-
lived, because the topoisomerase rapidly religates the DSB once
DNA strand passage through the gap has occurred. However,
under certain circumstances, such as the presence of nearby DNA
lesions, cleavage complexes can be stabilized and interfere with the
transcription or replication machinery. If this is the case, trapped
TOP2 is degraded, leading to the formation of irreversible DSBs
with peptidic blockages at the 50 ends of the DNA. This mechanism
underlies the clinical efﬁcacy of a widely used class of antitumour
agents that ‘poison’ topoisomerase activity (for example,
etoposide)16, thereby prolonging the half-life of the intermediate
and increasing the possibility of DSB formation16.
Etoposide can therefore be used to generate DSBs homo-
geneously characterized by covalent peptide blockage of the 50
ends. Tyrosyl DNA phosphodiesterase 2 (TDP2) is the only
known enzyme in higher eukaryotes with the physiological
capacity to unblock this type of DNA ends, converting them into
50 phosphate/30 hydroxyl ligatable termini17–19. This scenario
offers a unique opportunity for the speciﬁc induction of clean and
blocked DSBs (Fig. 1a). Following etoposide treatment, the
majority of the induced DSBs will be efﬁciently unblocked by
TDP2 in wild-type cells. However, when TDP2 is not present, the
blockage will be irreversible and will necessarily require
alternative nucleolytic processing to allow repair to proceed.
This way, clean and blocked DSBs can be speciﬁcally induced by
etoposide treatment of wild-type and TDP2-deﬁcient cells,
respectively.
In this study, we exploit this genetic tool to demonstrate that
ATM functions speciﬁcally in the rejoining of blocked DSBs, in a
manner that is independent of the chromatin status of the lesions.
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Figure 1 | Protein-blocked DSBs accumulate in Tdp2-deﬁcient
background upon TOP2 poison treatment. (a) Scheme of the strategy
used to generate breaks with speciﬁc structure. (b) SLOPE assay performed
in Tdp2þ /þ and Tdp2� /� conﬂuency-arrested primary MEFs.
Average±s.e.m. of signal from three independent experiments and
statistical signiﬁcance by two-way ANOVA test with Bonferroni post-test is
shown (*Pr0.05; **Pr0.01; ***Pr0.001).
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We determine that this novel ATM-dependent repair pathway is
particularly relevant for cell survival and the maintenance of
genome stability upon induction of blocked DSBs. Finally, we
conﬁrm these results using a molecularly deﬁned system and
determine that ATM functions in promoting appropriate
processing of blocked DSBs. These results put forwards DNA-
end structure as a key factor determining ATM involvement
during DSB repair, something that could have important
implications on our understanding of A-T pathogenesis.
Results
Protein-blocked DSBs accumulate in the absence of TDP2. As
mentioned above, we can use TOP2 poisons such as etoposide to
induce DSBs that are homogeneous in structure. Furthermore,
theoretically, we can modulate the ends of these DSBs by working
in different genetic backgrounds (Fig. 1a): 30-hydroxyl 50-phos-
phate clean ends will be formed in cells containing TDP2 activity,
while breaks with a peptide block on 50 ends will accumulate in
TDP2-deﬁcient cells. To validate this experimental setup, we
aimed at developing a methodology to speciﬁcally measure pro-
tein-blocked DSBs, which we have named SLOPE (Selective
Labelling Of Protein-blocked Ends). It is based on a previously
described assay that has been used to identify genomic regions of
TOP2 cleavage20. Following isolation of genomic DNA with
standard Proteinase K treatment and silica columns, tyrosine
residues will remain covalently linked to DNA at the sites of
TOP2-blocked DSBs. Biotin is then speciﬁcally conjugated to
these residues, and ﬁnally, the amount of biotin conjugation is
measured in dot blots, and used as a speciﬁc indicator of protein
covalently linked to DNA. To speciﬁcally detect irreversible
TOP2-blocked DSBs resulting from etoposide treatment, cells are
incubated in the absence of the drug to allow cleavage complex
reversal before DNA isolation. As can be seen in Fig. 1b,
incubation of wild-type primary mouse embryonic ﬁbroblasts
(MEFs) with etoposide did not detectably change the amount of
protein covalently linked to DNA compared with untreated
samples, while a clear and signiﬁcant increase was observed in
Tdp2� /� cells. These results experimentally demonstrate that,
upon etoposide treatment, protein-blocked DSBs accumulate in
TDP2-deﬁcient cells, validating our genetic approach for
inducing DSBs with different structure.
ATM facilitates repair of TOP2-blocked but not clean DSBs.
We decided to apply the experimental setup described above to
analyse the impact of ATM loss on the repair of either clean or
blocked DSBs. As an indicator of DSB repair, we followed the
time course of Ser139-phosphorylated H2AX (gH2AX) foci dis-
appearance in primary MEFs after etoposide treatment. Since
TOP2 activity is subject to cell cycle variations21,22, cells were
conﬂuency arrested to avoid discrepancies in DSB induction. In
addition, this simpliﬁes the interpretation of the results, as DSB
repair during G0/G1 is limited to non-homologous end-joining23.
We found that the absence of ATM caused a marked reduction in
the intensity of etoposide-induced gH2AX foci (Supplementary
Fig. 1a); this is not surprising given the key involvement of ATM
in H2AX phosphorylation in response to DSBs. However, the
number of gH2AX foci per cell was not affected, validating the
use of this parameter as a DSB-scoring tool in our setup. In
addition, consistent with identical DSB induction, cleavage
complexes of TOP2b (the main source of TOP2 activity in
quiescent cells22) were also accumulated at similar levels
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Figure 2 | ATM facilitates repair of TOP2-blocked DSBs. (a) Time course of gH2AX foci disappearance after 30min 10mM etoposide treatment and
repair at different times following drug removal in Tdp2þ /þ Atmþ /þ , Tdp2þ /þ Atm� /� , Tdp2� /� Atmþ /þ and Tdp2� /� Atm� /� conﬂuency-
arrested primary MEFs. Representative images of gH2AX foci (green) and DAPI counterstain (blue) for the 24 h repair time point are shown. Scale bar,
10mm. (b) As above, in Tdp2þ /þ and Tdp2� /� conﬂuency-arrested primary MEFs with or without 10mM ATM inhibitor (KU55933). (c) As above, in
conﬂuency-arrested primary ﬁbroblast derived from A-Tpatients (AT) and wild-type controls (BJ1) depleted (shTDP2) or not for TDP2. In this case 20 mM
etoposide treatment was applied. In all cases, average±s.e.m. of the percentage of foci remaining from at least three independent experiments and the
minimal statistical signiﬁcance between cells deﬁcient in both TDP2 and ATM and all other cells by two-way ANOVA test with Bonferroni post-test is
shown (*Pr0.05; **Pr0.01; ***Pr0.001).
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(Supplementary Fig. 1b), ruling out an effect of ATM in the
generation and processing of TOP2 cleavage complexes.
As can be seen in Fig. 2a, the difference in repair rate between
Tdp2þ /þ and Tdp2� /� cells was only minor at the etoposide
dose used, which was chosen to avoid artefacts of overwhelming
cellular repair capacity. Furthermore, the absence of ATM did
not affect the rate of etoposide-induced DSB repair in a TDP2-
proﬁcient background. This is consistent with previous
observations of a limited DSB-repair defect for IR- but not for
etoposide-induced DSBs8. ATM, therefore, does not inﬂuence
repair of clean DSBs. In contrast, a striking drop in the repair
kinetics was observed in double Tdp2� /� Atm� /� cells, with
B40% of the breaks remaining unrepaired even 24 h after
induction (Fig. 2a and Supplementary Fig. 2a), suggesting that
ATM facilitates repair when DSBs are blocked. A single copy of
the Tdp2 gene was enough to eliminate blockages, as Tdp2þ /þ
and Tdp2þ /� cells were indistinguishable in ATM-deﬁcient
background (Supplementary Fig. 3). Importantly, the effect of
ATM was speciﬁc to TOP2-mediated breaks, not being observed
with ionizing radiation (Supplementary Fig. 2b), in which case,
repair ofB10% of the breaks was ATM dependent, as previously
described7, but was not affected by TDP2 deﬁciency. It is worth
noting that, as mentioned above, signalling in response to
etoposide strongly relies on ATM (Supplementary Fig. 1a), but it
only has an impact on repair efﬁciency in the absence of TDP2.
Consistent with this independence between signalling and repair,
ATM and downstream checkpoint proteins were equally activated
in Tdp2þ /þ and Tdp2� /� cells (Supplementary Fig. 4).
To conﬁrm the synergism between Tdp2 and Atm in the repair
of etoposide-induced damage during G0/G1, we repeated the
analysis but using ATM chemical inhibition instead of deletion
(Fig. 2b and Supplementary Fig. 2c). As expected, incubation with
an ATM inhibitor affected repair of TOP2-induced DSBs in a
Tdp2� /� but not in a Tdp2þ /þ background. This suggests that
the role of ATM in the repair of blocked DSBs depends on its
kinase activity and rules out artefacts caused by heterogeneity in
MEFs. A similar DSB-repair defect was observed when con-
ﬂuency-arrested primary ﬁbroblasts derived from A-T patients
were depleted for TDP2 and not in neither wild type nor non-
depleted controls (Fig. 2c and Supplementary Fig. 2d). In this
case, however, the effect was milder, perhaps due to an
incomplete knockdown of TDP2, as determined by residual 50
tyrosyl DNA phosphodiesterase activity (Supplementary Fig. 2e).
Finally, the effect was not restricted to quiescent cells and was
also observed in cycling conditions, both in G1 and G2 stages
(Supplementary Fig. 5). Overall, these results constitute strong
evidence of an involvement of ATM in DSB repair and suggest
that it is speciﬁcally linked to DSBs with blocked ends.
ATM function on blocked DSBs is heterochromatin independent.
In the currently accepted model, ATM is speciﬁcally required to
repair DSBs occurring at heterochromatic regions where it pro-
motes decompaction and facilitates access of the repair machin-
ery24. Since TOP2-mediated breakage requires on-going
transcription25, it should therefore rarely occur within
heterochromatin. Thus, we reasoned that the function of ATM
in opening chromatin would unlikely account for its involvement
in the repair of TOP2-blocked DSBs. In any case, to rule out
this possibility, we decided to analyse the location of etoposide-
induced gH2AX foci with respect to heterochromatin in
Tdp2� /� Atm� /� conﬂuency-arrested primary MEFs, by
three-dimensional confocal microscopy (Fig. 3). As expected,
none of the gH2AX foci induced with etoposide colocalized with
highly dense chromocenters and only 15.45% (34 out of 220 foci
scored) were located at less than 0.4 mm (Fig. 3a), which we
considered to be heterochromatin associated. In these same
conditions, a signiﬁcantly higher percentage of the breaks
(B40%) required ATM activity for their repair (Fig. 2a),
indicating that the chromatin status of a TOP2-blocked DSB is
not a major determinant of ATM requirement for repair.
Furthermore, the overall distribution of heterochromatin-
associated foci was not signiﬁcantly changed following 24 h of
repair (Fig. 3b), with 81.92% of unrepaired foci (154 out of 188)
being located within euchromatin (Fig. 3a). We conclude that the
involvement of ATM in the repair of TOP2-blocked DSBs is
largely independent of the reported role of this protein in
facilitating repair at heterochromatin regions.
ATM function on blocked DSBs has consequences for the cell.
The incapacity to properly repair a small number or even a single
DSB can lead to cell death and/or genome rearrangements. It is
therefore conceivable that the DSB-repair defect caused by ATM
loss, although affecting a minor fraction of the lesions, underlies
the profound radiosensitivity and chromosomal instability
observed in A-T patients and cells. We exploited Tdp2� /�
Atm� /� cells to directly address the cellular implications of
ATM-linked DSB-repair deﬁciencies, ﬁrst by monitoring cell
survival in response to etoposide treatment (Fig. 4a). Atm dele-
tion in transformed MEFs had a negligible effect on etoposide
sensitivity in a wild-type (Tdp2þ /þ ) background. In contrast,
sensitivity of Tdp2� /� cells, which was mild at this low etopo-
side doses, was signiﬁcantly increased by ATM loss, correlating
with the observed DSB-repair defect (Fig. 2a). An even larger
effect was observed if ATM inhibition was used instead of dele-
tion (Fig. 4b), conﬁrming the requirement of ATM kinase activity
and ruling out differences being caused by heterogeneity intrinsic
to the MEFs or the cellular transformation process. Furthermore,
the difference observed between deletion and chemical inhibition
suggests a possible negative effect of inactive ATM and is con-
sistent with recently observed enhanced phenotypes of catalyti-
cally dead ATM26,27.
Furthermore, we addressed the impact of ATM loss on
genome integrity following etoposide treatment in Tdp2þ /þ
and Tdp2� /� transformed MEFs. First, we monitored micro-
nuclei formation, which arise from the mis-segregation of
chromosomes or acentric chromosomal fragments, and is a
well-established indicator of genome instability. To restrict our
analysis to micronuclei arising during the cell cycle in which
treatment was applied, cytokinesis was blocked with cytochalasin
B and only binucleated cells were scored (Fig. 5a). Independent
deletion of either Atm or Tdp2 caused an increase in etoposide-
induced micronuclei. Interestingly, however, the levels were
further increased when both genes were simultaneously deleted,
doubling the frequency observed in either single mutant. It is
worth noting that the frequency observed corresponds to
extremely high levels of instability, with many of the cells
displaying multiple micronuclei, a qualitative difference com-
pared with single mutants. To conﬁrm these results, we scored
chromosomal aberrations in metaphase spreads (Fig. 5b). Follow-
ing etoposide treatment, Tdp2� /� Atm� /� cells displayed a
marked increase in the number of chromosomal aberrations
observed. On average, these cells showed a striking 15% aberrant
chromosomes, which represent a 7.5-fold and 3-fold increase
when compared with single Tdp2� /� and Atm� /� mutants,
respectively. A wide variety of aberration types was observed,
including breaks, radial chromosomes and fusions. Overall, these
results demonstrate that ATM-mediated repair promotes cell
survival and the maintenance of genome integrity in response to
blocked DSBs, presenting this particular structure as a possible
molecular trigger of important A-T symptoms. One must bear in
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mind, however, that the cell death and genome instability
phenotypes may not be uniquely caused by the blocked
DSB-repair defect, but by its combination with a defective
checkpoint that allows cell cycle progression in the presence of
DNA lesions.
ATM function on blocked DSBs prevents loss of DNA
sequence. TOP2-blocked DSBs are only one type of many pos-
sible blockages occurring in vivo. We therefore aimed at con-
ﬁrming the involvement of ATM in the repair of blocked DSBs
using a different, TOP2-independent, system in which the
structure of DNA ends could be molecularly controlled. We
started by searching for a 50 modiﬁcation that could block DNA
ends in vitro. We found that a commercially available 50-biotin
modiﬁcation was not removed from duplex oligonucleotides
in vitro by HEK293T cellular extracts, while clear a 50 tyrosyl
DNA phosphodiesterase activity was observed under the same
conditions (Supplementary Fig. 6a,b). We decided to use this
modiﬁcation to block the ends of the pEGFP-Pem1 system, which
uses reconstitution of GFP expression to measure recirculariza-
tion of a linear plasmid following transfection into mammalian
cells28 (Fig. 4a). Using PCR-mediated ampliﬁcation with primers
with different 50 end structure, we were able to generate DNA
substrates that harboured either clean 50-phosphates or blocked
50-biotins at their ends, something that was conﬁrmed by
streptavidin-mediated pull-down (Supplementary Fig. 3c). As
can be seen in Fig. 6b, repair of pEGFP-Pem1 plasmids
containing clean 50-phosphate ends was not signiﬁcantly
affected by incubation of HEK293T cells with an ATM
inhibitor, as measured by either the percentage of GFP-
expressing cells or the total accumulated GFP ﬂuorescence. In
contrast, repair of 50-biotin containing plasmids was signiﬁcantly
decreased by ATM inhibition, regardless of the quantiﬁcation
method used. As an additional control, we found that ATM was
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Figure 3 | Unrepaired TOP2-blocked DSBs are not associated with heterochromatin. Conﬂuency-arrested Atm� /� Tdp2� /� primary MEFs were treated
as described in Fig. 1. (a) Percentage of gH2AX foci that are located within heterochromatin (Het) or euchromatin (Eu) following 0 and 24h repair after
etoposide treatment. A cutoff distance of 0.4mM from the centroid of each focus to the nearest euchromatin/heterochromatin boundary was applied.
Statistical signiﬁcance by Chi Square test is indicated. (b) Distribution of distances between gH2AX foci and heterochromatin as determined above. Bins of
0.4mm centred on the indicated distance were used for representation. (c) Example of the automatic calculation of distances between gH2AX foci (green) and
densely DAPI-stained chromocenters (blue) used for the data shown above. Both a z-stack projection (left) and a 3D reconstitution (right) are shown.
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Figure 4 | ATM promotes survival upon induction of blocked DSBs.
(a) Clonogenic survival of the indicated transformed MEFs following acute
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not required to repair a modiﬁcation such as 50 hydroxyl that
should not result in end blockage due to the existence of cellular
machinery to solve the problem (PNKP) (Supplementary Fig. 6d).
Therefore, by using a molecularly deﬁned system, we conﬁrm that
ATM speciﬁcally facilitates repair of DSBs that are blocked.
The system also allows partial loss of sequence at the repair
junction thanks to the Pem1 intron (see Fig. 6a). Thus, not only
the quantity, but also the quality of repair can be monitored,
something that can provide insights into the mechanisms
involved. For this purpose, a minimum of 46 individual events
for each condition were cloned in bacteria and subjected to
restriction analysis to determine the accuracy of the repair
process (Supplementary Fig. 7). Interestingly, ATM inhibitors
caused a qualitative change in repair of the 50-biotin but not the
50-phosphate substrates, with a marked decrease (from 20% to
5%) in the percentage of repair events not harbouring detectable
loss of sequence (Fig. 6c). However, in the clones showing DNA
loss, the average size of this deleted sequence was unchanged by
ATM inhibition (Fig. 6d). This demonstrates that ATM prevents
excessive sequence loss from DNA ends, which is indicative of its
involvement in blocked DSB end processing.
Discussion
Our study demonstrates that ATM is speciﬁcally required for the
repair of blocked DSBs. With these results in mind, it is tempting
to speculate that the observed existence of two subpopulations of
DSBs, according to their ATM dependency or independency for
repair8, to some extent might be based on the structural
heterogeneity in the ends induced by DNA-damaging agents.
Thus, ATM would not impact in the repair of DSBs with
30-hydroxyl 50-phosphate ligatable ends, or those that can be
converted into these structures by direct unblocking, while it
would greatly facilitate rejoining of DSBs with ends that are
blocked and require processing.
In addition, we observe that the role of ATM in blocked DSB
repair is independent of the chromatin status of the broken DNA,
in apparent contradiction with previous observations of a speciﬁc
role of ATM in the repair of DSBs occurring in hetero-
chromatin24. We understand, however, that blocked end and
heterochromatin models for ATM involvement in DSB repair are
not conﬂicting, and it is therefore possible to unify both
observations if one thinks that ATM is speciﬁcally required in
conditions in which repair is suboptimal, regardless of the
particular molecular reason. Alternatively, it is also possible that
heterochromatin, due to its densely packed structure, is more
prone to suffer blocked damage, such as clustered DNA lesions
and/or DNA-protein crosslinks, than more open regions. It is
worth noting that progressive cerebellar ataxia, which is perhaps
the most enigmatic (and also debilitating) symptom of A-T, could
hardly be explained based on a heterochromatin hypothesis, since
the clearest target population in the cerebellum, Purkinje cells,
possess a mostly euchromatic nucleus29. Our ﬁndings change this
picture, as blocked DSBs could also occur in Purkinje cells, and
could therefore potentially contribute to this aspect of pathology.
We would like to clarify that TOP2-mediated DSBs, although
successfully used as a tool in this study, may constitute only
one particular type of many possible physiological blockages
requiring ATM in vivo, and which could, altogether, contribute
to A-T pathogenesis. In this sense, ATM has already been
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directly implicated in two examples of blocked DSB repair
with consequences for A-T symptomatology. First, during
V(D)J recombination induced by the RAG endonucleases,
ATM promotes the stability of coding ends, which are hairpin-
blocked, but not of signal ends, which are clean30. This deﬁcit
likely contributes to immunodeﬁciency and the development
of lymphoid malignancies in A-T31. Second, meiotic
recombination, which involves the repair of DSBs covalently
blocked by the SPO11 protein, is severely compromised in the
absence of ATM and is likely the cause of sterility in A-T10,11.
Our results put forward end blockage as a possible molecular
explanation for the particular sensitivity of these systems to ATM
loss. Finally, it is worth noting that the extreme etoposide
sensitivity of double Tdp2� /� Atm� /� cells opens the door for
the use of TDP2 inhibitors, which are currently under
development, in sporadic ATM-deﬁcient cancers32–34.
We envision mainly two complementary manners in which
ATM can regulate processing of blocked DSBs (Fig. 7). First, it
can promote nucleolytic activity to eliminate the blockage
through the action of nucleases such as the MRN complex, CtIP
and/or Artemis8,35,36, some of which have already been reported
to affect cellular response to etoposide37,38. Second, it can restrict
excessive nucleolytic degradation of DNA ends39. This can
actually operate by a direct inhibitory action on these same
nucleases40 or others such as EXO141, and/or by promoting
modiﬁcations at the DSB, such as for example gH2AX, which can
protect from nucleolytic action42. This dual impact of ATM on
DSB ends, exerted through its wide range of phosphorylation
targets, makes it an ideal candidate to orchestrate blocked DSB
processing, so it is restricted to the minimal resection necessary to
allow rejoining.
In summary, we demonstrate that ATM does indeed function
in DSB repair, but speciﬁcally to limit the potentially detrimental
consequences of blocked DNA ends. If not properly dealt with,
these lesions can impact cell survival and genome integrity, which
can contribute to the development of A-T symptomatology.
Determining the identity of physiologically occurring blockages
and their speciﬁc inﬂuence on pathogenesis should therefore
attract future efforts to unravel the aetiology of this devastating
disease.
Methods
Cells and cell culture. Primary MEFs were isolated from crosses between
Tdp2� /� and Atm� /� mice19,43 at day 13 p.c. and cultured at 37 �C, 5% CO2,
3% O2 in Dubelcco’s Modiﬁed Eagle’s Medium (DMEM) supplemented with
penicillin, streptomycin, 15% FCS and non-essential amino acids. All experiments
were carried out between P1 and P5. MEFs were transformed by retroviral delivery
of T121, a fragment of the SV40 large T antigen that antagonizes the three Rb
family members but not p53 (ref. 19). Transformed MEFs and HEK293T cells
were maintained at 37 �C, 5% CO2 in DMEM supplemented with penicillin,
streptomycin and 10% FCS. A-T (Coriell’s Repository GM05823D) and BJ1
primary ﬁbroblasts were cultured at 37 �C, 5% CO2, in DMEM supplemented
with penicillin, streptomycin and 15% FCS.
Selective labelling of protein-blocked DNA ends. The selective labelling of
protein-blocked DNA ends (SLOPE) assay is a modiﬁcation of selective labelling of
TOP2 cleavage sites (SLOT) protocol20. Cells were treated 30min with 100 mM
etoposide or vehicle (DMSO), and 300 after drug removal (to allow reversal of
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cleavage complexes) genomic DNA was extracted with the Qiagen Blood and
Tissue Kit, which includes proteinase K treatment. Tyrosine residues that remain
covalently linked to DNA were labelled with biotin using EDC and amine-PEG3-
biotin (Thermo Scientiﬁc). DNA was precipitated to eliminate unreacted amine-
PEG3-biotin and resuspended in TE buffer. Five hundred nanograms of DNA were
dotted on a Hybond-Hþ (Amersham Bioscience) membrane and cross-linked with
70,000 mJ cm� 2 UV. The membrane was blocked with Odyssey blocking buffer
(LI-COR Biosciences) with 1% SDS, incubated with IRDye Streptavidin 800CW, 1/
10,000 (LI-COR Biosciences) in the same buffer, washed (three times in TBS-0.1%
Tween20) and allowed to dry. Dots were analysed and quantiﬁed in Odyssey CLx
with ImageStudio Odyssey CLx Software. The results are related to an internal
control of the same labelling protocol performed on plasmid DNA.
Immunoﬂuorescence. Cells were grown on coverslips for 7 days until conﬂuency-
arrested, treated as indicated and ﬁxed 10min in ice-cold methanol or 4% PFA-
PBS. Cells were then permeabilized (2min in PBS-0.2% Triton X-100), blocked
(30min in PBS-5% BSA) and incubated with the required primary antibodies
(1–3 h in PBS-1% BSA). Cells were then washed (three times in PBS-0.1% Tween
20), incubated for 30min with the corresponding AlexaFluor-conjugated secondary
antibodies (1/1,000 dilution in 1% BSA-PBS) and washed again as described above.
Finally, they were counterstained with DAPI (Sigma) and mounted in Vectashield
(Vector Labs). gH2AX foci were manually counted (double-blind) in 40 cells from
each experimental condition. Primary antibodies were used at the indicated dilu-
tion: gH2AX (Millipore, 05-636), 1/1,000; a-Tubulin (Abcam, ab18251), 1/2,000;
Vinculin hVIN-1 (Sigma, V9131) 1/2,000.
TOPIIb cleavage complexes. Conﬂuency arrested primary MEFs were treated 1 h
with 100 mM etoposide or vehicle (DMSO), immediately lysed in 1% Sarkosyl
(Sigma) and processed according to the in vivo complex of enzyme (ICE) assay44.
Samples were centrifuged at 57,000 r.p.m. for 20 h at 25 �C using 3.3ml
13� 33mm polyallomer Optiseal tubes (Beckman Coulter) in a TLN100 rotor
(Beckman Coulter). 2.5 mg of precipitated DNA was transferred onto Hybond ECL
membranes (GE Healthcare) using a Bio-Dot SF Microﬁltration Apparatus
(Biorad). Membranes were blocked 1 h with Odyssey Blocking Buffer (LI-COR
Biosciences), incubated with 1/1,000 anti-TOP2b antibody (Santa Cruz, sc-13059),
in Odyssey Blocking Buffer-0.1% Tween20, washed (three times with TBS-0.1%
Tween20), incubated with 1/15,000 IRDye 800CW Goat anti-Rabbit IgG (LI-COR)
and ﬁnally washed (three times with TBS-0.1%-Tween20 and three times with
TBS). Once the membranes were dry, slots were analysed and quantiﬁed in
Odyssey CLx using ImageStudio Odyssey CLx Software.
TDP2 knockdown. Lentiviral vectors for TDP2 knockdown (pLKO.1-puro-Tdp2-
2; SIGMA, clone TRCN0000003072) and empty control (pLKO.1-puro) were
generated in HEK293T transfected with the packaging vectors pCMVDR8.91 and
pMDG. A-T and BJ1 primary ﬁbroblasts were infected with pLKO.1-puro-Tdp2-2
or pLKO.1-puro lentiviruses in 100mm dishes, incubated for 3 days and then
placed under puromycin selection (1 mgml� 1) for 7 days.
50 activity in vitro. For the preparation of labelled double-stranded 50-phospho-
tyrosyl, 50-phosphobiotin and 50-phosphate substrates, 50- TAT ACT TCT CTT
TCC AGG GCT ATG T-30 oligonucleotides with tyrosine (Midland Certiﬁed
Reagents), biotin (Sigma) or phosphate (Sigma) modiﬁcations at the 50 end were
annealed to 50-AGA CAT AGC CCT GGA AAG AGA AGT ATA-30 (Sigma) and
labelled in the presence of [a-32P]-dCTP, ddTTP and Klenow polymerase. Cell
extracts were prepared by mild sonication in Lysis Buffer (40mM Tris–HCl, pH
7.5, 100mM NaCl, 0.1% Tween-20, 1mM DTT) supplemented with 1mM PMSF
and protease inhibitor cocktail (Sigma) followed by clariﬁcation 10min 16,500 g
4 �C. Protein concentration was measured with Bradford reagent (Sigma).
50 reactions contained 50 nM substrate, 80 mM competitor single-stranded oligo-
nucleotide and the indicated amount of cellular extract in a total volume of 6 ml
Reaction Buffer (50mM Tris–Cl, pH 7.5, 50mM KCl, 1mM MgCl2, 1mM DTT,
100 mgml� 1 BSA). Reactions were stopped by the addition of 3 ml 3� Formamide
Loading Buffer and 5min 95 �C incubation. Samples were resolved by denaturing
polyacrylamide gel electrophoresis and analysed by phosphorimaging in a Fujiﬁlm
FLA5100 device (GE Healthcare).
cH2AX foci in speciﬁc cell cycle stages. Immunoﬂuorescence was performed as
described above with the following modiﬁcations. Fixation was performed 10min at
room temperature in 4% PFA-PBS. Cyclin A staining was used to distinguish G1 and
S/G2 cells. To exclude replicating cells, 5-ethynyl-20-deoxyuridine (EdU, Invitrogen)
was added throughout treatment and repair at a ﬁnal concentration of 10mM. Click
chemistry reaction was performed by incubating (30min r.t.) with 1mM AlexaFluor
647-conjugated azide (Invitrogen) in reaction cocktail (100mM TrisHCl pH 8.5,
1mM CuSO4, 100mM ascorbic acid). gH2AX foci were manually counted (double-
blind) in 40 G1 cells (Cyclin A negative) or 20 G2 cells (Cyclin A positive EdU
negative) from each experimental condition. Antibodies were used at the indicated
dilution: gH2AX (Millipore, 05-636), 1/1,000; Cyclin A (Santa Cruz, sc-751), 1/200.
Western blot. Conﬂuency-arrested primary MEFs were resuspended on ice using
a cell scraper 30min after treatment with the indicated concentration of etoposide.
They were lysed in Laemli buffer and boiled at 96 �C for 5min. Protein con-
centration was measured by Pierce 660 nm Protein Assay with Ionic detergent
compatibility reagent (Thermo Scientiﬁc). Thirty micrograms of sample was run in
NuPAGE Tris-Acetate Mini gels 3–8% (Novex) and transferred to Immobilon-FL
Transfer Membranes (Millipore). Membranes were blocked in Odyssey Blocking
Buffer (LI-COR Biosciences) incubated with primary antibodies in Odyssey
Blocking Buffer-0.1% Tween20 and washed (three times in TBS-0.1% Tween20).
They were then incubated with the corresponding IRDye-conjugated secondary
antibodies in Odyssey Blocking Buffer-0.02% to 0.1% Tween20 and washed (three
times in TBS-0.1% Tween20 and 1� in TBS buffer). Membranes were analyzed in
Odyssey CLx with ImageStudio Odyssey CLx Software. Primary antibodies were
used at the indicated dilution: ATM (Sigma, MAT3-4G10/8), 1/1,000; ATM pS1981
(Cell Signaling, #4526), 1/1,000; p-CHK2 Thr68 (Cell Signaling, #2661), 1/1,000;
p-p53 Ser15 (Cell Signaling, #9284), 1/1,000; p-CHK1 Ser345 (Cell Signaling,
#2341), 1/1,000; a-tubulin (Sigma, T9026), 1/50,000.
Image processing. An in-house MATLAB R2012a-based application was designed
to segment nuclei images. For each nucleus, a series of Z-sections (0.21mm step) were
obtained using a Leica TCS-SP5 confocal microscope with a HCX PL APO 63x/
1.40lBL objective. These series were segmented to obtain the number, position,
intensity and volume values of gH2AX foci and heterochromatin (G and B compo-
nents of the RGB image, respectively). The segmentation from the different sections
was integrated to reconstitute the 3D information of each entire nucleus. Using this
reconstitution, the distance between each focus and the nearest euchromatin/het-
erochromatin boundary in the 3D space was determined.
Clonogenic survival assays. Survival assays were carried out seeding 2,000 cells in
100mm dishes, in duplicate for each experimental condition. After 12 h, cells were
preincubated with 10 mM ATM inhibitor KU55933 (Tocris) or vehicle for 1 h.
The indicated concentration of etoposide was added and cells were incubated for
additional 3 h. Following one wash with PBS, fresh medium was added and cells
were incubated for 10–14 days. Dishes were ﬁxed and stained for colony scoring in
Crystal Violet solution (0.5% Crystal violet in 20% ethanol). The surviving fraction
at each dose was calculated by dividing the average number of visible colonies in
treated versus untreated dishes.
A-T symptomatology
DSBs
Cell death 
Genome
instability 
Degradation
Repair
Processing
ATM
Figure 7 | Model for ATM involvement in blocked DSB repair. ATM promotes processing of blocked DSBs and inhibits excessive degradation.
This promotes efﬁcient and accurate repair, preventing the accumulation of unrepaired DSBs, cell death and genome instability, which can trigger the
development of A-T symptomatology.
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Cytogenetic analysis. Micronuclei were analysed in transformed MEFs previously
seeded onto coverslips. Following treatment, cytochalasin B (Sigma) was added at
4mgml� 1. Twenty-two hours post treatment, cells were ﬁxed and subjected to DAPI
staining as described above. Only binucleated cells were scored, which was conﬁrmed
by visualization of the cytoplasm with Tubulin and Vinculin immunoﬂuorescence
(performed as described above). Chromosomal aberrations were scored in Giemsa-
stained metaphase spreads. Following treatment, recovery in fresh medium was
allowed for 2 h, and demecolcine (Sigma) was added at a ﬁnal concentration of
0.2mgml� 1. Four hours later, cells were collected by trypsinization, subjected to
hypotonic shock for 1 h at 37 �C in 0.3M sodium citrate, and ﬁxed in 3:1 metha-
nol:acetic acid solution. Cells were dropped onto acetic acid-humidiﬁed slides and
stained 20min in Giemsa-modiﬁed (Sigma) solution (5% v/v in H2O).
Validation of pEGF-Pem1 substrates. The structure of 50 DNA ends was analysed
by streptavidin-mediated precipitation. Dynabeads (10 mg) M-270 Streptavidin
magnetic beads (Invitrogen) were prewashed (3� in 5mM Tris–HCl pH 7.5,
0.5mM EDTA in the presence of 1M NaCl) and incubated with 100 ng of puriﬁed
PCR products in the same buffer for 1 h. Beads were then washed 4� in the same
buffer, gradually decreasing NaCl concentration to 0. Finally, DNA was eluted
by 2 h incubation with BglII restriction enzyme (New England Biolabs) in the
recommended buffer. Input, unbound and bound DNA was analysed by agarose
gel electrophoresis.
Plasmid-circularization assays. Substrates were generated by PCR-mediated
ampliﬁcation of plasmid pEGFP-Pem1-Ad228 with primers 50-AAT TCT TCT
CTT TCC AGG GCT AT GT-30 and 50- AAT TCA TCC CCA GAA ATG TAA
CTT G-30 harbouring phosphate or biotin moieties at 50 ends (Sigma). DNA of the
correct size was then gel-puriﬁed and transfected into HEK293T cells, pretreated
for 30min with 10 mM ATM inhibitor KU55933 (Tocris) or vehicle. Sixteen hours
later, cells were analysed by FACS. Individual repair events were cloned in E. coli by
plasmid rescue from transfected cells and analysed by digestion with DraI.
Statistical analysis. In all cases the indicated statistical test was applied using
Prism 5 package (Graphpad).
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Abstract
Anticancer topoisomerase ‘‘poisons’’ exploit the break-and-rejoining mechanism of topoisomerase II (TOP2) to generate
TOP2-linked DNA double-strand breaks (DSBs). This characteristic underlies the clinical efficacy of TOP2 poisons, but is also
implicated in chromosomal translocations and genome instability associated with secondary, treatment-related,
haematological malignancy. Despite this relevance for cancer therapy, the mechanistic aspects governing repair of
TOP2-induced DSBs and the physiological consequences that absent or aberrant repair can have are still poorly understood.
To address these deficits, we employed cells and mice lacking tyrosyl DNA phosphodiesterase 2 (TDP2), an enzyme that
hydrolyses 59-phosphotyrosyl bonds at TOP2-associated DSBs, and studied their response to TOP2 poisons. Our results
demonstrate that TDP2 functions in non-homologous end-joining (NHEJ) and liberates DSB termini that are competent for
ligation. Moreover, we show that the absence of TDP2 in cells impairs not only the capacity to repair TOP2-induced DSBs
but also the accuracy of the process, thus compromising genome integrity. Most importantly, we find this TDP2-dependent
NHEJ mechanism to be physiologically relevant, as Tdp2-deleted mice are sensitive to TOP2-induced damage, displaying
marked lymphoid toxicity, severe intestinal damage, and increased genome instability in the bone marrow. Collectively, our
data reveal TDP2-mediated error-free NHEJ as an efficient and accurate mechanism to repair TOP2-induced DSBs. Given the
widespread use of TOP2 poisons in cancer chemotherapy, this raises the possibility of TDP2 being an important etiological
factor in the response of tumours to this type of agent and in the development of treatment-related malignancy.
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Introduction
The double-stranded helical structure of DNA creates topolog-
ical problems in all processes that involve opening of the double
helix and accessing the genetic information [1,2]. In particular, the
transcription and duplication of DNA and its condensation into
chromosomes generates knots and tangles that need to be resolved
to avoid interference with diverse cellular processes and to ensure
faithful chromosome segregation during mitosis. DNA topoisom-
erases are enzymes that introduce transient breaks in DNA to solve
these topological problems. Type II topoisomerases, such as
topoisomerase II in eukaryotes (TOP2) are essential homodimeric
enzymes that relax, unknot and decatenate DNA molecules by
catalyzing the passage of duplex DNA through a transient DNA
double strand break (DSB) created by the enzyme [3]. Two
isoforms of TOP2, a and b, exist in higher eukaryotes, with
primary roles in replication and chromosome segregation and in
transcription, respectively.
A key intermediate of TOP2 activity is the cleavage complex, in
which each of two topoisomerase subunits is covalently linked to the 59-
terminus of an enzyme-generated DSB via a phosphodiester bond
between the active-site tyrosine and the 59-phosphate. The cleavage
complex is normally a very short-lived intermediate, because the
topoisomerase rapidly re-ligates the DSB once DNA strand passage
through the DSB has occurred. However, under certain circumstances,
such as the presence of nearby DNA lesions, cleavage complexes can
be stabilized resulting in an increased likelihood of collision with RNA
or DNA polymerases [4]. Such collisions can convert cleavage
complexes into potentially clastogenic or lethal DSBs that require
cellular DNA repair pathways for their removal.
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Cleavage complexes are the target of a widely used class of anti-
tumor agents that ‘poison’ topoisomerase activity, thereby
prolonging the half-life of the intermediate and increasing the
possibility of DSB formation [4,5]. Thus, these drugs kill tumor
cells by inducing high levels of TOP2-associated DSBs. Conse-
quently, TOP2 poisons are commonly used antineoplastic drugs in
the treatment of a broad range of tumor types including malignant
lymphomas, sarcomas, leukemias, and lung, ovarian, breast and
testicular cancers [5]. However, similar to other chemotherapeutic
agents, TOP2-targeting drugs are only partially selective for
tumour cells, resulting in unwanted toxicity in normal tissues and
in therapy-associated chromosome translocations and secondary
leukemias [6–14]. Moreover, some breakpoints in such transloca-
tions have actually been correlated with preferential sites of
cleavage by TOP2 [13–17].
A characteristic feature of TOP2-induced DNA breaks is
covalent attachment of the enzyme to 59 ends of the DNA, which
must be removed by cellular end-processing enzymes if DSB
repair is to occur [18]. Until recently, the only known mechanism
for removal TOP2 peptide from DNA 59-termini in mammalian
cells involved excision of the DNA fragment linked to the peptide
using nucleases such as the MRN complex, CtIP or Artemis [19–
21]. Recently, however, we identified a human 59-tyrosyl DNA
phosphodiesterase (59-TDP) that can cleave 59-phosphotyrosyl
bonds and thereby release TOP2 from DSB termini without the
need to also remove DNA sequence [22]. Consequently, this
enzyme, which was previously known as signalling protein and
transcription cofactor TTRAP/EAPII [23,24], is now denoted
tyrosyl DNA phopshodiesterase-2 (TDP2; Human Gene Nome-
clature Organisation). Notably, consistent with its enzyme activity,
TDP2 is required for cellular resistance to the anti-cancer TOP2
poison etoposide, but is not required for cellular resistance to
ionizing radiation or methylmethane sulphonate [22,25]; agents
that induce DNA damage independently of TOP2 activity.
Following DNA end processing, DSBs can be repaired either by
homologous recombination (HR) or by non-homologous end
joining (NHEJ) [26]. However, these pathways utilize fundamen-
tally different mechanisms for rejoining DSBs and consequently
differ in their accuracy. In particular, HR utilizes undamaged
sister chromatids to replace any nucleotides removed from DNA
termini during DNA end processing and consequently is normally
‘error-free’. However, this process is available only during S phase
or G2, when sister chromatids are available. In contrast, NHEJ is a
‘cut-and-splice’ process in which DSB termini are ligated together
following DNA end processing without accurate replacement of
missing nucleotides, and thus is potentially ‘error-prone’.
Here, we employ avian and murine experimental models to
show that TDP2/Tdp2 deletion results in hypersensitivity to a
structurally diverse range of anti-cancer TOP2 poisons. Moreover,
we present genetic, biochemical and cellular evidence for TDP2
functioning in a mechanism of NHEJ that protects genome
integrity in response to TOP2-induced damage. Finally, we show
that this TDP2 dependent pathway also operates in vivo, as, upon
exposure to TOP2 poisons, it is required for normal adult mouse
lymphopoiesis, intestinal mucosa homeostasis and the mainte-
nance of genome stability in the bone marrow. Collectively, our
results suggest that TDP2 defines an error-free mechanism of
NHEJ in mammals, which is specialized in the repair of TOP2-
induced DSBs and reduces both tissue toxicity and genome
instability in response to this particular type of DNA damage.
These findings suggest the possibility of TDP2 being a significant
etiological factor in the clinical tolerance and response to widely
used TOP2 poisons.
Results
TDP2 is required for cellular resistance to clinical TOP2
poisons and is the major 59-TDP activity in the mouse
The discovery of TDP2 as the first 59-TDP activity raised the
possibility of it being an important factor in the clinical response to
TOP2 poisons [22,25]. Indeed, TDP2 deleted avian DT40 cells
are hypersensitive to etoposide [22,25]. To address this question
further, we examined the sensitivity of TDP22/2/2 cells to two
additional, structurally diverse, TOP2 poisons. These drugs,
denoted doxorubicin and amsacrine (m-AMSA), are employed
widely during cancer therapy but in contrast to etoposide, ‘poison’
TOP2 by intercalating into DNA [5]. Nevertheless, similarly to
etoposide, TDP22/2/2 cells displayed significant hypersensitivity
to both doxorubicin and m-AMSA (Figure 1A). Moreover, a
functional TDP2 phosphodiesterase domain was required for
cellular resistance to this type of drug, because expression of wild-
type human TDP2 (hTDP2) rescued the sensitivity of TDP22/2/2
DT40 cells to m-AMSA, whereas hTDP2D262A harbouring an
inactivating mutation in the catalytic active site [5] did not
(Figure 1A). These results show that TDP2 is required for cellular
resistance to a range clinically relevant and structurally diverse
TOP2 poisons, and support our contention that this requirement
reflects the 59-TDP activity of this enzyme.
To determine the impact of TDP2 on TOP2-induced DNA
damage in mammals, and thus its possible relevance to anti-cancer
therapy, we adopted a mouse model in which the first three exons
of Tdp2, plus the 59-UTR, were deleted by Cre-mediated excision
(Figure 1B; see Materials and Methods). Mice homozygous for the
deleted allele (Tdp2flD, from here-on denoted Tdp2D1–3) are viable,
and so far we have not detected any abnormal pathology
(unpublished observations). However, transformed Tdp2D1–3
mouse embryonic fibloblasts (MEFs) were hypersensitive to
etoposide (Figure 1C, left, and Figure S1), but were not
hypersensitive to DNA damage induced independently of TOP2
by c-irradiation (Figure 1C, right).
Author Summary
DNA double-strand breaks (DSBs) are dangerous because
they can lead to cellular death and tissue degeneration if
not repaired, or to genome rearrangements, which are a
common hallmark of cancer, if repaired incorrectly.
Although required for all chromosomal transitions in cells,
transient DNA cleavage by topoisomerase II (TOP2) is a
potential endogenous source of DSBs, which are charac-
teristic in that TOP2 remains covalently bound to the DNA
termini. In addition, numerous chemotherapeutic regimes
rely on compounds that ‘‘poison’’ TOP2 activity, stimulat-
ing the formation of DSBs that target tumour cells.
However, these compounds also affect healthy tissue
and confer undesirable side effects, including the stimu-
lation of genome rearrangements that can trigger
secondary malignancies (mainly acute leukemia). Identify-
ing the factors that participate in the repair of TOP2-
induced DSBs and fully understanding their mechanism of
action are therefore important for the design of chemo-
therapeutic regimes that are more effective and safer. Here
we demonstrate that TDP2, a recently identified protein
that can liberate DSB termini from blocked TOP2, functions
as part of established cellular DSB repair processes and is
required to safeguard genome integrity upon treatment
with TOP2 poisons, both in cells and in mice. These results
can therefore have important implications in cancer
treatment.
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Protein extracts from spleen, thymus, and bone marrow from
wild type mice possess robust 59-TDP activity, but, importantly,
this activity was absent in analogous protein extracts from
Tdp2D1–3 mice, confirming successful inactivation of the enzyme
(Figure 2A). Cell extracts prepared from primary Tdp2D1–3 MEFs
also lacked detectable 59-TDP activity (Figure 2B). This was true
Figure 1. TDP2 promotes survival following TOP2-induced DSBs. A. Clonogenic survival of the indicated DT40 cell line; wild-type, TDP22/2/2
and TDP22/2/2 complemented with human TDP2 (hTDP2) and catalytic-dead human TDP2 (hTDP2 262A) or empty vector (Empty V); following
continuous treatment with the indicated concentrations of doxorubicin (left) or mAMSA (right). Average 6 s.e.m. of at least three independent
experiments and statistical significance at the highest indicated dose when compared to TDP22/2/2 cells by Two-way ANOVA with Bonferroni post-
test is shown. B. Scheme showing the strategy for targeted deletion of the first three exons of Tdp2 in mouse. The wild-type (Tdp2+), conditional
(Tdp2flEx1–3,neo) and deleted (Tdp2flD) alleles are depicted. The EcoRI-EcoRI fragment of Tdp2 was used in the targeting construct. Southern-blot analysis
of PstI-digested DNA from wild-type (+/+), heterozygous (+/flD) and knock-out (flD/flD, from now on denoted Tdp2D1–3) mice, using the indicated
probe (red line), is shown (bottom right). C. Clonogenic survival of wild-type and Tdp2D1–3 transformed MEFs after 3 h acute exposure to the indicated
concentrations of etoposide (left) or the indicated dose of c-irradiation (right). Average 6 s.e.m. of three independent experiments and statistical
significance by Two-way ANOVA test with Bonferroni post-test is shown. In all figures (*P#0.05; **P#0.01; ***P#0.005).
doi:10.1371/journal.pgen.1003226.g001
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not only for blunt-ended DSB substrates, but also for DSB
substrates harbouring a 4-bp 59-overhang (Figure 2C), character-
istic of TOP2-induced DSBs. Additionally, EDTA-mediated
chelation of Mg2+, which is essential for TDP2 function,
completely eliminates 59-TDP activity in wild type MEF extracts.
These observations are significant because the related enzyme
TDP1, whose activity is Mg2+ independent, was recently reported
to possess weak activity on this type of substrate [27]. Our data
therefore suggest that TDP2 is the primary, if not only, source of
59-TDP activity in MEF extracts (Figure 2C).
TDP2 creates ligatable DSBs and functions in NHEJ
Based on the mechanism of TOP2 cleavage, we anticipated that
TDP2 activity would reconstitute ‘clean’ DSBs (59 phosphate and
39 hydroxyl termini) with 4-bp overhangs, which would be an ideal
substrate for ligation by NHEJ. Interestingly, these ligation events
would accurately preserve the DNA sequence, suggesting the
possibility of an error-free NHEJ mechanism that specifically acts
on TOP2-induced DSBs. To test this hypothesis, we examined
whether TDP2 action at DSBs typical of those induced by TOP2
creates termini that can be ligated by T4 DNA ligase. Indeed,
inclusion of T4 DNA ligase in reactions containing wild type MEF
extract resulted in the additional appearance of a product of 46-nt,
indicative of the completion of DSB repair by DNA ligation.
However, this product was not observed if reactions contained cell
extract from Tdp2D1–3 MEFs, confirming that DNA ligation was
dependent on TDP2 activity (Figure 2D). Interestingly, the length
of the product is consistent with a ligation event in which DNA
sequence is preserved. To analyse ligation events directly catalysed
by cell extracts, we generated linear plasmids harbouring 59
phosphate or 59 phosphotyrosine ends by PCR amplification with
the corresponding modified primers. The incubation of these
substrates with NHEJ-competent nuclear extracts [28] results in
plasmid circularization events that can be scored as colonies
following bacterial transformation. As can be seen in Figure 2E,
nuclear extracts from Tdp2D1–3 MEFs efficiently circularized linear
plasmids with 59 phosphate ends but not linear plasmids
harbouring 59-phosphotyrosine. This difference was lost upon
addition of recombinant TDP2 to the reaction, confirming the
TDP2–dependent nature of the repair reaction. Collectively, our
data suggest that TDP2 activity facilitates NHEJ of 59 tyrosine-
blocked ends by generating DSBs with ligatable termini, consistent
with our hypothesis that this enzyme can support error-free NHEJ
of TOP2-induced DNA damage.
To genetically test whether TDP2 functions indeed during
NHEJ, we generated TDP22/2/2 DT40 cells harboring a targeted
deletion of Ku70, a core component of the NHEJ pathway (Figure
S2). Whilst both TDP22/2/2 and KU702/2 cells were hypersen-
sitive to etoposide, cells in which both genes were deleted
(TDP22/2/2/KU702/2) were no more hypersensitive than cells
in which Ku70 alone was deleted (Figure 3A). In contrast to this
epistatic relationship with a core NHEJ factor, transient knock-
down of TDP2 further enhances etoposide sensitivity of HR
defective (BRCA2 mutated) human fibroblasts (Figure 3B). Based
on these genetic relationships, we conclude that TDP2 functions in
a NHEJ-mediated and HR-independent pathway for the repair of
TOP2-induced DSBs.
To further assign a role for TDP2 in the NHEJ pathway for DSB
repair, we measured DSB repair rates in primary Tdp2D1–3 MEFs by
immunodetection of cH2AX, a phosphorylated derivative of histone
H2AX that arises at sites of chromosomal DSBs [29]. We measured
DSB repair in specific phases of the cell cycle, because whilst NHEJ is
operative throughout, HR-mediatedDSB repair is operative only in S/
G2 [30]. Notably, DSB repair rates were markedly reduced in
Figure 2. Deletion of Tdp2 in mouse abolishes 59-TDP activity and ligation of 59 phosphotyrosine-blocked ends. A. Duplex substrate
harbouring a 59phosphotyrosine blunt end (left) was incubated with 9 mg Tdp2+/+ or Tdp2D1–3 tissue extract from bone marrow (BM), thymus and
spleen for 1 h. B. Substrate in ‘‘A’’ was incubated with 1.5 mg of cellular extract from Tdp2+/+ or Tdp2D1–3 primary MEFs for the indicated time. C.
Duplex substrate harbouring a 59phosphotyrosine self-complementary overhang end (left) was incubated with 10 mg cellular extract from Tdp2+/+ or
Tdp2D1–3 transformed MEFs for 2 h in the presence or absence of 50 mM EDTA. D. Self-ligation of 59 phosphate (P) and 59 phosphotyrosine (Y–P)
overhang substrates as depicted in ‘‘C’’ incubated for 1.5 h with 3.3 mg cellular extract from Tdp2+/+ or Tdp2D1–3 transformed MEFs in the presence of
T4 DNA ligase. In all cases migration of the 59 phosphotyrosine substrate (Y–P), 59 phosphate (P) and ligation (lig) products are indicated. E.
Circularization efficiency of a linear plasmid with 59 phosphotyrosine (Y–P) and 59 phosphate (P) catalysed by Tdp2D1–3 transformed MEFs extracts in
the presence and absence of recombinant human TDP2 (hTDP2). Reaction products were transformed into E. coli and the number of transformants
obtained per mg of initial substrate DNA (average 6 s.e.m. of three independent experiments) is shown. Statistical significance by Two-way ANOVA
test with Bonferroni post-test is indicated is shown.
doi:10.1371/journal.pgen.1003226.g002
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Tdp2D1–3 MEFs following etoposide treatment, both in G0/G1
(Figure 3C) and G2 (Figure 3D), consistent with TDP2 functioning,
as NHEJ, independently of cell cycle. These results were not specific to
murine cells, since similar results were observed in TDP2-depleted
human A549 cells (Figure S4). In contrast to treatment with etoposide,
the rate of DSB repair was normal in Tdp2D1–3 MEFs following c-
irradiation, consistent with a role for TDP2 specifically at TOP2-
induced DSBs (Figure 3E). Collectively, these data demonstrate that
TDP2 is required in mammalian cells for rapid repair of TOP2-
induced DSBs by NHEJ, and for cellular resistance to these lesions.
Figure 3. TDP2 promotes repair of TOP2-induced DSBs by NHEJ. A. Clonogenic survival of wild-type, TDP22/2/2, KU702/2 and TDP22/2/2
KU702/2 DT40 cells following continuous treatment with the indicated concentrations of etoposide. Average 6 s.e.m. of at least three independent
experiments and statistical significance at the highest indicated dose by Two-way ANOVA with Bonferroni post-test is shown. B. Clonogenic survival
of wild-type and BRCA2-mutant human transformed fibroblasts with (Tdp2si) and without (control) TDP2 depletion following 3 h acute exposure to
the indicated concentrations of etoposide. Western blot analysis of TDP2 levels in wild type and BRCA2-mutant cell extracts after 48 h of transfection
is indicated (inset). Other details as in ‘‘A’’. C. cH2AX foci induction after 30 min 20 mM etoposide treatment and repair at different times following
drug removal in confluency arrested Tdp2+/+ and Tdp2D1–3 primary MEFs. Representative images of the 3 h repair time point including DAPI
counterstain (right) and average 6 s.e.m. of at least three independent experiments (left) are shown. Statistical significance by Two-way ANOVA test
with Bonferroni post-test is indicated. D. G2 primary MEFs (see Matherials and Methods) following 30 min 10 mM etoposide treatment. Other details
as in ‘‘C’’. E. Confluency arrested primary MEFs exposed to 2Gy c-irradiation. Other details as in ‘‘C’’.
doi:10.1371/journal.pgen.1003226.g003
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TDP2 promotes genome stability following TOP2-
induced DNA damage
We hypothesized that this TDP2-mediated error-free NHEJ
mechanism would be important to maintain genome integrity
upon exposure to TOP2 poisons. To address this possibility, we
quantified the frequency of micronuclei (MN), nucleoplasmic
bridges (NB), and chromosomal aberrations following etoposide
treatment. These events constitute well-established indicators of
genome instability caused by misrepair of DSBs in which acentric,
dicentric and aberrant chromosomes or chromosome fragments
can be formed. As expected, etoposide increased the number of
micronuclei and nucleoplasmic bridges in both transformed
Tdp2+/+ and Tdp2D1–3 MEFs, but this increase was significantly
higher (up to three-fold) in Tdp2D1–3 cells (Figure 4A). Primary
Tdp2D1–3 MEFs at low passage (P3–4) similarly displayed elevated
levels of micronuclei and nucleoplasmic bridges following etopo-
side treatment, compared to wild type primary MEFs (Figure 4B),
although in the case of nucleoplasmic bridges the low number of
cells displaying these structures prevented the difference from
reaching statistical significance.
An additional indicator of genome instability is elevated
frequencies of chromosome aberrations. Consequently, we quan-
tified the frequency of chromosome breaks and exchanges in
metaphase spreads of transformed Tdp2+/+ and Tdp2D1–3 MEFs.
In agreement with the increased cell cycle arrest of TDP22/2/2
DT40 cells in G2 following etoposide treatment [25], we noted an
etoposide-dependent reduction in metaphase cells that was
particularly severe in Tdp2D1–3 MEFs (unpublished observations).
However, of those metaphases observed and scored, both
chromosome exchanges and breaks were significantly higher (2
to 5-fold) in Tdp2D1–3 MEFs than in Tdp2+/+ MEFs (Figure 4C). A
similar increase in these events in Tdp2D1–3 MEFs, compared to
wild type cells, was observed if low-passage primary MEFs were
employed, ruling out the possibility that the elevated genome
instability in Tdp2D1–3 MEFs was an artefact of cellular transfor-
mation (Figure 4D). In the latter case, etoposide treatment almost
ablated the appearance of mitotic cells in populations of both wild
type and Tdp2D1–3 MEFs, necessitating the use of caffeine to
prevent G2 arrest. Taken together these results demonstrate that
loss of TDP2 results in increased genome instability following
TOP2-induced DNA strand breakage.
Loss of TDP2 results in elevated homologous
recombination
The above results demonstrate increased genome instability in
Tdp2D1–3 MEFs, consistent with a role for TDP2 in error-free
NHEJ-mediated repair of TOP2-induced DSBs. In this scenario,
we considered the possibility that loss of TDP2 might also result in
channelling of DSB repair towards HR. To address this question,
we analyzed the formation of RAD51 foci, a well-established
indicator of repair by HR. Following treatment with etoposide, the
average number of Rad51 foci per cell was ,3-fold higher in
Tdp2D1–3 than in wild-type MEFs (Figure 5A), in agreement with
an increase in the use of HR to repair TOP2-induced DSBs when
TDP2 is not present. Furthermore, we compared the frequency of
etoposide-induced sister chromatid exchanges (SCEs), a molecular
hallmark of HR [31], in wild type and Tdp2D1–3 MEFs (Figure 5B).
Notably, SCE levels increased substantially in transformed MEFs
following acute etoposide exposure, being significantly higher in
Tdp2D1–3 cells at two etoposide concentrations tested (1 and
2.5 mM). These data confirm that, upon etoposide treatment, the
frequency of HR is elevated in Tdp2D1–3 MEFs, consistent with
TDP2 functioning in NHEJ.
Elevated hypersensitivity to TOP2-induced DNA damage
in Tdp2D1–3 mice
To address the relevance of TDP2-mediated repair of TOP2-
induced DSBs in vivo, we compared the impact of etoposide on
adult (8 wk) wild type and Tdp2D1–3 mice. A single intraperitonal
injection of etoposide (75 mg/kg) caused a decrease in body
weight in the initial 4 days post-treatment both in wild type and
Tdp2D1–3 animals (Figure 6A). However, whereas Tdp2+/+ mice
exhibited relatively mild and transient weight loss, Tdp2D1–3
littermates lost weight progressively and were sacrificed at day 6 to
prevent suffering. No differences in body weight were observed
between mock-treated (with DMSO) wild type and Tdp2D1–3 mice.
Histopathological analysis of Tdp2D1–3 mice sacrificed 6 days after
etoposide treatment revealed marked villous atrophy in the small
intestinal mucosa as the likely cause of the drastic weight loss
(Figure 6B). This was not observed in either wild-type and/or
DMSO treated animals (data not shown), suggesting a protective
role for TDP2 against adverse effects of etoposide in vivo.
TOP2-induced DNA damage results in increased
lymphoid toxicity in Tdp2D1–3 mice
In addition to severe intestinal damage, etoposide administra-
tion resulted in elevated splenic and thymic atrophy in Tdp2D1–3
mice, compared to wild type mice (Figure 6C), consistent with the
known hypersensitivity of these organs to this drug [32].
Histological analysis of these tissues revealed a marked reduction
in the cellular content in Tdp2D1–3 animals (Figure 6C, right, note
the low density of dark-stained nuclei). In light of these results, we
analysed B-cell and T-cell maturation in wild type and Tdp2D1–3
mice (Figure 6D and Figure S5). In the case of B-cell precursors in
bone marrow, treatment with etoposide resulted in a decrease of
30–50% in the fraction of cells that were CD43+ B220+
progenitors (Pro-B cells) and a decrease of .95% in the fraction
of cells that were CD432 B220low (Pre-B cells) or CD432 B220high
(immature B cells) precursors. In all cases the reduction in B-cell
precursors was greater in Tdp2D1–3 mice, but the differences were
not statistically significant at the administered dose. In contrast, in
the case of T-cell maturation, whereas etoposide treatment
reduced the fraction of CD4+ CD8+ immature T cells by 30–
40% in wild type mice, these cells were almost completely
eliminated in Tdp2D1–3 mice (Figure 6A, bottom right). No effect
was observed in CD11b/Mac-1+ myeloid cells in the bone marrow
(Figure S6). Taken together, these results suggest that loss of TDP2
increases cellular attrition in the lymphoid system, particularly in
the T-cell lineage, in response to TOP2-induced DNA damage.
Tdp2D1–3 mice display increased TOP2-induced genome
instability in bone marrow
A major side-effect of cancer therapy employing TOP2 poisons
is secondary hematological malignancy, and in particular acute
leukemia, resulting most likely from error prone/erroneous repair
of TOP2-induced DSBs and chromosome translocations [4,7].
Given our findings that TDP2 limits genome rearrangements
induced by etoposide in cells, we examined whether TDP2 also
promotes genome stability in bone marrow in vivo. We quantified
the fraction of micronucleated polychromatic erythrocytes (PCEs)
in bone marrow smears from Tdp2D1–3 and Tdp2+/+ mice 24 hour
after intraperitoneal injection of etoposide (1 mg/kg). The rodent
erythrocyte micronucleus test is a standard procedure to detect
cytogenetic damage in toxicological studies and is based on the
detection of micronuclei in erythrocyte precursors (Hayashi et al
1994). As expected, etoposide increased the fraction of PCEs that
were micronucleated in both wild type and Tdp2D1–3 animals
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Figure 4. The absence of TDP2 increases etoposide-induced genome instability in mammalian cells. A. Micronuclei (MN, left) and
nucleoplasmic bridges (NB, right) in binucleated (following cytochalasin B-mediated cell cycle arrest) Tdp2+/+ and Tdp2D1–3 transformed MEFs
following acute treatment (30 min) with indicated dose of etoposide. See insets for representative images. Histogram bars represent the average 6
s.e.m. of n$600 cells coming from three independent experiments. Statistical significance by Mann-Whitney test. B. Primary MEFs in the absence of
cytochalasin B treatment (n$1500). Other details as in ‘‘A’’. C. Break-type (left) and exchange-type (right) chromosomal aberrations in transformed
Tdp2+/+ and Tdp2D1–3 MEFs following acute treatment (30 min) with indicated dose of etoposide. See insets for a representative image. Plots show
the number of breaks/exchanges per 100 chromosomes from individual metaphase spreads (n = 100) obtained in at least two independent
experiments. Average 6 s.e.m. and statistical significance by Mann-Whitney test is also indicated. D. Metaphase spreads from primary MEFs (n = 50).
Caffeine was added 4 h after etoposide treatment. Other details as in ‘‘C’’.
doi:10.1371/journal.pgen.1003226.g004
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(Figure 7). However, this increase was ,2-fold higher in Tdp2D1–3
mice than in wild type mice, suggesting that TDP2 protects
heamatopoietic cells from genome instability induced by anti-
cancer TOP2 poisons.
Discussion
TDP2 is the major 59-tyrosyl DNA phosphodiesterase in
mammals
In the current study we observe that Tdp2 deletion ablates
detectable 59-TDP activity in different mouse tissues and MEFs,
consistent with our previous observations in DT40 cells [25]. It is
worth noting that other roles have been assigned to this protein, in
other cellular processes such as signal transduction and transcrip-
tional regulation [33]. So far, however, we have been unable to
detect any spontaneous phenotype caused by TDP2 loss, either at
cellular level or in vivo, while dramatic effects are observed upon
etoposide treatment. This suggests that the most important
function of TDP2, following Top2 induced DNA damage at least,
is related to the 59 TDP activity of this enzyme. Additionally, our
data suggest that alternative, TDP2–independent, mechanisms of
DSB repair are sufficient to cope with the endogenous level of
TOP2 damage arising during normal mouse development and life.
A role for human TDP1 in repairing TOP2-induced DSBs was
recently suggested by a weak 59-TDP activity of human
recombinant protein on DSBs possessing 4-bp 59-overhangs, and
on a mild sensitivity of TDP12/2 DT40 cells to etoposide [27].
This is also consistent with the increased resistance to etoposide
reported in cells highly overexpressing TDP1 [34], and with the
reported 59-TDP activity of Tdp1 in Saccharomyces cerevisiae [35].
However, while our standard activity assays employs DSBs with
blunt-ended 59-phosphotyrosyl termini, in the current study we
similarly failed to detect residual 59-TDP activity in Tdp2D1–3 MEF
extracts on DSB substrates with 4-bp 59-overhangs (Figure 2C). In
addition, in our hands, TDP12/2 DT40 cells are not hypersen-
sitive to etoposide, and deletion of TDP1 in TDP22/2/2 DT40
cells does not increase sensitivity to etoposide above that observed
by TDP2 deletion alone [36]. Consequently, we conclude that
TDP2 is the major if not only 59-TDP activity in mammals (as in
DT40 chicken cells), at physiologically relevant enzyme concen-
trations at least.
TDP2 is required for survival and efficient repair upon
induction of TOP2-mediated DSBs in mammals
We have shown that Tdp2-deleted mouse cells are hypersensitive
to TOP2-induced DNA damage, but not to ionizing radiation, in
agreement with previous results with TDP22/2/2 DT40 cells [25].
Moreover, we demonstrate that this hypersensitivity correlates
with a defect in the repair of etoposide-induced DSBs, as measured
by immunostaining for sites of cH2AX, which suggests that
TDP2-mediated repair promotes tolerance to TOP2-induced
DNA damage in mammalian cells. Remarkably, we observed that
TDP2 is required for resistance to TOP2-induced DNA damage
not only at the cellular level, but also at the whole-organism level.
Indeed, etoposide administration in Tdp2D1–3 mice resulted in both
increased mortality due to intestinal damage and in elevated
Figure 5. The absence of TDP2 increases etoposide induced homologous recombination. A. Total number of foci per RAD51 foci-
containing cell in Tdp2+/+ and Tdp2D1–3 primary MEFs following 30 min 10 mM etoposide treatment and 2 h recovery (left). Replicating cells were
excluded from the analysis. A representative image is shown (right). Average 6 s.e.m. from 3 independent experiments and statistical significance by
T test is indicated. B. Sister chromatid exchanges (SCEs) scored in Tdp2+/+ and Tdp2D1–3 transformed MEFs after 30 min acute treatment with the
indicated concentration of etoposide. Plots show the number of SCEs per chromosome from individual metaphase spreads (n$50) obtained in at
least two independent experiments. Average 6 s.e.m. and statistical significance by Mann-Whitney test is also indicated.
doi:10.1371/journal.pgen.1003226.g005
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Figure 6. The absence of TDP2 causes etoposide sensitivity in vivo. A. 8-week old wild-type and Tdp2D1–3 littermates were intraperitoneally
injected with a single 75 mg/kg dose of etoposide or vehicle (DMSO) and body weight was recorded in the following 6 days. Average 6 s.e.m. of the
percentage of initial body weight from at least 8 mice and statistical significance by One-way ANOVA with Bonferroni post-test is shown. B.
Representative image of hematoxylin-eosin stained jejunum slices from wild-type and Tdp2D1–3 animals 6 days after etoposide treatment. C.
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toxicity in lymphoid tissue, established in vivo targets of etoposide
[32]. TDP2 is therefore a critical factor in the cellular and
physiological response to TOP2 poisons.
TDP2 functions in NHEJ and protects genome integrity
One important result of our study was to uncover the
relationship between TDP2 and the major DSB-repair pathways,
NHEJ and HR. We have shown that TDP2 can convert DSBs
with 59-phosphotyrosyl termini into DSBs that are directly
ligatable, and might thus be of particular utility in facilitating an
error-free NHEJ pathway for repair of TOP2-induced DSBs.
Several of our observations support the idea that TDP2 is a
component of NHEJ. First, the contribution of TDP2 to cellular
resistance to TOP2 induced DNA damage is dependent on the
NHEJ machinery and independent on HR, as, with regards to
etoposide sensitivity, KU70 is epistatic over TDP2 deletion in
DT40 cells while an additive effect is observed when TDP2 is
depleted in BRCA2-deficient human fibroblasts. Second, loss of
TDP2 results in a DSB repair defect not only in G2 but also in
G0/G1, cell cycle stages in which NHEJ is the main if not only
DSB repair mechanism available [26,30,37,38]. Third, Tdp2D1–3
MEFs exhibit increased levels of HR-mediated DSB repair, as
measured by elevated frequencies of RAD51 foci and sister
chromatid exchange in response to etoposide treatment, which is a
phenotype observed in other cell lines in which NHEJ is defective
[39–41]. Additionally, we have been unable to generate DT40
cells in which both TDP2 and XRCC3 are deleted, suggesting that
loss of both TDP2 and HR-mediated DSB repair is cell lethal
(unpublished observations).
Whilst the above observations argue strongly that TDP2 is a
component of NHEJ, it is important to note that TDP-
independent NHEJ mechanisms to process TOP2-linked termini
most likely also exist and employ nucleases such as MRN complex,
CtIP or Artemis [5,18–21]. This explains why KU702/2 DT40
cells exhibit much greater hypersensitivity to etoposide than
TDP22/2/2 DT40 cells, and why Tdp2D1–3 MEFs still repair a
significant fraction of etoposide-induced DSBs in G0/G1 (when
NHEJ is the only DSB repair pathway available). Whilst nuclease-
mediated NHEJ can support cell survival in response to TOP2-
induced DNA damage, they most likely do so at the expense of
increased genetic instability. This is because the removal of
sequence from 4-bp complementary 59-overhang during NHEJ
will, on the one hand, likely result in chromosome deletions, and
on the other hand, increase the propensity for DSB misjoining and
chromosome translocation. In contrast, HR provides an error-free
pathway to repair TOP2-induced DSBs that have been processed
by nucleases, by restoring any missing DNA sequence from and
intact sister chromatid in S and G2 [30,37,42]. In this scenario, the
increased etoposide-induced genome instability in Tdp2D1–3 mice,
both in cultured cells from these animals and in bone marrow in
vivo, likely reflects the use of TDP2–independent NHEJ in cellular
contexts in which HR-mediated DSB repair is unavailable (e.g. in
cells in G0/G1), or is saturated by the number of etoposide-
induced DSBs.
In summary, based on these and our previously published data,
we suggest that TDP2 defines a novel error-free NHEJ sub-
pathway that converts TOP2-linked 59-termini into ligatable DNA
termini. We suggest that this may be particularly important during
G1 and in post-mitotic cells, which lack HR-mediated repair, and
thus in which it may be the only mechanism for error-free DSB
repair of TOP2-induced DSBs (Figure 8).
TDP2 and cancer therapy
The results presented here can have important implications in
the treatment of cancer. Given the widespread use of TOP2
poisons in cancer therapy, and the observed hypersensitivity to
TOP2 poisons of cells lacking TDP2, our findings suggest that
TDP2 could affect the response of tumour cells to chemotherapy.
In this context, TDP2 expression is reportedly elevated in the
majority of non-small cell lung cancer cells [43], and mutant-p53-
dependent over-expression of TDP2 has been implicated in
cellular resistance to etoposide in lung cancer cells [44]. TDP2
might therefore be a valid target for overcoming tumour resistance
to TOP2 poisons and/or a useful predictive biomarker for clinical
response to these agents.
In addition, our toxicity assays in mice and the increased
genome instability in cells and in mouse bone marrow correlate
well with known side effects of treatment with TOP2 poisons
during cancer therapy. This raises the possibility that heteroge-
neity in expression levels or activity of TDP2 could be an
Macroscopic (left) and histological (right) representative image of spleen and thymus from wild-type and Tdp2D1–3 animals 6 days after treatment.
Average weight of these organs 6 s.e.m. and statistical significance by Two-way ANOVA with Bonferroni post-test is shown (centre). D. FACS analysis
of B-cells in bone marrow (top and bottom-left) and T-cells in thymus (bottom right) in wild-type and Tdp2D1–3 animals 6 days after treatment. See
insets to compare etoposide treated samples when required. Average percentage of the indicated cell type among the total number of cells in the
corresponding tissue 6 s.e.m. of at least 3 animals and statistical significance by Two-way ANOVA with Bonferroni post-test is shown.
doi:10.1371/journal.pgen.1003226.g006
Figure 7. The absence of TDP2 increases etoposide-induced genome instability in vivo. Percentage of micronucleated polychromatic
erythrocytes (MN-PCE) among the total number of polychromatic erythrocytes (PCE), examples of which are shown (right), in bone marrow smears of
wild-type and Tdp2D1–3 mice 24 h after intraperitoneal injection of 1 mg/kg etoposide or vehicle (10% DMSO). Average 6 s.e.m. of 4 (DMSO) and 6
(VP16) animals and statistical significance by paired T test is shown.
doi:10.1371/journal.pgen.1003226.g007
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important etiological factor both in the toxicity that accompanies
chemotherapy involving TOP2 poisons [45] and on the incidence
of treatment-related hematological malignancy, typically acute
leukemia occurring in a relatively high proportion of patients
[4,7,8]. Like other acute leukemias, therapy-related malignancies
are linked to specific translocations that result in the expression of
fusion proteins and contribute in some way to disease develop-
ment. Intriguingly, in some cases, these translocations map to
regions of preferential TOP2 cleavage, supporting a model in
which the translocations arise via erroneous repair of TOP2-
induced DSBs. These translocations are also surprisingly similar to
those found in infant leukemia [46], suggesting that erroneous
repair of TOP2-induced DSBs may also be a source of primary
malignancy. Consistent with this idea, TOP2-induced DSBs are
implicated in translocations commonly associated with prostate
cancer [47]. In the light of our findings, it is tempting to speculate
that TDP2 activity reduces the likelihood of oncogenic transloca-
tions, by ensuring rapid and accurate repair of TOP2-induced
DSBs. It is possible, however, that TDP2 might occasionally
promote a translocation, by liberating a DSB that engages in
erroneous DNA ligation, as might be the case in some extremely
conservative rearrangements that have been reported [12,13].
Conclusions
We have shown that TDP2 protects mouse cells from the
cytotoxic and clastogenic effects of TOP2 poisons, most likely by
functioning in error-free pathway for NHEJ. These results have
important implications in the treatment of cancer. For example,
development of small molecule inhibitors for TDP2 may provide a
way of sensitizing particular types of tumor to chemotherapy,
though precaution is necessary to consider the possible conse-
quences of TDP2 inhibition on normal cells and on the generation
of secondary malignancies.
Materials and Methods
Ethics statement
All animal procedures were performed in accordance with
European Union legislation and with the approval of the Ethical
Committee for Animal Experimentation of the University of
Leuven and the University of Seville, respectively.
Cells and cell culture
Chicken DT40 B lymphoma cells were cultured at 39uC, 5%
CO2 in RPMI 1640 medium supplemented with 10
25 M b-
mercaptoethanol, penicillin, streptomycin, 10% fetal calf serum
(FCS), and 1% chicken serum (Sigma). TDP22/2/2 cell line was
previously described [25]. To generate KU70 deletion constructs,
Hygromycin (HygroR) or Neomycin (NeoR) resistance cassettes
were inserted between sequences of 1.6 kb and 3.3 kb in length
from the KU70 locus [48]. KU70-HygroR and KU70-NeoR
deletion constructs were sequentially transfected into wild-type
and TDP22/2/2 cells. The gene targeting events were confirmed
by Southern blot analysis of EcoRI -digested genomic DNA
hybridized to an external probe (Figure S1).
Transformed human fibroblast lines 1BR (wild-type) and
HSC62 (BRCA2-mutant) were described previously [49]. Cells
were cultured in DMEM supplemented with penicillin, strepto-
mycin and 15% FCS.
Primary MEFs were isolated from littermate embryos at day 13
p.c. and cultured at 37uC, 5% CO2, 3% O2 in Dubelcco’s
Modified Eagle’s Medium (DMEM) supplemented with penicillin,
streptomycin, 10% FCS and non-essential aminoacids. All
experiments were carried out between P2 and P4. MEFs were
transformed by retroviral delivery of T121, a fragment of the
SV40 large T antigen that antagonizes the three Rb family
members but not p53 [50]. Transformed MEFs were maintained
at 37uC, 5% CO2 in DMEM supplemented with penicillin,
streptomycin and 10% FCS.
Generation of Tdp2 conditional and knockout mice
A targeting construct was generated for Tdp2 in which the first
three exons were flanked by loxP sites, followed by an FRT- and
loxP-flanked neomycin-resistance (neo) cassette. These three exons
encode for the N-terminal half of TDP2 and contain mapped
interaction domains for e.g. TDP2 itself, CD40 and TRAF6 [23].
The Tdp2flEx1–3,neo targeting construct was electroporated in E14
(129Ola) ES cells and correctly recombined ES cell clones were
confirmed by Southern blot analysis. The functionality of the loxP
sites was shown in vitro by electroporation of a correctly targeted
ES cell clone with a Cre-expressing vector. Several correctly
targeted ES cell clones were used for aggregation with CD1
morulae and transferred into pseudo-pregnant recipient females to
Figure 8. Model for the repair of TOP2-induced DSBs. (a) TDP2-mediated cleavage of the 59 phosphodiester link between TOP2 peptide and
DNA results in 39 hydroxyl (OH) 59 phosphste (P) cohesive ends that are easily ligatable by NHEJ resulting in error-free repair. (b) Alternatively,
nucleolytic attack on the DNA backbone can also remove the protein adduct from the DSB but genetic information is lost from the ends. Accurate
repair of this break would therefore need HR to copy the missing information from the sister chromatid, while NHEJ would result in error-prone
repair.
doi:10.1371/journal.pgen.1003226.g008
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obtain chimaeric mice. Three chimaeric males produced hetero-
zygous offspring after breeding with CD1 wild-type females. The
obtained offspring was genotyped with both a loxP-specific and a
neo-specific PCR. Intercrosses between Tdp2flEx1–3,neo/+ mice led to
the generation of homozygous floxed Tdp2 mice which were viable
and fertile. To delete the critical exons we crossed the
heterozygous Tdp2 mice with an EIIa-Cre mouse (Adenovirus
EIIa-promoter driven Cre) and obtained Tdp2flD/+ mice. Inter-
crosses of the latter mice resulted in viable homozygous knockout
mice (from now on denoted Tdp2D1–3) at the normal 25%
Mendelian distribution. Southern blot analysis confirmed the
complete recombination of the loxP-flanked sequences in the
homozygous mice and hence the generation of Tdp2 knockout
mice.
59-TDP activity in vitro
Labelled double-stranded 59-phosphotyrosyl substrates were
generated essentially as previously described [22,22,25]. For 59
overhang substrates 59-Y-P-AATTCTTCTCTTTCCAGGGC-
TATGT-39 (Midland Certified Reagents) and 59-AGACA-
TAGCCCTGGAAAGAGAAG-39 (Sigma) oligonucleotides were
annealed. Cell and tissue extracts were prepared by mild
sonication in Lysis Buffer (40 mM Tris–HCl, pH 7.5, 100 mM
NaCl, 0.1% Tween-20, 1 mM DTT) supplemented with 1 mM
PMSF and protease inhibitor cocktail (Sigma) and clarification by
centrifugation 10 min 16500 g 4uC. Protein concentration was
measured with Bradford reagent (Sigma). 59-TDP reactions
contained 50 nM substrate, 80 mM competitor single-stranded
oligonucleotide and the indicated amount of protein extract in a
total volume of 6 ml Reaction Buffer (50 mM Tris-Cl, pH 7.5,
50 mM KCl, 1 mM MgCl2, 1 mM DTT, 100 mg/ml BSA).
Ligation reactions with oligos contained in addition 5 units of T4
DNA ligase (Fermentas) and 1 mM ATP (Sigma) Reactions were
stopped by the addition of 3 ml 36 Formamide Loading Buffer
and 5 min 95uC incubation. Samples were resolved by denaturing
polyacrylamide gel electrophoresis and analysed by phosphorima-
ging in a Fujifilm FLA5100 device (GE Healthcare).
Plasmid circularization assays
Substrates were generated by PCR-mediated amplification of
plasmid pEGFP-Pem1-Ad2 [51] with primers 59-
AATTCTTCTCTTTCCAGGGCTATGT-39 and 59- AATT-
CATCCCCAGAAATGTAACTTG-39 harbouring phosphate
(Sigma) or phosphotyrosine (Midland Certified Reagents) moieties
at 59 ends. NHEJ-competent nuclear extracts were prepared as
previously described [28]. Reactions were performed by incubat-
ing (6 h at 16uC) 100 ng of each substrate with 7 mg of nuclear
extracts in NHEJ Buffer (50 mM Tris-HCl pH 7.5, 50 mM KCl,
1 mM DTT, 2 mM MgCl2, 1 mM ATP, 100 mg/ml BSA) in the
presence or absence of 50 nM hTDP2 recombinant protein
(purified as previously described [22]). Reactions were stopped by
addition of EDTA (to a final concentration of 100 mM) and
treated 309 with Proteinase K (0.2 mg/ml). DNA was purified
using FavorPrep GEL/PCR Purification Mini Kit (Favorgen) and
transformed into MegaX DH10B T1 Electrocompetent Cells
(Invitrogen). Positive transformants were selected by plating on LB
agar plates containing kanamycin (25 mg/ml).
Clonogenic survival assays
To determine sensitivity in DT40, cells were plated in 5 ml of
medium containing 1.5% (by weight) methylcellulose (Sigma) in 6-
well plates at 50, 500, and 5000 cells/well per treatment condition.
Media also contained the indicated concentration of doxorubicin
(Sigma), mAMSA (Sigma) or etoposide (Sigma). In all experiments,
cells were incubated for 7–11 days and visible colonies were
counted.
Survival assays in MEFs were carried out seeding 2000 cells in
100 mm dishes, in duplicate for each experimental condition.
After 6 hours, cells were irradiated or treated with the indicated
concentrations of etoposide for 3 hours, washed with PBS and
fresh medium was added. Cells were incubated for 10–14 days and
fixed and stained for colony scoring in Crystal violet solution
(0.5% Crystal violet in 20% ethanol). The surviving fraction at
each dose was calculated by dividing the average number of visible
colonies in treated versus untreated dishes.
Human fibroblasts were transfected with non-targeting Negative
Control and TDP2 smartpool siRNAs (Thermo Scientific) using
HyperFect transfection reagent (Invitrogen). Cells were transfected
twice in two consecutive days and used for survival 48 hours after
second transfection. Other details as described above.
Immunofluorescence and antibodies
MEFs grown on coverslips for the required time, 7 days for
confluency-arrested cells and 2 days for cycling cells, were treated
as indicated and fixed (10 min in PBS-4% paraformaldehyde),
permeabilized (2 min in PBS-0.2% Triton X-100), blocked
(30 min in PBS-5% BSA) and incubated with the required
primary antibodies (1–3 h in PBS-1% BSA). Cells were then
washed (365 min in PBS-0.1% Tween 20), incubated for 30 min
with the corresponding AlexaFluor-conjugated secondary anti-
bodies (1/1000 dilution in 1% BSA-PBS) and washed again as
described above. Finally, they were counterstained with DAPI
(Sigma) and mounted in Vectashield (Vector Labs). Rad51 foci
scoring requires 30 sec. pre-extraction in PBS-0.1% Triton X-100
prior to fixation. cH2AX and Rad51 foci were manually counted
(double-blind) in 40 cells from each experimental condition. When
necessary to identify replicating cells, 5-ethynyl-29-deoxyuridine
(EdU, Invitrogen) was added throughout treatment and repair at a
final concentration of 10 mM. Click chemistry reaction was
performed before DAPI staining by incubating (30 min r.t.) with
1 mM AlexaFluor-conjugated azide (Invitrogen) in reaction cock-
tail (100 mM TrisHCl pH 8.5, 1 mM CuSO4, 100 mM ascorbic
acid). For the analysis of G0/G1 confluency-arrested cells only
Cyclin A negative cells were scored. For G2, as EdU was present
(10 mM) during and after treatment, only Cyclin A positive cells
without EdU incorporation were scored (see Figure S3). Primary
antibodies were used at the indicated dilution: cH2AX (Millipore,
05-636) 1/1000, Cyclin A (Santa Cruz, sc-751) 1/500, Rad51
(Abcam, ab213) 1/200 and Tubulin (Santa Cruz, sc-5286) 1/
2500.
Cytogenetic analysis
Micronuclei and nucleoplasmic bridges were analysed in
transformed and low passage primary MEFs previously seeded
onto coverslips. Following treatment, cytochalasin B (Sigma) was
added at 4 mg/ml to transformed but not to primary MEFs. 22 h
(transformed) or 30 h (primary) post-treatment, cells were fixed
and subject to DAPI staining as described above. In transformed
cells only binucleated cells were scored, which was confirmed by
visualization of the cytoplasm with anti Tubulin immunofluores-
cence (performed as described above).
Chromosomal aberrations were scored in Giemsa stained
metaphase spreads. Following treatment, recovery in fresh
medium was allowed for 2 h (transformed MEFs) or 4 h (primary
MEFs) and demecolcine (Sigma) was added at a final concentra-
tion of 0.2 mg/ml. Caffeine (Sigma) was also added at a final
concentration of 0.1 mg/ml but only to primary cells. 4 h later cells
were collected by trypsinisation, subject to hypotonic shock for
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1 hour at 37uC in 0.3 M sodium citrate and fixed in 3:1
methanol:acetic acid solution. Cells were dropped onto acetic
acid humidified slides and stained 20 minutes in Giemsa-modified
(Sigma) solution (5% v/v in H2O).
For SCEs 10 mM BrdU (Sigma) was added to the medium for
two complete cycles (approximately 48 hours) before collection.
Drug treatment was applied for 30 minutes 6–8 hours before cell
collection. Metaphase spreads were obtained as described above.
Before Giemsa staining, slides were incubated in Hoescht 33258
solution (10 mg/ml) for 20 minutes, exposed to UV light (355 nm)
for 1 hour and washed for 1 hour at 60uC in 206 SCC.
Animal maintenance
The mouse colony was maintained in an outbred 129Ola, CD1
and C57BL/6 background under standard housing conditions, at
2161uC with a photoperiod of 12:12 h (lights on at 8:00). They
were housed in isolated cages with controlled ventilation trough
HEPA-filters and were in flow cabins. Sterile food pellets and
water were available ad libitum. Breeding pairs between heterozy-
gotes (Tdp2+/flD6Tdp2+/flD) were set to obtain wild-type (Tdp2+/+)
and knock-out (Tdp2D1–3) littermates for analysis. Mice were
genotyped with Phire Animal Tissue Direct PCR Kit (Thermo)
following manufacturer instructions and using primers 59-
CCTTCATTACTTCTCGTAGGTTCTGGGTC-39, 59-AC-
CCGCTCTTCACGCTGCTTCC-39 and 59-TACACCGTGC-
CATAATGACCAAC-39. This results in amplification of a 429 bp
fragment from the wild-type allele or 561 bp fragment from the
mutant allele.
In vivo etoposide sensitivity
At 8 weeks of age, Tdp2+/+ and Tdp2D1–3 mice underwent
intraperitoneal injection with 3 ml/g of body weight of either
DMSO (vehicle control) or etoposide at 25 mg/ml in DMSO for a
final dose of 75 mg/kg. Weight and general health status was
monitored daily from the day of injection (inclusive). 6 days post-
treatment mice were sacrificed by cervical dislocation and
dissected for histopathological analysis. Weight of spleen and
thymus was recorded prior to their histological or cell content
analysis. Bone marrow (BM) from femurs and tibias of each mouse
was also obtained.
For histological analysis organs were fixed in 4% paraformal-
dehyde for 2 days, embedded in paraffin, cut in 6 mm slices by
microtome, stained with Hematoxylin-Eosin and visualized under
the microscope. For cell content analysis by FACS, BM and
thymus were homogenized in EDTA Buffer (140 mM NaCL,
1.5 mM KH2PO4, 2.7 mM KCl, 8.1 mM Na2HPO4, 0.6 mM
EDTA). Cells from both tissues were immunolabelled with the
appropriate fluorescently-labelled antibodies according to manu-
facture’s recommendations and analyzed using a FACScalibur
flow cytometer (Becton Dickinson): B220-APC (17-0452), CD43
FITC (11-0431), CD8 APC (17-0081) and CD4 FITC (11-0043)
(eBiosciences); CD11b/Mac-1 PE (550019) (Becton Dickinson).
Data was compiled and analysed using CellQuest software (Becton
Dickinson).
Micronuclei analysis in vivo
At 8 weeks of age, Tdp2+/+ and Tdp2D1–3 mice underwent
intraperitoneal injection with 2.5 ml/g of body weight of either
10% DMSO (vehicle control) or etoposide at 400 mg/ml in 10%
DMSO for a final dose of 1 mg/kg. Mice were sacrificed by
cervical dislocation 24 h after injection and BM from one femur
and tibia was extracted and homogenized in 3 ml FBS. Cellular
content was concentrated in 150 ml FBS by centrifugation and
smears were prepared on glass slides. Following 5 min fixation in
methanol, slides were stained 30 min in Giemsa-modified (Sigma)
solution (5% v/v in 100 mM Tris-HCl pH 6.8) and visualized
under the microscope. 2000 polychromatic erythrocytes (PCE)
were scored for the presence of micronuclei (MN-PCE) in each
slide.
Supporting Information
Figure S1 TDP2 promotes survival following TOP2-induced
DSBs in mammalian cells. Clonogenic survival of wild-type and
Tdp2D1–3 transformed MEFs after continuous exposure to the
indicated concentrations of etoposide. Average 6 s.e.m. of three
independent experiments and statistical significance by Two-way
ANOVA test with Bonferroni post-test is shown.
(TIF)
Figure S2 Targeted deletion of KU70 in DT40 cells. Southern-
blot analysis of EcoRI-digested DNA from wild-type (+/+),
heterozygous (+/2) and knock-out (2/2) DT40 cells in TDP2+/
+/+ and TDP22/2/2 background. A probe hybridizing to a region
of the KU70 locus not contained in the deletion construct was used.
The 5.5-kb (wild-type) and 2.8-kb (deleted) expected bands are
indicated. Note that two clones were selected for further analysis.
(TIF)
Figure S3 Cell cycle dependent induction of DSBs following
etoposide treatment in primary MEFs. DSBs detected as cH2AX
foci (bottom left), Cyclin A content (Cyc A, top right), 5-ethynyl-29-
deoxyuridine incorporation (EdU, bottom right) and DAPI
counterstain (top left) are shown. G1 (Cyc A negative, EdU
negative), S-phase (Cyc A positive, EdU positive) and G2 (Cyc A
positive, EdU positive) nuclei are indicated (arrows).
(TIF)
Figure S4 TDP2 depletion impairs repair of TOP2-induced
DSBs in human A549 cells. A. cH2AX foci induction after 30 min
50 mM etoposide treatment and repair at different times following
drug removal in G1 TDP2-depleted (pS-TDP2) and control non-
depleted (pS) cells. B. G2 cells with 10 mM etoposide treatment.
Other details as in ‘‘A’’. Average 6 s.e.m. of at least three
independent experiments is shown. Statistical significance by Two-
way ANOVA test with Bonferroni post-test is indicated. TDP2
depletion was performed as previously described [22].
(TIF)
Figure S5 The absence of TDP2 sensitizes lymphocyte precur-
sors to etoposide treatment in vivo. FACS analysis of B-cells in bone
marrow (A) and T-cells in thymus (B) in wild-type and Tdp2D1–3
animals 6 days after treatment with 75 mg/kg etoposide or vehicle
control (DMSO). Pro-B cell (CD43+ B220+), Pre-B cell (CD432
B220low) immature B cell (CD432 B220high) and immature T cell
(CD4+ CD8+) populations are indicated (rectangles).
(TIF)
Figure S6 Myeloid cells are not significantly affected by
etoposide treatment. FACS analysis of Mac1+ myeloid cells in
bone marrow in wild-type and Tdp2D1–3 animals 6 days after
treatment with 75 mg/kg etoposide or vehicle control (DMSO).
Scatter plot (A) and quantification (B) are shown. The mild
increase correlates with the observed decrease in lymphocite
precursors.
(TIF)
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